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ABSTRACT 
 
Introduction: Malnutrition, as defined by the Malnutrition Universal Screening Tool (MUST), Mini-
Nutritional Assessment-Short Form (MNA-SF), Subjective Global Assessment (SGA), Nutritional Risk 
Screening Tool-2002 (NRS-2002), Short Nutritional Assessment Questionnaire (SNAQ), Nutritional 
Risk Indicator (NRI) and Malnutrition Screening Tool (MST), has been associated with adverse 
outcomes in hospitalised patients. Therefore nutritional risk screening is recommended for all 
hospitalised patients to improve the recognition and treatment of malnutrition. However, little is 
known about the use of screening tools in an intensive care unit (ICU) setting. The aim of this study 
was to assess which of these screening tools could best predict clinical outcomes in ICU patients and 
to comment on their feasibility, in order to make suggestions on their applicability for this patient 
population. 
 
Methods: Over an eight month study period all patients (>18years) with a surgical ICU stay of >48 
hours were included. Patients were screened within 48 hours of admission using each of the seven 
screening tools. Clinical outcomes (mortality, APACHE II score, length of stay (LOS), length of 
ventilation (LOV), complications, serum-albumin, white cell count (WCC) and C-reactive protein) 
were recorded until discharge or death. Feasibility and applicability of the screening tools were also 
assessed. 
 
Results: A total of 206 patients (62.6% males) were included. The average age was 49.5 ±17.4 years 
and average LOS was 5.7 ± 5.5 days. Screening was not feasible in 18.3% of patients. The MUST 
classified 18.9% of patients as at risk of malnutrition and 30.1% as malnourished, but was not 
predictive of any clinical outcomes. According to the MNA-SF, 52.2% of patients were at risk of 
malnutrition and 16.5% were malnourished. This was associated with progressively decreasing 
serum-albumin levels (p<0.01) and WCC (p=0.01). The SGA classified 30.6% of patients as 
moderately and 18.4% of patients as severely malnourished and was significantly associated with 
LOS (p=0.03), LOV (p=0.01), mild complications (p=0.04) and serum-albumin (p=0.01). However, 
except for serum-albumin which progressively declined with a poorer nutritional status, the 
moderately malnourished patients showed the worst outcomes and the severely malnourished 
patients the best. According to the NRS-2002, 72.8% of patients were malnourished; and this 
correlated significantly with LOV (p=0.02) and the development of moderate (p=0.04) and total 
(p=0.01) complications. A non-significant but consistent trend for worse results in the malnourished 
group was also seen for the other outcomes studied. The SNAQ classified 35.9% of patients as 
malnourished or at risk thereof. This was associated with lower serum-albumin levels (p=0.04), but 
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also with decreased LOV (p<0.01). The NRI classified 2.3% of patients as mildly malnourished, 21.0% 
as moderately malnourished and 75.0% as severely malnourished and only effectively predicted 
serum-albumin (p<0.01). The MST classified 78.2% of patients as malnourished and this was 
predictive of developing more complications (p<0.01). Almost all of the other variables also showed 
worse outcomes for the malnourished group, but this was not significant.  
 
Conclusion: Screening in an ICU seems to have only moderate feasibility and applicability and limited 
value. Only the NRS-2002 and MST showed potential for predicting clinical outcomes in ICU patients. 
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ABSTRAK 
 
Inleiding: Wanvoeding, soos gedefinineer deur die “Malnutrition Universal Screening Tool” (MUST), 
“Mini-Nutritional Assessment-Short Form” (MNA-SF), “Subjective Global Assessment” (SGA), 
“Nutritional Risk Screening Tool-2002” (NRS-2002), “Short Nutritional Assessment Questionnaire” 
(SNAQ), “Nutritional Risk Indicator” (NRI) en die “Malnutrition Screening Tool” (MST), is al met 
nadelige uitkomste in hospitaal pasiënte geassosieer. Daarom word voedings-risiko-sifting vir alle 
gehospitaliseerde pasiënte aanbeveel om die herkenning en behandeling van wanvoeding te 
verbeter. Daar is egter min bekend oor die gebruik van siftingshulpmiddele in ‘n intensiewe sorg 
eenheid (ISE) omgewing. Die doel van die studie was om te assesseer watter van hierdie 
siftingshulpmiddele kliniese uitkomste in ISE pasiënte die beste kon voorspel en om kommentaar te 
lewer op die uitvoerbaarheid daarvan, om sodoende voorstelle te maak oor die toepaslikheid 
daarvan vir hierdie pasiënt populasie. 
 
Metodes: Alle pasiënte (>18 jaar) met ‘n chirurgiese ISE verblyf van >48 uur gedurende ‘n ag maande 
studieperiode is ingesluit. Pasiënte is binne 48 uur na toelating gesif m.b.v. al sewe 
siftingshulpmiddele. Kliniese uitkomste (mortaliteit, APACHE II telling, lengte van verblyf (LVVer), 
lengte van ventilasie (LVVen), komplikasies, serum-albumien, witseltelling (WST) en C-reaktiewe 
proteïen) is genoteer tot en met ontslag of dood. Uitvoerbaarheid en toepaslikheid van die 
siftingshulpmiddele is ook geassesseer. 
 
Resultate: ‘n Totaal van 206 pasiënte (62.6% manlik) is ingesluit. Die gemiddelde ouderdom was 
49.5 ±17.4 jare en die gemiddelde LVVer was 5.7 ± 5.5 dae. Siftings was onuitvoerbaar in 18.3% van 
die pasiënte. Die MUST het 18.9% van die pasiënte as wanvoeding-risikogevalle geklassifiseer en 
30.1% as wangevoed, maar kon nie enige kliniese uitkomste voorspel nie. Volgens die MNA-SF was 
52.2% van die pasiënte wanvoeding-risikogevalle en 16.5% was wangevoed. Dit was geassosieer met 
progressief dalende serum-albumienvlakke (p<0.01) sowel as WST (p=0.01). Die SGA het 30.6% van 
pasiënte as matig en 18.4% as erg wangevoed geklassifiseer en het ‘n beduidende assosiasie met 
LVVer (p=0.03), LVVen (p=0.01), ligte komplikasies (p=0.04) en serum-albumien (p=0.01) getoon. 
Behalwe vir serum-albumien wat progressief verlaag het met ‘n swakker voedingstatus, het die 
matig wangevoede pasiënte egter die swakste uitkomste getoon en die erg wangevoede pasiënte 
die beste. Volgens die NRS-2002 was 72.8% van die pasiënte wangevoed en dit het ‘n beduidende 
korrelasie met LVVen (p=0.02) en die ontwikkeling van matige (p=0.04) en totale (p=0.01) 
komplikasies gehad. ‘n Nie-beduidende, maar konsekwente neiging vir swakker resultate in die 
wangevoede groep is ook vir die ander studie-uitkomste gesien. Die SNAQ het 35.9% van pasiënte as 
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wangevoed of as risikogevalle daarvoor geklassifiseer. Dit was geassosieer met laer serum-
albumienvlakke (p=0.04), maar ook met ‘n korter LVVen (p<0.01). Die NRI het 2.3% van pasiënte as 
lig, 21.0% as matig en 75.0% as erg wangevoed geklassifiseer en het slegs serum-albumien effektief 
voorspel (p<0.01). Die MST het 78.2% van pasiënte as wangevoed geklassifiseer en dit het die 
ontwikkeling van meer komplikasies (p<0.01) voorspel. Amper al die ander veranderlikes het ook 
swakker uitkomste getoon in die wangevoede groep, maar dit was nie-beduidend. 
 
Gevolgtrekking: Dit blyk of sifting in ‘n ISE slegs matige uitvoerbaarheid en toepaslikheid en 
beperkte waarde het. Slegs die NRS-2002 en die MST het potensiaal gewys om kliniese uitkomste in 
ISE pasiënte te voorspel. 
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CHAPTER 1: REVIEW OF THE LITERATURE 
 
2 
 
1.1 INTRODUCTION 
This study aimed at shedding light on the use of nutritional risk screening tools (NRSTs) in an 
intensive care unit (ICU) setting – a topic that has not received much attention thus far. In the review 
of the literature on this topic, the researcher starts by reviewing the scope of hospital and 
specifically ICU malnutrition. The definition, prevalence, consequences and current recognition of 
hospital malnutrition is presented, to illustrate the critical need for nutritional risk screening. The 
second part of the review focuses on nutritional risk screening and the different screening tools used 
in this study. A brief description of each NRST is provided as well as an overview of its use in clinical 
practice. The goal was to discuss all the information available on the use of NRSTs in critically ill 
patients, but since not much is known on this topic, the review also encompasses the clinical utility 
of NRSTs in the broader hospital environment. Specific reference is made to the link between NRSTs 
and clinical outcomes as well the general feasibility of NRSTs. The review concludes by giving a 
summary of the key arguments that motivated the choice of study topic. 
 
1.2 HOSPITAL MALNUTRITION 
1.2.1 Definition and etiology 
Many organisations and individuals have over many years proposed various definitions for 
malnutrition; nevertheless a universally accepted, gold standard definition is still lacking.1,2 Broadly, 
malnutrition can be described as a nutritional state where there is an imbalance (lack or excess) of 
macro- and/or micronutrients that may cause significant unfavourable effects on body size, 
composition and function as well as clinical outcomes.3 The term malnutrition therefore 
encompasses both under- and overnutrition; in this study it will refer to undernutrition only. 
A variety of causes may give rise to a malnourished nutritional state. In simple terms either a 
decreased intake of nutrients or the complications of disease (or a combination of both) lead to 
malnutrition.4 Hospital malnutrition may therefore occur due to a decreased intake, or poor 
provision of nutrients, and also to the role of disease.3 The link between malnutrition and disease 
has been described as a vicious circle in which the one feeds into the other.5 Disease conditions may 
lead to increased nutritional requirements, malabsorption, decreased utilization of nutrients, 
increased losses through wounds, vomiting or diarrhoea and decreased dietary intake all of which 
may result in mild to severe cases of malnutrition.3,6-8 Malnutrition on the other hand is known to 
weaken the body’s defense mechanisms against disease leading to an aggravated state of disease, 
which in turn can again aggravate the presence of malnutrition.5 
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Disease conditions are also associated with a heightened inflammatory response that may lead to 
the rapid development of malnutrition. In the inflammatory state a change in stress metabolism and 
body composition is brought on by the presence of pro-inflammatory cytokines. These cytokines are 
potent catalysts of increased energy expenditure, hypercatabolism of lean body mass, 
gluconeogenesis, fluid shifts and alterations in acute phase protein synthesis including decreased 
protein synthesis. Furthermore, the inflammatory cytokines suppress appetite which may lead to 
anorexia and a decreased intake of nutrients. The net effect of these changes is a decrease in the 
body’s protein stores, especially a loss of muscle protein.9 
To provide scope for the role that the inflammatory response plays in disease-related malnutrition, 
Soeters et al5 has proposed the following definition for malnutrition: “A subacute or chronic state of 
nutrition in which a combination of varying degrees of over- or undernutrition and inflammatory 
activity have led to a change in body composition and diminished function.” This definition may be 
more accurate for hospital (and especially ICU-related) malnutrition, where inflammation in varying 
degrees is common.  
An international Consensus Guideline Committee put together by the American Society for 
Parenteral and Enteral Nutrition (ASPEN) together with the European Society for Parenteral and 
Enteral Nutrition (ESPEN), has recently proposed that the etiology of malnutrition should be 
integrated into its diagnosis. It recommends that starvation-related malnutrition resulting from pure 
chronic starvation only, should be distinguished from malnutrition related to either injury or disease 
(chronic or acute) since the latter two include the role of inflammation (either mild to moderate 
sustained inflammation or severe acute inflammation) in their diagnosis.6 Given the general 
confusion regarding the exact definition or diagnosis of malnutrition and the current acceptance of 
the role of inflammation in the etiology of disease-related malnutrition, this proposal might be the 
first step towards a universally accepted and standardised approach to defining malnutrition. 
1.2.2 Prevalence 
The prevalence of hospital malnutrition has been documented since the 1970s when Dr. Charles E. 
Butterworth published the landmark paper on this topic titled the “Skeleton in the hospital closet”.10 
Butterworth recognized that hospital malnutrition was a large-scale problem that needed urgent 
attention from the medical community. Twenty years later, in 1994, McWhirter et al. undertook a 
study to reassess the prevalence of hospital malnutrition. They found that at least 40% of patients 
suffered a degree of malnutrition, of whom nearly half were moderate to severely malnourished. 
Also documented was the fact that patients continued to experience weight loss during hospital 
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stay, especially those who were already malnourished upon admission. Sixty-four percent of 
malnourished patients experienced further nutritional deterioration.10 
Today, a large body of literature supports the fact that hospital malnutrition remains a significant 
problem. The prevalence of malnutrition differs according to the specific hospital patient population 
studied and the method used to assess malnutrition.3 As already stated, a gold standard definition 
for malnutrition is still lacking as is a universally accepted assessment method. Therefore, 
determining the exact scope of the problem, without these mechanisms in place, is challenging.11 
Still, even though different definitions and methods are used, there is overwhelming evidence that 
hospital malnutrition is widespread and a serious problem.12 
In general, hospital malnutrition since 1994 has been reported at 20-59%.13-22,22-25 Some hospital 
settings show higher rates of malnutrition than others. For instance, patients undergoing surgical 
procedures have been shown to have high rates of malnutrition.17 Gastrointestinal surgical patients 
especially are at risk with a reported malnutrition prevalence of 57-82%11,23 and a high risk of further 
deterioration.11 
Not a great deal is known about the prevalence of malnutrition in South African hospitals. Studies 
from the 1980s and 1990s indicate that many hospitalised patients present with a body weight 
below 80% of their ideal body weight and low body fat stores, indicated by a triceps skinfold 
thickness of less than 60% of the reference standard. Indexes of muscle stores such as arm-muscle 
circumference or arm-muscle area are have also been reported to be less than ideal in many 
hospitalised patients.26,26-29 One previous study was conducted among medical patients in Tygerberg 
Academic Hospital (TAH)26, the same hospital where the present study was conducted. In the 
previous study, the researcher assessed BMI and other anthropometrical and biochemical indices 
and found that 17% of patients were malnourished, while 77% presented with subclinical 
manifestations of malnutrition. More recently, malnutrition prevalence was reported to affect 40-
60% of patients in another South African hospital, when measured with one of the screening tools 
included in this study.30 It is therefore clear that malnutrition also affects South African hospitalised 
patients. 
The ICU setting is also known as a danger zone for malnutrition. Many patients are already 
nutritionally depleted before admission and this is aggravated by poor oral intake, metabolic stress 
and inflammation.11 Not being able to eat (i.e. requiring enteral or parenteral nutrition) 
compromises immediate nutritional intake and may lead to the development of large energy and 
protein deficits. This is often exacerbated by interrupted feeding periods to allow for various medical 
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or surgical procedures.6,7 Furthermore, critically ill patients are known to experience 
hypermetabolism, hypercatabolism and a heightened inflammatory response, which all play a 
significant part in the development of malnutrition.6,7 
Very few studies have documented the exact prevalence of ICU malnutrition, mostly because it is 
difficult to measure.11 Stratton et al. report on two small-scale studies using anthropometry and 
biochemistry to detect malnutrition that reported respectively a 43% and 100% prevalence of 
malnutrition.11 Three more studies used the subjective global assessment (SGA) method to identify 
malnutrition in ICU patients. In the first of these, 22% of patients were found to be moderately 
malnourished and 7% severely malnourished.31 The second study was conducted in mechanically 
ventilated patients and found that 54% of patients were moderately malnourished and 5% severely 
malnourished.32 Both these studies were relatively small (n=55 and n=57 respectively). The third 
study (n=124) found 26% of medical and surgical ICU patients to be moderately malnourished and 
11% severely malnourished.33 In summary it seems that at least 29% of ICU patients and most likely 
more may be nutritionally at risk. 
1.2.3 Consequences 
Malnutrition, especially malnutrition associated with underlying disease, can affect every system of 
the body and lead to detrimental changes in metabolic, physiologic and psychological function.4 In 
their book on disease related malnutrition, Stratton et al.34 describe in detail the consequences of 
malnutrition as shown in the literature. The following is a summary of the most important and life 
threatening outcomes. 
On a cellular level, it is known that even in the early stages, malnutrition delays wound healing and 
increases the risk of developing pressure ulcers and wound infections. It also leads to diminished 
immunological function which renders the body unable to effectively respond to local or systemic 
infections. Gut-barrier function may also be compromised which increases the risk of bacterial 
translocation, systemic inflammation and sepsis. Malnutrition may also impair thermoregulation and 
can result in hypothermia.34 
On a physiological level, malnutrition leads to depletion of body stores, most detrimental of which is 
diminished muscle mass and function. This affects skeletal, cardiac and respiratory muscles. When 
cardiac muscle mass is diminished it can lead to decreased cardiac output, hypotension, renal 
impairment and eventually circulatory failure. Decreased respiratory muscle mass and function may 
lead to decreased voluntary ventilation and cough pressure which in turn can result in increased 
ventilator dependency and occurrence of chest infections.34 
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Malnutrition even impacts the body on a psychological level, by bringing about higher levels of 
anxiety, depression and cognitive impairment and decreasing the overall quality of life. 
Malnourished patients are often fatigued, apathetic and lack the will to recover.34 
The consequences of malnutrition as described here have serious implications for clinical outcomes 
such as morbidity and mortality. For example it has been shown that the malnourished patient is at 
risk of developing more complications and infections than well-nourished patients.1,4,8,13,24,34 They 
also have a longer length of stay (LOS) in hospital4,8,13,17,19,22,24,34 and greater mortality.8,19,24,34 This 
also holds true for ICU patients in whom malnutrition may be even more common. Malnutrition in 
the ICU has been linked to increased ventilator dependence, deterioration of the gut-barrier 
function, longer LOS, higher Acute Physiological, Age and Chronic Health Evaluation II (APACHE II) 
scores, lower serum-albumin (s-albumin) levels and higher morbidity and mortality.11,33,34 
It is thus clear that the consequences of malnutrition in hospitalised patients can be devastating. 
Importantly, not only patient outcomes are affected: adverse patient outcomes increase the 
pressure on hospital resources such as nursing care and medication, resulting in ballooning health 
care costs associated with treating the malnourished patient.4,8,13,20,21,35 A few studies have looked at 
the financial implications of malnutrition in hospital patients. The British Association for Parenteral 
and Enteral Nutrition (BAPEN) found that in 2003 roughly 10% of its total health care expenditures 
were for the treatment of disease-related malnutrition.36 Other studies also found that health care 
costs were much higher for malnourished patients or those with declining nutritional status than for 
those not at risk of malnutrition.8,37,38 
1.2.4 Recognition and treatment 
Even though the scope and magnitude of hospital malnutrition is known it seems to be a problem 
that is not often recognised or treated. A number of studies have reported low rates of 
documentation of patients’ nutritional status (8, 19, 23 and 60% respectively).17,19,23,25 In 2009, the 
United States Department of Health and Human Services reported that only 3% of hospital 
admissions receive a formal diagnosis of malnutrition.2 That is far off from the estimated prevalence 
malnutrition of 20-59%. 
Likewise, implementation of a nutritional care plan may be carried out for as few as one in every ten 
patients on average.17,23,25 Kondrup et al. also report that less than a third of nutritionally at risk 
patients are monitored during their hospital stay and only a quarter receive sufficient amounts of 
calories and protein.19 Referral of nutritionally at risk patients to a health care worker specialised in 
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nutrition also seems to be poor. A 2011 review found that only 7-36% of at risk patients were 
referred to a dietician.4 
Further proof that malnutrition is not effectively managed is found when looking at the 
deterioration of nutritional status during hospital stay. In one study (n=135), 42% of hospitalised 
patients lost more than 5% of their body weight and 39% of the patients had a decreased dietary 
intake.18 A bigger study (n=750) reported that 31% of nutritionally at risk patients showed additional 
weight loss of which more than half of the patients had weight loss greater than 5% of body 
weight.19. Kyle et al. also found that when measuring nutritional status at admission and during the 
period of hospitalisation, malnutrition grew more prominent during hospital stay.39 
Many reasons are proposed for why malnutrition is not adequately treated; one of these is poor 
awareness of nutritional risk.10,19,23 It is clear that the treatment of malnutrition is ultimately 
dependent on the recognition thereof.4  
If malnutrition is recognised and appropriately treated it may go a long way to improving clinical 
outcomes and reducing health care costs. Elia et al. found that most cases of malnutrition that are 
currently not recognised are in fact treatable and that nutritional support could improve outcomes 
such as LOS, mortality and morbidity.12 Also in the critically ill, randomized controlled trials (RCTs) 
have shown that treatment of malnutrition can improve clinical outcomes.12 
 
1.3 SCREENING FOR NUTRITIONAL RISK 
1.3.1 What is screening for nutritional risk? 
In simple terms, screening is a process that identifies a certain, sometimes not immediately visible, 
condition that may respond to treatment.12 According to ESPEN the purpose of nutritional screening 
is “to predict the probability of a better or worse outcome due to nutritional factors, and whether 
nutritional treatment is likely to influence this”.40 It can therefore be used to identify malnutrition or 
the risk of developing malnutrition and more importantly, identify patients who are likely to benefit 
from treatment. 
Nutritional screening should not be confused with nutritional assessment. Where screening can be 
described as a quick and simple method that can be used by all health care workers and applied to 
all patients,40 assessment is a more comprehensive and time-consuming approach that seeks to 
define nutritional status using a wide range of measures and which requires the skill of a nutrition 
professional to complete.4,40 The American Dietetic Association defines nutritional screening as “the 
process of identifying patients with characteristics commonly associated with nutritional problems 
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who may require comprehensive nutrition assessment.”4 This implies that screening is the first step 
in the nutritional care of a patient and that a positive screen would then identify the need for further 
assessment and treatment. ASPEN supports this stating that screening aims to detect malnutrition or 
risk thereof which would then indicate the need for nutritional assessment.41,42 
1.3.2 Why screen? 
As previously mentioned, malnutrition is a common and serious problem that may affect 20-59% of 
hospitalised patients13-22,22-25 including ICU patients.11,31-33  The problem is worsened by the fact that 
it is often not recognised and therefore not treated.17,19,23 In most cases, however, malnutrition can 
be treated inexpensively, yielding improved patient outcomes.12  
It is therefore suggested that special effort be made to identify hospital malnutrition;12 this is where 
nutritional risk screening plays a crucial role. Nutritional risk screening procedures are designed to 
identify malnutrition or risk of malnutrition, currently or in the patient’s future.40 Routine use of a 
screening procedure may therefore increase the recognition of malnutrition and enable better 
treatment thereof. The evidence also points towards this. A review of intervention studies found 
that nutritional risk screening markedly helped increase the identification of malnutrition, and 
improved clinical outcomes such as LOS and complications when appropriate treatment was used.12 
Thus there is no doubt that screening for nutritional risk is a fundamental step in the management of 
hospital malnutrition. Instead of asking “Why screen?” the question should rather be “How to screen 
for hospital malnutrition?” 
1.3.3 How to screen for nutritional risk 
A universally accepted malnutrition screening method for hospitalised patients does not exist; this is 
most likely due to the lack of a gold standard definition or diagnosis for malnutrition. The literature 
reveals a large variety of different methods with varying degrees of acceptability, feasibility and 
accuracy. A number of guidelines directing nutritional screening have been published by 
international bodies such as ASPEN and ESPEN. Although these guidelines do not indicate a specific 
method, they provide a gauge with which to evaluate the different aspects of screening methods. 
The next section discusses the general agreement on how screening should be conducted and which 
elements could be included in the screening. 
1.3.3.1 The screening procedure 
The screening procedure includes both the actual screening of patients and the effective treatment 
and monitoring of malnourished patients.12 According to ESPEN’s guidelines published in 2003, all 
patients should be screened upon hospital admission. The screening procedure should be simple 
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enough so that any health care worker or admission staff member would be able to complete it and 
rapid enough in order to be practical. Importantly the screening procedure should also be linked to a 
nutritional care plan depending on the outcome of the screening. In cases where a standard 
nutritional care plan is insufficient or where malnutrition is severe, a referral to a dietician for a 
detailed assessment and follow-up may be implied.40 More recently, ASPEN also published clinical 
guidelines on nutrition screening, assessment and intervention. These guidelines are similar to those 
set out by ESPEN, highlighting that all hospitalised patients should be screened and that those with 
nutritional risk be subjected to more detailed assessment and appropriate treatment.2,42 
1.3.3.2 Screening components 
The screening components include the various criteria that are used to diagnose an individual as 
well-nourished or malnourished. Because a universally accepted standardised set of criteria with 
specified cut-off points does not exist, the various screening tools available include different sets of 
criteria and differ with the regards to the specific cut-off points used. 
As part of its screening guidelines, ESPEN has proposed the different categories of criteria that 
screening tools should cover. First the screening tool should assess the current nutritional situation. 
In this instance anthropometrical measurements can be used, of which the simplest may be weight 
and height in order to calculate the body mass index (BMI).40 However, many different BMI cut-offs 
for malnutrition exist (ranging between 17-23.5) which makes the interpretation of malnutrition 
challenging. Most often a BMI of <18.5-20 is used to identify malnutrition.3 ESPEN recommends 
using a BMI of 18.5-20 as an indication of borderline malnutrition and <18.5 as malnutrition. 
Alternatively, the mid-upper arm circumference (MUAC) may be used as an index of current 
nutritional status.40 Although not mentioned by ESPEN, some screening procedures include a 
physical examination which is also a measure of current nutritional status.43 Biochemical measures 
have also been recommended, especially the measurement of inflammatory activity which may be 
associated with decreased fat free mass.1,5 There is however a large amount of controversy 
regarding biochemical measures and nutritional status.44 There is evidence that inflammatory 
markers such as acute phase proteins neither reflect nutritional status accurately nor respond to 
nutritional intervention, or at least in ways that can be accurately measured. However, although 
their relevance in terms of nutritional status may be low, inflammatory markers may still indicate 
the presence of inflammation and risk of poor clinical outcomes.9 Common markers of inflammation 
include s-albumin, pre-albumin, C-reactive protein (CRP), white blood cells and hyperglycaemia.6,8 
Low s-albumin levels for example, have been linked to adverse outcomes such as longer LOS, 
readmissions, more complications and higher mortality. CRP, a positive acute phase protein, may be 
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useful in determining the presence of active disease and predicting poor clinical outcomes.9 
However, other factors such as cost-effectiveness and practicality should also be considered when 
deciding to include inflammatory markers in nutritional screening.44 
The second component of screening should be to assess whether the current condition is stable.40 
Weight-loss history is a good measure of the stability of nutritional status and may reveal 
malnutrition in individuals whose current status stills seems good i.e. obese patients.40 The general 
consensus is that unintentional weight loss of more than 5% over 3-6 months indicates a risk for 
malnutrition and more than 10% over the same period indicates significant malnutrition.3 ESPEN 
recommends using a cut-off of more than 5% over 3 months as an indication of malnutrition.40 
Third, screening should assess if the current condition of a patient is likely to change in the near 
future.40 Assessment of dietary intake can be used to measure this component. If dietary intake is 
below nutritional requirements, then further nutritional depletion is likely.40 Gastrointestinal 
symptoms such as anorexia, nausea, vomiting and diarrhoea may also play a role in decreasing 
intake or depleting the body of nutrients.3,43 
Lastly, screening should take into consideration any disease condition that might progressively 
worsen nutritional status.40 Acute and chronic diseases may increase nutritional requirements as 
well as deplete fat free mass through inflammation and catabolic stress metabolism.1,2 Disease-
related factors play a large role in the development of malnutrition, especially in a hospital setting.40 
In 2012, ASPEN proposed a set of criteria of which at least two should be included to make an 
adequate diagnosis of malnutrition. The criteria include 1) assessing energy intake, 2) assessing 
weight loss, 3) assessing loss of muscle mass, 4) assessing loss of fat mass, 5) assessing fluid 
accumulation that may mask weight loss and 6) assessing grip strength as a measure of functional 
status. They also proposed some cut-off points for these criteria which allow standardisation, as well 
as differentiation between moderate and severe malnutrition. The cut-offs differ between acute 
disease- or injury-related malnutrition and chronic disease-related malnutrition contexts. ASPEN 
discourages the inclusion of a marker of inflammatory status due to its limited ability to reflect 
nutritional status.2 Although these propositions are paving the way to a standardised diagnosis of 
malnutrition, ASPEN is still unclear how these criteria can be incorporated into a screening tool. 
The guidelines presented by ESPEN and ASPEN provide a framework for nutritional screening. 
However there is no consensus on exactly which components to include in a screening procedure or 
which cut-offs to use.12 In a recent Delphi study1 the experts nominated BMI, weight loss history and 
a measure of nutritional intake as most vital in indentifying malnutrition. They were not conclusive 
11 
 
however on the cut-off values that should be used. They also believed that disease severity should 
be included in the definition of malnutrition, but could not decide on how it should be measured.  
It is further likely that different clinical settings could demand different screening methods according 
to the patient population and practical or economic issues.41 A screening procedure that works for 
the general hospitalised patient may not be suitable for use in an ICU setting. ASPEN highlights that 
critically ill patients pose a complex and unique risk for malnutrition and that certain criteria such as 
inability to eat, long periods of nil per os (NPO), interruption of feeding and unintentional weight 
loss should take precedence in diagnosing malnutrition.2 
1.3.4 Screening in an ICU 
There are currently no specific guidelines for nutritional screening in an ICU setting. 
Recommendations for nutritional screening in hospitals rarely distinguish between different clinical 
settings. It is however clear that nutritional screening is recommended for all hospitalised patients, 
which would automatically include critically ill patients.40,42 
Using the currently recommended screening procedures in an ICU setting may present many 
obstacles. ICU patients are mostly bedridden and often comatose or sedated, which can render 
anthropometry and questioning either very difficult or even impossible. Traditional methods for 
measuring nutritional status might thus be inadequate. ICU patients may also present a unique risk 
for disease-related malnutrition due to high levels of metabolic stress and inflammation. Both of 
these clinical conditions are potent aggravators of nutritional depletion2 and some screening 
procedures may not be sensitive enough to detect them. 
Very few studies have focused specifically on the nutritional screening of the critically ill. Whether 
current screening practices are indeed feasible or accurate is still largely unknown. It is however 
known that ICU patients are at high risk of malnutrition and that this may have deleterious effects on 
patient outcomes.11 
Evidently, there is a lack of information on screening for nutritional risk in an ICU setting. This can be 
seen as a critical preventative factor to optimal patient care as malnutrition may remain largely 
unrecognized and therefore undertreated in this patient population. 
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1.4 NUTRITIONAL RISK SCREENING TOOLS 
For the purpose of nutritional screening many nutritional risk screening tools (NRSTs) have been 
developed over the years. These are usually in the form of a questionnaire which differ in the 
procedure followed and the components of screening that they include, but all aim to identify 
patients who are either malnourished or at risk thereof.45 Screening and NRSTs have been a topic of 
extensive study in the last decade. The numerous NRSTs have been studied in different clinical 
settings and in different patient populations. They have been evaluated for validity and reliability as 
well as for practical and economic factors. They have been assessed for their ability to predict 
patient outcomes or even influence patient outcomes by intervening with appropriate treatment. 
However, there is still no consensus on the optimal NRST for hospitalised patients, a fact that is 
ascribed to the lack of a universally accepted definition for malnutrition.5,12,40 
No specific NRST exists or is recommended for use in ICU patients. A few NRST studies have included 
ICU patients in their study samples11,31-33 but on the whole very little information is available about 
using NRSTs in this patient population. 
When studying NRSTs a number of aspects merit attention. First, screening tools have to be valid 
and reliable i.e., be able to accurately detect the presence or absence of malnutrition and be 
reproducible with reasonable agreement between different raters.40,41,45 Of particular interest with 
regard to validity, is a screening tool’s ability to predict clinical outcomes. The screening tool has to 
be able to identify malnourished patients who will benefit from treatment or, if not treated, might 
show worse outcomes than patients who were not classified as malnourished.40 This measure of 
validity might be particularly helpful when a gold standard measure for nutritional status is lacking. 
Screening tools also have to be practical; they should be simple to master, quick to perform and not 
require unnecessary equipment or skill. Cost-effectiveness is also important so that large-scale 
implementation will be possible. Lastly a clear screening methodology has to be specified which 
outlines the target patient population; when, how and by whom screening should be conducted; and 
how the outcome of the screening should be managed.40,41,45 
The following seven NRSTs are most widely recommended for screening hospitalised patients for 
nutritional risk and have proven most valuable in recognizing malnutrition. 
1.4.1 Malnutrition Universal Screening Tool 
1.4.1.1 Development and validation 
The Malnutrition Universal Screening Tool (MUST) was developed and published by the Malnutrition 
Advisory Group of BAPEN in 2003. The grouped aimed to create a NRST that would assess current 
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weight as well as recent or likely weight changes which would reflect upon dietary intake and 
disease conditions. Scientific criteria with evidence-based cut-off points were chosen to form part of 
this screening tool. These components are independently related to clinical outcomes, but together 
they showed the greatest strength for predicting outcomes. The tool also had to be practical to 
implement, valid and reliable, linked to a plan for nutritional care and be applicable to use across all 
health care settings.46 
The content validity of the MUST was assured by including professionals from different health care 
disciplines in the development phase. Face validity was also ensured by including components that 
are relevant to the identification of malnutrition risk.46,47 Concurrent validity with another measure 
of nutritional risk (dietician’s assessment) was excellent.48 
1.4.1.2 Components of the MUST 
The MUST (Figure 1.1) consists of five steps that include guidelines for rescreening and nutritional 
management as a fifth step. The criteria used to screen the patient are: BMI, percentage of weight 
loss in the past 3-6 months and the presence of acute disease with no nutritional intake for longer 
than five days.46 These three criteria are all objective and proven to be effective measures of 
malnutrition.40 The patient will be classified as either low risk, medium risk or high risk for 
malnutrition.46,47 
The MUST also describes alternative measurements that can be used if any of the above three 
screening criteria cannot be performed. If weight and height cannot be measured, clinical judgment 
can be used to determine BMI by assessing whether the patient is wasted or of normal weight for 
height. BMI can also be estimated using MUAC, where a MUAC of <23.5cm will be indicative of a 
BMI <20. Self-reported weight and height may also be used. Other alternative measurements 
include using ulna length, knee height or demi-span length to determine height. If the patient is 
unsure about recent weight changes they may be asked whether their clothes are looser or if their 
dietary intake has been reduced. The patient can also be asked about underlying disease states, 
dysphagia or other disabilities that may have lead to a reduced food intake and weight loss.46 
For critically ill patients it is assumed that most will be at risk of malnutrition and should therefore 
receive an acute disease effect score of 2, which will classify them as at high risk of malnutrition.46 
However it has been reported that classifying patients with acute disease as high risk of malnutrition 
leads to an overestimation of high nutritional risk, whereas moderate nutritional risk is 
underestimated.22,49 Not all ICU patients will have a similar risk of malnutrition and classifying them 
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all as high risk will be a gross overestimation. The MUST also does not provide an option for the 
grading of chronic disease conditions.49 
The MUST provides a nutritional care plan depending on the outcome of the screening. Patients at 
low risk of malnutrition should be rescreened weekly, whereas those with a medium risk should be 
closely monitored for three days to assess dietary intake and, if necessary, action should be taken 
according to protocol. Patients at high risk of malnutrition should be referred for specialised 
nutrition support and monitoring. A detailed plan for nutritional care is stipulated in the MUST 
explanatory booklet.46 
Figure 1.1 (next page) graphically illustrates the MUST process. 
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Figure 1.1 The Malnutrition Universal Screening Tool (MUST)46 
 
1.4.1.3 Clinical studies 
A few studies have proven the MUST’s ability to predict clinical outcomes. In elderly50 as well as 
surgical and medical48 hospitalised patients the MUST significantly predicts mortality. It also predicts 
LOS in these patient populations16,22,48,50 and specifically in oncology patients.51 Velasco et al. found 
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that the MUST can predict the number of complications in surgical and internal medicine patients16 
and Stratton et al. found that the MUST predicts a trend towards discharge to a care facility versus 
discharge to home.48 On the other hand, a 2010 study in a mixed hospital patient population (n=705) 
could not find any predictive validity of the MUST with regard to LOS, mortality and rate of 
complications.49 
The criterion validity of the MUST in comparison to the Subjective Global Assessment (SGA) has been 
explored. The MUST has shown sensitivities of 61–96% which indicates insufficient to excellent 
sensitivity.16,22,52 The worst sensitivity was found in a group of mixed hospitalised patients22 and the 
best sensitivity in oncology patients.52 When Velasco et al. stratified their patient population the 
sensitivity of the MUST was better in internal medicine versus surgical patients and in elderly 
patients versus those younger than 65 years.16 In these studies, the specificity of the MUST ranged 
from fair (76%) to excellent (90%).16,22,52 Compared to the Nutritional Risk Score-2002 (NRS-2002) the 
MUST has shown excellent (97%) sensitivity and fair (77%) specificity. A possible explanation for 
these positive results is that the MUST and NRS-2002 use similar criteria to screen patients i.e. BMI, 
weight loss, severity of disease and food intake.46,53  
The criterion validity of the MUST has also been studied compared to a definition of malnutrition 
based on BMI (<18.5) and percentage of weight loss (>5% in 1 month or >10% in 6 months) in a 
group of mixed hospital patients. Compared to this definition, the MUST showed fair sensitivity 
(73%) and good specificity (82%) when only “high risk of malnutrition” was used as an indication of 
malnutrition. When both “moderate and high risk of malnutrition” was used as an indicator, 
sensitivity improved dramatically to 97% and the specificity fell slightly to 80%.54 
With regard to convergent validity the MUST has been compared to various other screening tools. In 
surgical and medical inpatients the MUST showed moderate to good agreement (κ=0.55-0.61) with 
the Mini Nutritional Assessment - Short Form (MNA-SF) and good agreement (κ=0.70) with the 
Malnutrition Screening Tool (MST).48 It also showed good agreement (κ=0.64-0.78) with the NRS-
2002 in medical and surgical48 and oncology patients51 and moderate agreement (κ=0.52) in mixed 
hospital patients.49 Convergence with the SGA ranged from fair to excellent (κ=0.28-0.8) in various 
patient populations.22,48,49,52 From these studies it can be concluded that the MUST has acceptable 
convergent validity with other NRSTs. 
The reliability of the MUST has been tested among a rage of health care professionals and in 
different patient settings. An excellent reproducibility of κ=0.81-1.00 has generally been found.48,55 
17 
 
The prevalence of malnutrition in hospitals, as assessed by the MUST, ranges from 10-25% at 
moderate risk of malnutrition and 18-41% at high risk of malnutrition.16,22,46,48,50,54,56-59 Some studies 
have only reported the combined prevalence of moderate and high risk of malnutrition ranging from 
28-78%.48,49,51,52 Only one study specifically reports the prevalence of malnutrition defined by the 
MUST in critical care patients. In this study 77% of patients were classified as at “high risk of 
malnutrition”.58 
Only one study has been conducted using the MUST in a South African population. This study did not 
report the prevalence of malnutrition found nor the specific patients included in the study. Poor 
agreement was found between the MUST and the NRS-2002; sensitivity was 59% and specificity 90% 
using the NRS-2002 as a gold standard measure. It is important to note that this study was 
conducted retrospectively and used data collected by final year dietetic students.30 
To the researcher’s best knowledge the MUST has not been studied in an ICU setting specifically. 
Many of the studies implementing the MUST have excluded bedridden, unconscious or oedematous 
patients as well as patients who couldn’t give consent.49,51,52,54 These patient characteristics are 
abundant in an ICU setting and therefore most studies would have excluded the majority of ICU 
patients. This makes it difficult to extrapolate the results for the ICU patient population. 
1.4.1.4 Feasibility and applicability 
According to the developers of the MUST, the tool is applicable for use in all adult patients across all 
health care settings. This would then include all hospitalized adults, even those who are bedridden 
and/or unconscious. They have also reported it as a simple NRST that is user-friendly for a wide 
spectrum of health care workers.47 
Interestingly, ESPEN only recommends the use of the MUST in the community setting.40 According to 
the literature however, the MUST seems to be a valid and reliable NRST to use in most hospital 
patients.16,48,51,52,56,58,59 
The feasibility of using the MUST in all hospital patients can be questioned even though the tool was 
developed to offer alternative measurements when patients cannot be weighed or measured. 
Although one study in elderly patients (where only 56% of patients could be weighed) obtained a 
100% screening rate by successfully using the alternative/surrogate measurements,48 another study, 
also on elderly patients, reported only an 80% successful screening rate.59 The main problem was 
that there was no information available regarding recent weight loss.59 Another study in general 
hospitalised patients reported only 61% of patients were successfully screened using the MUST. In 
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this case the staff responsible for completing the screen struggled to ascertain disease severity. 
Interestingly this study already excluded bedridden, unconscious and demented patients.54 
Hypothetically, similar problems would be experienced in an ICU setting where patients are often 
bedridden and unable to provide the necessary information. Even though surrogate measurements 
can be used to obtain information about current weight,46 determining weight loss history might be 
problematic. As mentioned previously, deciding on disease severity in the ICU setting is also 
controversial. The MUST tool recommends that all ICU patients be assigned a score of two which will 
routinely classify them as “at high risk of malnutrition”,46 whereas it can be argued that not all ICU 
patients are equally critically ill and therefore shouldn’t receive similar MUST classifications. 
The MUST is user-friendly in the sense that it offers a very comprehensive implementation guide 
(The MUST explanatory booklet) to ensure the careful and accurate use of the screening tool.46 This 
booklet serves as a training manual for health care workers and explains in detail each step of the 
screening process. The booklet also provides information on which alternative measurements to use 
in bedridden patients or those who are unsure about recent weight loss.46 Although this booklet 
provides the means for in-depth training it also points toward the fact that this NRST is more 
complex than some of the other quick-and-easy screening tools. It indicates that thorough training is 
needed to ensure that58 health care workers are able to perform the necessary measurements, 
calculations and assessment of disease severity.58 The MUST should therefore be considered a more 
complex screening tool requiring skilled assessors.54 
Two hospitals in Australia have implemented the MUST choosing this specific tool based on its 
“validity, reliability, precision, minimal time commitment, expense, quantitative scoring system and 
ease of use with adult patients”. However, a study exploring the use of the MUST in these hospitals 
found low levels of compliance with the screening protocol. Some of the reasons stated were “not 
enough time” and “not being able to handle the anthropometric measurements”.60 The MUST 
includes the measurement of weight and height or other surrogate measurements should the 
patient be bedridden.46 These measurements take time and add to the complexity of the MUST.54 
Nonetheless, Stratton et al., Velasco et al. and Raslan et al. have all employed the MUST in their 
studies with ease and found that it could be completed in a few minutes.16,48,49 
In a large multinational audit of hospitalized patients (n=21,007) across Europe, it was found that the 
MUST is used least often compared to the NRS-2002 and other national or local tools to screen for 
nutritional risk. The authors however did not explore possible reasons for this finding.14 
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1.4.2 Mini Nutritional Assessment – Short Form 
1.4.2.1 The original Mini Nutritional Assessment 
The original Mini Nutritional Assessment (MNA) is a valid and reliable assessment tool for 
determining the nutritional status of elderly patients (>65 years). It was first published in 1994 and 
has since been extensively studied and validated for clinical use and even called the gold standard 
for geriatric nutritional risk screening.61-63 It has been shown to correlate well with other measures of 
nutritional status and clinical outcomes.64 The MNA is the NRST used most often to assess the 
nutritional status of elderly patients61 and is also recommended by ESPEN for the elderly.40 The MNA 
consists of 18 questions and takes approximately 10-15minutes to complete; it is therefore too 
comprehensive and time-consuming to use for screening purposes. For that reason a shortened 
version of the MNA was also developed;64 this will be discussed in Section 1.4.2.2 below. 
A 2006 literature review62 found that the MNA showed fair to excellent sensitivity in 11 previous 
studies, with only two studies showing sensitivity below 70%. However specificity ranged from 13-
98% with the majority of studies indicating an insufficient specificity below 70%.62 A recent study16 
among internal medicine and surgical hospitalised patients compared the MNA to the SGA. The MNA 
showed excellent sensitivity, but specificity was low at 61%. When the patients were stratified 
according to age and admission department the MNA showed the best sensitivity in elderly (>65 
years) and internal medicine patients.16 The MNA is thus considered to have good criterion validity, 
although it seems to overestimate nutritional risk. 
The literature review also reports that the MNA is associated with adverse hospitalisation outcomes 
such as longer LOS, mortality and discharge to nursing homes.62 Beck et al. however also looked at 
previous studies to assess the efficacy of the MNA to predict adverse outcomes and found that very 
few of the associations reported in the literature have good sensitivity, specificity and predictive 
validity. The associations also did not always reach statistical significance. According to their review, 
mortality is the adverse outcome with the highest sensitivity, but it still lacks specificity.67 More 
recently the MNA has been reported to predict mortality68-71, development of complications16 and 
LOS15,16,49,69,70,72,73 by some authors. On the other hand Cereda et al. reported one study were the 
MNA did not predict mortality74 and another study where only the malnourished MNA category was 
predictive and not the “at risk” category.71 Vischer et al. also found that the MNA was unable to 
predict hospital mortality and LOS as well as discharge to long-term care facility and 4-year 
mortality.75 The authors concluded that the MNA is not sensitive enough to disease-related 
malnutrition and that it struggles to predict outcomes in a hospital setting where acute disease and 
20 
 
comorbidities are abundant.75 It therefore seems that the MNA may lack predictive validity and that 
clinicians are still unsure exactly what a positive screen for malnutrition means in clinical terms.67 
The MNA has been studied using intervention protocols such as supplementation for patients 
classified as malnourished or at risk of malnutrition. Intervention in these cases has resulted in 
improved nutritional status and shortened hospital stay.62 This may provide some evidence of clinical 
benefit when using the MNA to direct nutritional intervention. 
According to the MNA 3-57% of elderly patients in all health care settings are malnourished, and 29–
65% are at risk of being malnourished.15,16,64,68,71,73,74,76-81 Malnutrition in the hospital setting looks 
similar to this.15,16,64,68,71,73,74,76-81 Only one study has looked at the prevalence of malnutrition, using 
the MNA, in Africans. In this study, which only included community-dwelling and institutionalized 
elderly, 5% of the population was malnourished and 50% at risk of malnutrition.82 
The MNA is by far the most widely studied and documented NRST for elderly patients. It can be 
considered the gold standard screening tool for elderly patients63 and its use is recommended by 
ESPEN.40 It should however be noted that the MNA tends to overestimated risk67,83,84 and its 
predictive validity in the hospital setting may be limited.67,71,74,75 
1.4.2.2 Development and validation of the MNA-SF 
The Mini Nutritional Assessment – Short Form was developed using the same patient population 
used to develop the MNA. The study sample consisted of 105 hospitalised elderly patients and 50 
community-dwelling elderly. The questions from the original MNA that 1) best correlated with the 
MNA score, 2) had good sensitivity and specificity compared to physician clinical assessment of 
nutritional status and 3) were internally consistent, were chosen for inclusion. This resulted in a 6-
question version of the MNA. For validation, this version was then further studied in two additional 
patient populations against the full MNA. Each of the 6 questions selected for the Mini Nutritional 
Assessment – Short Form correlated well with the full MNA score and had diagnostic accuracies 
above 72%. It its totality, the Mini Nutritional Assessment – Short Form had 97% sensitivity and a 
perfect specificity for predicting malnutrition as defined by the MNA. It was therefore considered a 
valid screening tool for assessing nutritional status in elderly patients.64 However, the Mini 
Nutritional Assessment – Short Form was only able to determine patients who were “normal” and 
those who were “at risk of malnutrition”; for patients to be identified as “malnourished” the full 
MNA still had to be administered.61,64 This led to a final revision and revalidation of the Mini 
Nutritional Assessment – Short Form by Kaiser et al. in 2009.65 
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The modified version of the Mini Nutritional Assessment – Short Form (hereon referred to as the 
MNA-SF) was developed using the same methodology described above, but included data from 12 
previous studies. Again, six questions emerged as most accurate and predictive with only one of 
them different from the original Mini Nutritional Assessment – Short Form. The increase in 
sensitivity was however marginal (which proves the validity of the original Mini Nutritional 
Assessment – Short Form) and therefore no changes were made in the questions included in the 
new MNA-SF. The researchers explored the use of three cut-off points similar to those used in the 
full MNA that would classify patients as “normal”, “at risk of malnutrition” or “malnourished”. This 
scoring system showed good accuracy (sensitivity and specificity above 80%) compared to the MNA 
and eliminated the need to complete the full questionnaire. Lastly, the researchers investigated the 
use of MUAC and calf circumference as alternative measurements for when weight and height 
cannot be measured. Only calf circumference showed good congruence with BMI and was included 
as an alternative measure.65 
The MNA-SF is thus a stand-alone screening tool to identify the nutritional status of elderly patients. 
It has good criterion validity and accuracy compared to the full MNA.62 
1.4.2.3 Components of the MNA-SF 
The MNA-SF (Figure 1.2) consists of six questions that cover aspects of dietary intake, weight loss (in 
kg), mobility, psychological stress/acute disease, neuropsychological problems and current 
nutritional status (BMI). The fact that it includes indices of functionality makes it more applicable for 
use in elderly patients than most of the other NRSTs.62,63 According to the final screening score the 
patient will be classified as “well nourished”, “at risk of malnutrition” or “malnourished”. The MNA-
SF’s screening score is different from the other NRSTs in that a higher score is associated with a 
better nutritional status and a lower score with a worse nutritional status.65 
With regard to weight loss history, the MNA-SF provides an option for when patients are unsure 
about whether or how much weight they have lost. In these cases the option “does not know” can 
be used and the patient will receive a score of 1 (no weight loss scores 3, 1-3kg weight loss scores 2 
and >3kg weight loss scores 0). The MNA-SF and the MST are the only two screening tools that make 
provision for patients not familiar with their weight history.65,66 The MNA-SF still requires weight and 
height measurements for calculating BMI, which will be problematic in bedridden patients. However, 
calf circumference can be used as an alternative to BMI, as it is much easier to measure in bedridden 
patients and has been shown to be a reliable measure of nutritional status in elderly patients.65 The 
above mentioned characteristics make the MNA-SF a more feasible NRST to complete in hospitalised 
and specifically ICU patients. 
22 
 
 
 
Figure 1.2 The Mini-Nutritional Assessment Short Form (MNA-SF) 
Source:  http://www.mna-elderly.com/mna_forms.html 
 
1.4.2.4 Clinical studies of the MNA-SF 
Apart from the original validation studies, a few other studies have looked at the validity of the 
MNA-SF compared to the full MNA. They have generally found good to excellent sensitivity and 
specificity (>80%) in a variety of health care settings.77,78,82,85 High agreement between the two tools 
has also been reported.77,83 One study found that both the MNA-SF using BMI and the MNA-SF using 
calf circumference could classify 85% and 81% patients respectively into the correct MNA category.83 
A very recent study among hospitalised elderly also found a strong association between the 
classification of patients according to the MNA-SF and the full MNA: 80% to 85% of patients were 
correctly classified as “at risk of malnutrition” or as “malnourished”.75 One study has used the MNA 
and MNA-SF in elderly Africans residing in the community or long-term care institutions. Although 
excellent sensitivity was found the positive predictive value was only 16% with almost 50% of 
patients wrongly classified as “normal”. The authors concluded that the MNA-SF is useful to identify 
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patients who are clearly malnourished, but that it struggles to identify the patients who are at risk.82 
Others have however reported good and even excellent positive predictive values when the MNA-SF 
is used.77,78 The MNA-SF is considered to be a sufficient and stand-alone NRST to use in elderly 
patients.78 
Compared to other screening methods the MNA-SF has also shown good sensitivity but poorer 
specificity. In elderly hospitalised patients the MNA could identify all patients malnourished 
according to BMI and weight loss criteria, but it also overestimated the malnourished group by 
60%.54 A similar trend was found when the MNA was compared to a comprehensive nutritional 
assessment including anthropometric, clinical, dietary and biochemical evaluation in hospitalised 
elderly86 and to biochemical, anthropometric and gastrointestinal assessment of elderly in a sub 
acute facility.87 The MNA-SF, similar to the MNA, seems to overestimate nutritional risk. Although 
high sensitivity is the preferred goal for a NRST, a low specificity has clinical implications in terms of 
time and cost effectiveness.86 It has been suggested that the MNA-SF may not be suitable for the 
hospital setting due to the high rate of false-positive screens.49,54  
The MNA-SF has shown reasonable convergence with other NRSTs such as the MST, NRS-2002, 
MUST and SGA. In elderly hospitalised patients good agreement was found with the MUST 
(κ=0.75).73 In a similar patient group a kappa of 0.23 was found with the NRS-2002 indicating only 
fair agreement.49 In a sample of adult internal medicine and surgical patients, the MNA-SF 
demonstrated fair agreement with the MUST and NRS-2002 and moderate agreement with the 
SGA.16 Better convergence may have been found if only elderly patients were included in the study. 
Reasonable agreement was also found in a study using the NRS-2002 and MST.88 
With regard to predictive validity, the MNA-SF has been associated with post operative infectious- 
and wound complications in surgical patients.88 Interestingly this study was conducted on adult 
patients of all ages and not only elderly patients. In elderly hospitalised patients, Raslan et al. 
showed that the MNA-SF could predict rate of complications, LOS and mortality.49 Two other studies 
also demonstrated associations with adverse outcomes such as readmission to acute care or 
discharge to a long term care facility.70,87 However Vischer et al. found that neither the MNA-SF nor 
the MNA could predict hospital or long-term mortality in elderly patients.75 
The MNA-SF seems to be a reliable NRST. Good to very good agreement has been found when 
nursing staff perform the screening.89 It seems that there is good agreement for the different 
screening questions except for the question on loss of apetite.89 
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In studies using the older version of the MNA-SF 28-73% of patients were classified as a risk of 
malnutrition.49,76-78,84,86,88 This version of the MNA-SF only identified patients as normal or at risk of 
malnutrition. However Vischer et al. used the modified version of the MNA-SF in elderly hospitalised 
patients and found 51% were at risk of malnutrition and 26% were already malnourished.75 In a non-
acute setting Kaiser et al. found that 14% of elderly patients were malnourished and 30% at risk of 
becoming malnourished.83 
Neither the MNA nor the MNA-SF has specifically been studied in ICU patients. 
1.4.2.5 Feasibility and applicability 
The MNA-SF was developed for use by non-specialised staff.62 It seems that nurses are best suited to 
perform the screening as they have shown very good inter-rater reliability.68 
The MNA-SF is applicable to use in elderly patients as the tool was developed and validated 
specifically for patients over 65 years of age.64,65 The tool may possibly also be used in adults of all 
ages.88 The MNA-SF development and validation studies included hospitalised elderly patients and 
therefore it can be considered applicable to use in a hospital setting.64,65 There is however evidence 
that the MNA-SF may overestimate malnutrition by too large a degree which impedes on its clinical 
usefulness in a hospital setting.49,54 
The MNA is easy to use and screening can be done in less than 5 minutes.49,64,78,90 It does however 
require some anthropometrical measurements (height and weight, or calf circumference) and 
calculations which make it slightly more complex than some of the rapid screening tools that only 
entail questions.64,91 To improve the accuracy of screening and increase the ease of use, a training 
guide was developed that provides information on the practical implementation of the MNA and 
MNA-SF. Although training may be more extensive and time consuming, this guide makes the MNA 
more user-friendly and standardised.62 
The feasibility of implementing the MNA-SF in hospitalised elderly can be questioned. Height and 
weight measurements may be difficult in bedridden patients although in these cases it is suggested 
using calf circumference.64 Cognitive impairments such as dementia and delirium are also common 
problems among the hospitalised elderly which may hinder the completion of the MNA-SF 
questions.83 In the literature it is reported that the MNA-SF could be completed in 59-96% of the 
hospital-based study populations.15,54,75 The reasons for the failed screens were not reported but it 
can be surmised that there were difficulties obtaining all the relevant information. 
It is not known how feasible and applicable the MNA-SF is for critically ill patients. As with the other 
NRSTs it is assumed that a high number of bedridden and unconscious or cognitively impaired 
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patients will make it difficult to complete the MNA-SF. Even though surrogate measures such as calf 
circumference may be used, this may not always be feasible due to lower limb oedema. 
1.4.3 Nutritional Risk Screening–2002 
1.4.3.1 Development and validation 
The Nutritional Risk Screening-2002 (NRS-2002) was developed by an ESPEN working group in 2001 
and 2002. Their purpose was to create a screening tool which would measure current nutritional 
status as well as severity of disease state. They argued that disease state and its associated increase 
in requirements could play an important role in the development of malnutrition and therefore 
including this is the screening tool would not only help to recognize malnourished patients but also 
those at risk of becoming malnourished. The authors retrospectively studied controlled trials to 
ascertain which nutritional criteria or attributes are associated with specific outcomes. They felt a 
strong need to develop a tool which was valid in the sense that it could predict clinical outcomes, 
unlike some of the existing NRSTs.53 
Malnutrition was measured using the following variables: BMI, recent weight loss (as percentage of 
body weight) and changes in food intake. These variables are commonly used in NRSTs and have 
shown association with functional and clinical outcomes. Disease states were classified as absent, 
mild, moderate or severe depending on the effect nutritional support had on outcomes in previous 
trials.53 
A comprehensive validation study was also undertaken involving 128 controlled trials where the 
effect of nutritional support on clinical outcomes was measured. Patient groups from the RCTs were 
classified according to the NRS-2002 and then clinical outcomes were studied to see whether the 
screening tool could effectively predict them. After analysis they added an adjustment score for 
elderly patients (≥ 70 years) to their screening tool. Content validity was ensured by involving the 
ESPEN working group in the validation.53  
The reliability of the NRS-2002 has been reported good with a kappa value of 0.67 between a nurse, 
dietician and doctor40 and 0.76 between 28 doctors24. 
1.4.3.2 Components of the NRS-2002 
The NRS-2002 entails two screening phases (Figure 1.3). The initial screening phase consists of four 
simple questions covering BMI, reduced intake, recent weight loss and severity of illness. If the 
answer is “yes” to any of the questions e.g. “Yes, the patient has recently lost weight”, then the 
second phase screening should be done. Patients who answered no to all four questions should be 
rescreened on a weekly basis.53 
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The second phase screening entails scoring the patient on two aspects, namely nutritional status and 
disease state. For nutritional status a score is allocated looking at the variable (BMI, dietary intake or 
recent weight loss) that is the worst off. For example, a BMI <18.5 will take precedence over a 
weight loss of >5% in 2 months (see Figure 1.3 below). For disease state the patient is scored 
according to their illness. If the specific illness is not in the table (see figure), then clinical judgment 
must be used to score the patient. Generally, patients with chronic diseases with one or more 
complications fall into the “mild” category. They are sick, but still able to walk around and their 
nutritional requirements can be met with oral supplementation. Patients who are bedridden due to 
their illness and whose protein requirements are considerably increased so that artificial feeding 
may be necessary, fall into the “moderate” category. Lastly, patients requiring intensive care, 
ventilation, inotropic support and whose protein requirements are increased to a level that is 
difficult to provide, should fall into the “severe” category. For patients 70 years or older, an age 
adjustment score of 1 is also added.53 
A score of equal to or more than 3 is seen as “at risk of malnutrition” with a need for immediate 
nutritional support. The specific nutritional support to be followed is not specified. Patients with 
scores between 0-2 should be rescreened on a weekly basis.53 
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Figure 1.3 The Nutritional Risk Screening–2002 (NRS-2002) form53 
 
1.4.3.3 Clinical studies 
One of the strengths of the NRS-2002 is that it was developed and validated for predictive ability.53 
It’s ability to predict clinical and other outcomes have also been studied further, generally with good 
results.19,92-97 The NRS-2002 has been shown to predict LOS,19,94,96,98 development of moderate and 
severe complications,93 development of post-operative complications,96-99 mortality,93 decreased 
handgrip strength94 and increased hospital costs.95 A large, international, multicenter study of 5,051 
patients also found that patients at risk of malnutrition, as defined by the NRS-2002, developed 
significantly more complications and those with complications had significantly longer LOS in 
hospital. Mortality was also higher in the “at risk” group.24 This study included a small proportion 
(6.1%) of ICU patients. In another ICU patient population, risk of malnutrition as defined by NRS-
2002 was significantly associated with risk of pressure ulcers.100 
A RCT (n=212) used the NRS-2002 to identify patients at risk of malnutrition who were then assigned 
to an intervention or control group. The control group received standard nutritional support, 
whereas the intervention group received more intensive dietary treatment. Patients were followed 
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up for outcomes such as LOS, development of complications and quality of life. This study found that 
LOS was significantly reduced in patients with complications in the intervention group.92 Another 
very recent RCT had similar findings: patients with a NRS-2002 score of ≥ 3 and who received 
nutritional intervention had significantly better clinical outcomes than the control group patients.101 
The NRS-2002 is thus unique in the sense that it has to some degree been validated by two 
RCTs.92,101 A similar prospective study, though not a controlled trial, also found reduced rates of 
complications, especially infectious complications, in NRS-2002 “at risk” patients who received 
nutritional support.102 The value of these findings lies in the fact that it proves the clinical benefit of 
giving nutritional support to malnourished patients – patients that have been classified as 
“malnourished” according to the NRS-2002. 
In comparison to other measures of nutritional risk the NRS-2002 has shown moderate agreement 
with the SGA93 and good to excellent criterion validity compared malnutrition defined by BMI and 
unintentional weight loss cut-offs.54 In general there is a lack of data on the convergent validity of 
the NRS-2002. 
The NRS-2002 has been used in many studies to determine nutritional status. In these studies risk of 
malnutrition ranged from 6% to 42%.24,54,93-99,101-107 Important to note however, is that a substantial 
amount of heterogeneity exists between different hospital departments and different diagnostic 
groups. Specifically for ICU patients, risk of malnutrition measured by the NRS-2002 has been 
reported between 52-100%.24,105 
Only one study has been conducted using the NRS 2002 in a South African population. This study 
was however retrospective and the research investigators were final year dietetic students. The 
authors aimed to establish the agreement between the MUST and the NRS 2002 in hospitalised 
patients. The specific patients included in the study were not reported. Malnutrition prevalence was 
measured by the NRS 2002 at 40-60% of patients and poor agreement was found between the NRS 
2002 and the MUST.30 
1.4.3.4 Feasibility and applicability 
Even though the NRS-2002 is considered a more complicated and comprehensive NRST,54 it is still 
rated by many as feasible and simple to use in clinical practice.96,98,104 It has been reported that the 
NRS-2002 is more time-consuming than other quick-and-easy screening tools such as the Short 
Nutritional Assessment Questionnaire (SNAQ) and MST 54 and although this might be true, the NRS-
2002 screening can still be done in 5-10minutes.96,98 Guidelines for implementing the NRS-2002 are 
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available.53 One drawback however is that the measurements and calculations involved in the 
screening process requires a more skilled person to complete it.54 
A few studies have described the rate of successful screenings in their patient populations. Failed 
screening due to missing data (anthropometrical measurements that could not be taken or no 
information regarding dietary intake or weight loss history) was reported between 1-7%.19,23,24,98,104 
In most cases, however, these patient populations were general hospital patients and excluded 
patients who were not able to communicate effectively, ICU patients and patients who were not 
orientated with regard to place and time.19,23,98,104 If these patients were included it could be 
expected to lead to an increased rate of failed screens. 
In developing and validating the NRS-2002 the authors also reported that in some cases it was 
difficult to obtain accurate measurements of height and weight and obtain information about weight 
loss or dietary intake. They investigated the use of MUAC instead of weight, but could not find cut-
off points for all the different BMI categories in the literature. Their recommendation is that the 
patient should be classified as at risk whenever there is any doubt and until sufficient dietary intake 
can be confirmed.53 
The NRS-2002 has been studied in many different groups of adult patients. It is considered 
applicable to use in general hospitalized patients24,40,53,54,101,105 as well as, specifically, 
oncology,98,99,107 surgical96,102,104,106 and urology patients.97 It has also been validated for the Chinese 
population.102,104 Very few studies have used the NRS-2002 in an ICU setting and they did not 
specifically comment on the ease of use or applicability of the NRS-2002 in this setting.24,100,105 
1.4.4 Nutritional Risk Indicator 
1.4.4.1 Development and validation 
The Nutritional Risk Indicator (NRI) was developed by Buzby et al. in 1988108 for use in the Veterans 
administration cooperative group study of peri-operative parenteral nutrition in surgical 
patients.108,109 The NRI was thus specifically aimed at identifying nutritional risk in surgical patients. 
In the development phase Buzby et al. established various measures that could be used to identify 
nutritional risk: current body weight, percentage of usual body weight, percentage of ideal body 
weight, triceps skinfold, mid-arm muscle circumference, s-albumin and serum pre-albumin. These 
measures were thought to be relatively inexpensive, simple and quick (<8 hours) to use in a 
screening test. They then studied the association between different combinations of these measures 
to determine which combination could best predict risk of post-operative complications is surgical 
patients. When the combination of s-albumin and percentage of usual weight was used, patients 
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identified as at risk of malnutrition (abnormal) had significantly higher rates of complications and 
mortality.108 The NRI was thus developed and validated for its ability to predict clinical outcomes. 
1.4.4.2 Components of the NRI 
The NRI uses two variables to screen individuals: s-albumin and percentage of usual weight. An 
accurate measure of current weight and an indication of usual weight are necessary to determine 
percentage of usual weight, and s-albumin should be measured in grams per litre. The two variables 
are then used in a formula to calculate an NRI score.109 
According to the NRI score a patient can be classified as “not malnourished”, “mildly malnourished”, 
“moderately malnourished” or “severely malnourished”.109 Figure 1.4 below shows the NRI formula 
and the cut-offs used for the four categories of nutritional status. 
NRI score = (1.519 x serum-albumin) + 0.417 x (current weight/usual weight x 100) 
 
Score Classification 
>100 Not malnourished 
97.6 - 100 Mild malnutrition 
83.6 – 97.5 Moderate malnutrition 
≤ 83.5 Severe malnutrition 
 
Figure 1.4 The Nutritional Risk Indicator (NRI)109 
An s-albumin level of 27.8g/l is necessary to classify a patient as severely malnourished if the patient 
has not experienced any weight loss. In the presence of substantial weight loss however, only 
slightly decreased s-albumin levels are necessary to classify a patient as severe malnourished.108,109 
The NRI is the only NRST included in this study that has a biochemical variable and as such also an 
inflammatory marker, s-albumin, in its screening method. There are different opinions regarding the 
use of s-albumin as an indicator of nutritional risk; some authors suggest that is a good predictor of 
malnutrition whereas others report that it overestimates the prevalence of malnutrition.110,111 S-
albumin levels are influenced by more than just nutritional status. The acute phase reaction, sepsis, 
liver disease, cancer, nephrotic syndrome etc. may all lead to increased capillary leakage of s-
albumin, increased catabolism or decreased synthesis by the liver.9,112 It can therefore be argued 
that s-albumin levels are a good indicator of risk in general, but not such a sensitive indicator of 
nutritional risk per se.9,113 A few studies have found an association between hypoalbuminaenia and 
clinical outcomes such as mortality, nosocomial infections, complications, readmissions and 
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LOS,9,111,114 while others have not.110,115 Although it is currently accepted that inflammation plays an 
important role in the development of malnutrition and that is warrants attention during nutritional 
assessment, there is no consensus regarding how to measure the degree of inflammation. S-albumin 
has been proposed as a marker of inflammatory status, but as mentioned, it also has certain 
limitations regarding its relation to nutritional status.9 At the moment, ASPEN recommends against 
the use of inflammatory markers for diagnosing nutritional status, mainly due to the lack of an 
accurate and nutritionally related inflammatory marker.2 
The NRI does not provide any guidelines for implementation or treatment of patients according to 
nutritional risk classification. 
1.4.4.3 Clinical studies 
The NRI has mostly been studied in surgical patient populations for its ability to predict clinical 
outcomes. In gastroenterology,110 obstructive jaundice116 and general hospital patients including 
surgical and medical patient groups117-119 the NRI has been shown to predict LOS. It has also 
demonstrated good predictive ability for post-operative mortality in gastric cancer111 and obstructive 
jaundice116 patients. Furthermore it is able to predict post-operative morbidity such as the 
development of nosocomial infections,118 cellular immunosupression111 and pancreatic fistula after 
distal pancreatectomy.120 In a study of patients admitted for elective, major surgeries (n=480), the 
NRI also showed good predictive validity for post-operative mortality, morbidity (infectious and non-
infections severe complications) and LOS.121 
Kyle et al. used the NRI in a multicenter population based study of hospitalized patients (n=1,273). 
Apart from finding the NRI a good predictor of clinical outcomes, they also found that a severely 
malnourished classification by the NRI led to three times higher hospital costs than a well-nourished 
classification. They also proved that the NRI is better in categorizing nutritional risk than its 
counterparts, weight loss and s-albumin, on their own.119 
One study has found the NRI unable to predict clinical outcomes: in patients with oesophageal 
malignancies admitted for surgery the NRI could not predict LOS or the development of 
postoperative infections.122 
A few studies have compared the NRI to the SGA as a gold standard for defining 
malnutrition.110,115,117 In gastroenterology patients the NRI demonstrated fair agreement (κ=0.37) 
with the SGA110 and in a general hospitalized patient group it showed moderate agreement 
(κ=0.57).117 In the last mentioned study the authors also reported the NRI to have fair sensitivity 
(79%) and good specificity (82%).117 A study in gastric cancer patients however demonstrated poor 
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agreement between the NRI and the SGA with a kappa of 0.18. In this study the sensitivity was still 
fairly good (74%), but a poor specificity (40%) was found.115 
The NRI has also shown good correlation with other objective measures of malnutrition such as 
more detailed anthropometry, biochemistry (s-albumin and total cholesterol) and weight loss.117 
Reports of the prevalence of moderate to severe hospital malnutrition, as defined by the NRI, range 
from 24-68%.39,115,116,118-120  
The NRI has not been studied in an ICU patient setting specifically. 
1.4.4.4 Feasibility and applicability 
Not much is known about the ease of use of the NRI. It is safe to assume that including a 
biochemistry variable in a NRST could present some complexities. First, it is more time-consuming to 
draw blood and wait for laboratory analysis than to complete a quick questionnaire. Second, the 
variable may not be routinely screened in all hospital patients. Third, the cost involved in measuring 
biochemistry variables cannot be ignored; if it is not routinely screened it will result in a much higher 
cost of screening. Last, the biochemical test is much more invasive than the other parameters 
normally used in NRSTs. 
On the other hand, the advantage of a biochemistry variable is the fact that it is completely 
objective.39 It is also feasible to implement even in patients that are bedridden and/or comatose. 
However, even though the s-albumin test can be implemented, completion of the NRI also requires 
an accurate current and usual weight. It might therefore be difficult to screen bedridden patients as 
well as those unable to provide information on their usual weight. 
A number of studies have reported the rate of failed screens that were found when the NRI was 
implemented. This number ranged from 1%,121 10%,116 16%,122 19% and 32%39 to 62%.118 The reasons 
given to explain the failed screens were incomplete data on current weight,39,118 lack of information 
on usual or premorbid weight,39,116,118,122 no s-albumin values available39,118 and patients unable to be 
interviewed.121 The study with a 62% rate of failed screens was a national study including all 
hospitalized patients from participating hospitals in France.118 Although they didn’t report the rate of 
failed screenings specifically for ICU patients, it can be expected that it would have been high. Other 
studies with lower rates of failed screenings often excluded comatose and unconscious patients121 or 
were conducted in patient populations that were generally conscious and mobile e.g. pre-operative 
elective surgery patients.116,122 
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Clugston et al. reported that the NRI is easy to calculate if you have all the necessary data.116 
Nonetheless, a person trained in weight measurement would be needed to obtain an accurate 
weight. 
From the literature available it can be concluded that the NRI is applicable for use as a NRST in 
surgical patients,109,111,117,121 with the possible exceptions of gastric and oesophageal cancer 
patients.115,122 It also seems possible to apply it to general hospital patients.39,119 
The applicability of the NRI in ICU patients is unknown. In most cases, especially in a surgical ICU, it 
can be expected that most patient conditions will entail an inflammatory or infectious component 
which will lead to decreased s-albumin levels. It may thus be that the NRI will overestimate 
nutritional risk based on the high prevalence of decreased s-albumin levels. 
1.4.5 Malnutrition Screening Tool 
1.4.5.1 Development and validation 
The Malnutrition Screening Tool (MST) was developed by Ferguson et al. in 1999 and was one of the 
first of a number of quick- and-easy NRSTs that have been developed over the years. Ferguson et al. 
were frustrated with the lack of simple as well as valid and reliable NRSTs in the literature and 
therefore aimed to develop such a tool for the acutely ill hospitalised adult population.123 Their 
objectives were to create a tool that would be applicable for the general hospital patient, make use 
of data that is readily available, be quick and easy to complete, be cost-effective and non-invasive 
and lastly, would be accurate and reliable.123 
For the development of the MST, hospital patients (n=408) from various wards (general medical, 
cardiology, gynaecology, orthopedic, oncology, plastic surgery, gastrointestinal and general surgery) 
were conveniently sampled. All maternity, psychiatric, patients younger than 18 years and patients 
that could not communicate were excluded. The SGA was used as the gold standard to identify 
malnourished patients. A list of questions that could possibly identify malnutrition was analysed 
against the SGA results. In the end, two questions were identified as most predictive of 
malnutrition.123 
To validate the questionnaire, the researchers studied criterion and convergent validity. The 
sensitivity, specificity and positive predictive value were all excellent (>90%). The negative predictive 
value rated fair with 27% of malnourished patients being wrongly classified as not at risk of 
malnutrition. Compared with other measures of nutritional status (biochemical and in-depth 
anthropometrical measures), the MST also appeared to be accurate. Furthermore, the MST was able 
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to predict a clinical outcome i.e. LOS in hospital. Reliability also appeared to be excellent as 
measured between dieticians as well as between nutritional assistants and dieticians.123 
1.4.5.2 Components of the MST 
The MST (Figure 1.5) consists of two questions: one dealing with recent unintentional weight loss (in 
kg) and the other with loss of appetite. The MST is unique in the fact that it provides an “unsure” 
option for when patients are not sure about whether they have lost weight or how much weight 
they have lost. Patients are classified as either not at risk of malnutrition (score of 0-1) or at risk of 
malnutrition (score of ≥ 2). The MST also includes implementation guidelines: patients at risk of 
malnutrition should be subjected to a more thorough nutritional assessment whereas patients not at 
risk of malnutrition should be rescreened on a weekly basis.123 
 
 
Figure 1.5 The Malnutrition Screening Tool (MST)66 
 
1.4.5.3 Clinical studies 
After initial validation in the acute adult hospital population, the validity of the MST was further 
studied in different groups of hospital in- and outpatients using the SGA as a gold standard measure 
of malnutrition.88,124-126 Among oncology outpatients receiving radiology the MST showed good to 
excellent criterion validity124 and excellent to perfect criterion validity compared to a version of the 
SGA in patients receiving chemotherapy.126 Inter-rater reliability was also measured in the 
chemotherapy population; there was good agreement between MST scores when completed by 
nursing or administration staff or patients themselves. This can be expected as the MST only entails 
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two questions which decrease the chances of disagreement.126 The MST has also been compared to 
the SGA in a large adult inpatient sample (n=2,211) in Turkey. In this study the MST showed only fair 
sensitivity and specificity. Although still acceptable, other screening methods such as assessing loss 
of subcutaneous fat proved far more accurate.125 
The MST has been studied in relation to NRSTs other than the SGA. Compared to the MUST in a 
group of medical inpatients, the MST showed fair-good agreement and a similar prevalence of 
malnutrition. However, even though the proportions of malnutrition were comparable, the 
individuals classified as “at risk of malnutrition” differed.48 The MST was also compared to the NRS-
2002 in oncology inpatients and in this study the MST showed very poor sensitivity (49%), while 
specificity was excellent.51 
Among elderly patients, the MST has also been shown to have poor sensitivity of 59%, but good 
specificity of 85% when compared with the NRS-2002.127 On the other hand, in a 2009 study among 
elderly patients admitted to an emergency medicine department, the MST showed good sensitivity 
and specificity of 84% and 85% respectively. In this study, however, the SGA was used as the 
standard definition for malnutrition.128 Furthermore, the MST also showed good sensitivity in elderly 
patients in a residential care setting, when compared to the SGA.129 
The above discrepancies and poorer relative validity found when the MST is compared to NRSTs 
other than the SGA can possibly be explained by the fact the MST was developed to predict 
malnutrition as defined by the SGA and not by other NRSTs66. Due to the absence of a gold standard 
measure for malnutrition it is difficult to identify which tool should be considered as the more 
accurate. A very recent study on NRSTs in hospital inpatients found the MST to be a sufficiently valid 
screening tool that could identify malnourished patients just as well as other assessments. In this 
study a BMI <18.5 and unintentional weight loss of >5% in 1 month or >10 % in 6 months was used 
as the definition for malnutrition. The MST was also able to identify older patients at risk of 
malnutrition.54 
A few studies have looked at the MST’s ability to predict clinical outcomes. In pre-operative surgical 
inpatients the MST, along with three other screening tools, was studied for its ability to predict post-
operative infectious and wound complications. Although the MST could predict post-operative 
outcomes to some degree, it scored the worst out of the four NRSTs and did not add any useful 
information above that provided by known risk factors for post-operative infectious and wound 
complications such as s-albumin.88 Moreover the MST was not able to predict LOS in oncology 
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inpatients51 or elderly orthopaedic trauma patients.127 It therefore seems as if the MST is not 
particularly good at predicting clinical outcomes and this can be considered one of its limitations. 
The prevalence of malnutrition as identified by the MST ranged from 18-55% among hospitalised 
patients.48,51,54,125,127 
The MST has not specifically been studied in an ICU patient setting. 
1.4.5.4 Feasibility and applicability 
The MST is one of the few NRSTs that is really quick and easy to complete. The two questions that 
comprise the MST are simple to answer and no calculations are necessary.123 It has been reported 
that the screening tool takes 1-3minutes to complete.48 Screening can be done by nursing staff, 
administration staff or the patients or friends or family of the patient themselves; no trained 
personnel are required.48,123,124 This ensures better use of specialised personnel such as doctors and 
dieticians. The MST is also non-invasive, uses data that is routinely available (when assuming that 
the patient is able to communicate) and it includes implementation guidelines which further 
increase its ease of use.123 
Another advantage of the MST is its scoring system. All patients with a score of equal to or higher 
than two are classified as at risk of malnutrition, with a maximum score of five. Patients can be 
prioritized based on their score in terms of urgency of treatment needed.123,124. Furthermore, for 
patients who do not know their current or previous weights, the MST provides an “unsure” option 
the question about recent weight loss. This will however immediately categorize the patient as at 
risk of malnutrition as the patient scores 2 when choosing the “unsure” option.123 Although this 
ensures that malnourished patients are classified as such, it may also lead to a large number of 
patients being misclassified as at risk of malnutrition, especially in a patient population who often do 
not know their weight history. 
A limitation of the MST is the fact that only subjective criteria are used.48 Although this simplifies the 
tool to a great extent, it does necessitate clinical judgment and may open the doorway to bias. 
The MST is applicable for use in a large adult patient population: from general hospital inpatients to 
the oncology outpatient setting.54,123-126 It is also applicable for use in elderly patients.128,129 It is 
currently unknown whether it is applicable for use in the ICU setting. It is estimated that the MST 
might be difficult to implement in the sample of ICU patients that are not able to communicate, 
especially if the necessary information is not readily attainable from other sources e.g. patient files, 
relatives or friends. 
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1.4.6 Short Nutritional Assessment Questionnaire 
1.4.6.1 Development and validation 
The Short Nutritional Assessment Questionnaire (SNAQ) was developed by Kruizenga et al. after a 
national nutritional risk screening study in hospitals in the Netherlands revealed current practices 
were impractical.130 This large-scale screening study found that when BMI or percentage of 
unintentional weight loss is used to identify malnutrition, nutritional risk was often not identified. 
The main reason was lack of time for nurses and clinicians to do the necessary measurements and 
calculations.131 Kruizenga et al. therefore wanted to develop a short questionnaire to identify 
malnutrition that could be incorporated into nursing staffs’ admission procedures and would take no 
longer than 5 minutes.130 
The questionnaire was developed in 2002 using adult patients (n=291) from internal medicine and 
surgical wards. The researchers determined three questions that were predictive of malnutrition, as 
defined by a BMI <18.5 and unintentional weight loss in the past 6 months of >5 to 10% of body 
weight. After the development phase a cross-validation study was performed in 2003 using 297 
patients from the same wards. The results from this study indicated that the SNAQ has a sensitivity 
of >76% and a specificity of 83% which is considered fairly good. Furthermore the SNAQ also showed 
good negative predictive values. The positive predictive value however scored only 62% and 70% for 
the severely malnourished and moderate and severely malnourished patient groups respectively 
which indicates that the SNAQ may overestimate the number of patients that are truly 
malnourished. Nonetheless, when dieticians were asked to rate the referrals they received based on 
the SNAQ score, 89% of the referrals were rated as very necessary. The reproducibility of the SNAQ 
was also assessed. A kappa score of 0.61 indicated moderate nurse-nurse reproducibility and a 
kappa score of 0.91 indicated good nurse-dietician reproducibility. It was suggested that these 
scores could further be improved with in-depth training of staff.130 
1.4.6.2 Components of the SNAQ 
The SNAQ (Figure 1.6) consists of three questions dealing with unintentional weight loss (in kg), 
appetite changes and enteral nutrition support received in the previous month. Each question is 
scored and then added together to obtain the total score. Depending on the outcome the patient 
will be classified as well-nourished, moderately malnourished or severely malnourished.130 The 
SNAQ also provides a dietary treatment plan based on the classification of nutritional status. 
Patients classified as moderately malnourished should receive nutritional intervention in the form of 
high energy and protein meals with two snacks, whereas patients classified as severely malnourished 
should also be referred to a dietician for additional support.132 
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Figure 1.6 The Short Nutritional Assessment Questionnaire (SNAQ)132 
 
1.4.6.3 Clinical studies 
Kruizenga et al. also tested whether the use of the SNAQ and its dietary intervention component, 
opposed to the usual protocol for identifying and treating malnutrition, could affect clinical 
outcomes. This was a controlled trial using the same patient population as for the SNAQ validation 
study and with the patient population from the SNAQ development study acting as a control group. 
With regard to clinical outcomes they measured LOS, weight changes during hospital stay, use of 
enteral or parenteral nutrition support and number of visits by a dietician. In short, they found that 
LOS was shorter in frail, malnourished patients when the SNAQ was used. The SNAQ did not 
significantly impact on weight changes although this was ascribed to the fact that weight is often an 
unreliable variable and hospitalisation is generally too short a period to expect noteworthy weight 
gain. The SNAQ did however impact nutritional support by increasing the number of meals patients 
received and the administration of normal food opposed to parenteral feeding, tube-feeding or 
supplemental drinks. The use of the SNAQ also led to greater efficiency with regard to number of 
visits by the dietician. A cost-effectiveness analysis demonstrated that although the use of the SNAQ 
was associated with additional costs, it still resulted in considerable savings by decreasing LOS in 
frail, malnourished patients and the use of unnecessary specialised nutrition support.132 This is a 
particularly important finding as it indicates the SNAQ’s ability to impact clinical outcomes, even if 
just in a subgroup of patients. 
The SNAQ has also been used to identify patient characteristics associated with malnutrition, 
specifically general health status and complexity of medical care. In this study, adult patients from 
internal medicine and surgical wards were assessed with the SNAQ at admission. The authors found 
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that patients classified as severely malnourished had reduced quality of life, handgrip strength and 
fat free mass indices indicating inferior physical functioning. They also had increased health care 
needs.133 This study underscored the fact that malnourished patients are often complex patients 
with more complex health care needs and that the SNAQ can be used as a NRST to identify these 
patients. 
In a recent comparison of five screening tools in one sample of hospital inpatients, the SNAQ along 
with the MST showed fair to excellent criterion validity when measured against malnutrition defined 
by BMI and weight loss parameters. The authors also found that it was a practical tool to implement. 
The MUST and NRS-2002 demonstrated acceptable criterion validity but were not as quick and easy 
to complete and had high rates of missing data. In this study, patients classified as moderately and 
severely malnourished in the SNAQ were grouped together and compared with the well nourished 
patients. This was done to make comparison between the different NRSTs possible since some of 
them only have two outcome categories. When the well-nourished and moderately malnourished 
patients were grouped together and compared with the severely malnourished patients, the 
sensitivity fell to an insufficient level (<70%). However, this can probably be explained by the fact 
that the SNAQ was not intended to be used in this manner and that if used correctly the criterion 
validity would be higher.54 
In a recent systematic review of NRSTs for hospital patients, the SNAQ along with the MST 
outperformed other NRSTs. The SNAQ and MST were both found to have good diagnostic accuracy 
(underlimit of 95% confidence interval for criterion validity >65%) and was the most practical and 
applicable NRSTs.134 
Since its initial validation in hospital inpatients, the SNAQ has also been validated and in some cases 
modified for other patient populations. In pre-operative and general hospital outpatients the SNAQ 
was found to have a sensitivity of 53-67% and specificity of 94-97% (measured against BMI and 
weight loss parameters).135 Considering the fact that detection and treatment of nutritional risk in 
the outpatient setting has previously been reported at 15% the SNAQ will drastically increase these 
numbers and can therefore be used with acceptable accuracy.135 A systematic literature review also 
found the SNAQ to be a valid and reliable NRST for elderly living in the community.136 Two modified 
versions of the SNAQ have also been developed and validated for use: one in the residential care 
setting (SNAQ-Residential Care or SNAQRC)91 and one for community-dwelling elderly (SNAQ65+).137 
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Looking at the studies in which the SNAQ was used to assess nutritional risk, the number of patients 
classified as moderately malnourished ranged from 5-14% and the number of patients classified as 
severely malnourished ranged from 7-29%.54,130,132,133,135 
The diagnostic accuracy and applicability of the SNAQ has not been studied in an ICU patient 
population. Also, limited data is available on the ability of the SNAQ to predict clinical outcomes in 
hospitalised patients. 
1.4.6.4 Feasibility and applicability 
One of the aims in the development of the SNAQ was to ensure that it could be completed in just a 
few minutes.130  It is an extremely practical and feasible NRST, because the questions are simple, 
require no calculations and can easily be performed by nursing staff during patient 
admissions.54,130,134 Completing the SNAQ has been reported to take less than three minutes and only 
upon scoring equal to or more than 3 will a patient be referred to the dietician, which helps to 
decrease workload among specialised hospital staff.134 
The SNAQ was developed using a mixed hospital patient population which included oncology, 
surgical, internal medicine, gastroenterology, dermatology and nephrology patients.130 This NRST is 
thus applicable for use in the majority of hospital inpatients. When considering the ICU patient 
population however, the feasibility and applicability of the SNAQ can be questioned. First, the SNAQ 
has not been validated among ICU patients and therefore it is not known whether it is valid and 
applicable to use in such a population. Second, the questionnaire completely relies on the patient’s 
ability to answer the questions. If the patient is unable to answer the questions (due to sedation, 
coma, oral conditions etc.) and the correct information is not available it would be impossible to 
implement the SNAQ. The fact that no anthropometrical measurements are required does however 
count in the SNAQ’s favour and might make it more feasible for use in ICU patients than some of the 
other NRSTs. 
1.4.7 Subjective Global Assessment 
The Subjective Global Assessment (SGA) is considered more a nutritional assessment tool and not as 
much a nutritional screening tool.42 Nevertheless it is often used for screening purposes and it has 
been implemented in ICU settings. It is therefore included in this study as one of the NRSTs to be 
examined. 
1.4.7.1 Development and validation 
The SGA was developed in the 1980s in an effort to change the way nutritional status was assessed. 
The developers wanted to use a more subjective approach rather than the extensive 
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anthropometrical and biochemical assessments that were the current practice at the time. A sample 
of gastrointestinal surgery patients was used to develop the SGA questionnaire. The subjective 
criteria employed in the questionnaire seemed to correlate well with objective measurements of 
nutritional status indicating convergent validity. The SGA was also able to predict the development 
of post-operative infections.43 A later study further confirmed the predictive validity of the SGA for a 
wider scope of post-operative outcomes such as mortality, wound healing and infectious 
complications. This study also tested the reproducibility of the SGA and found that it has good inter-
rater reliability (κ=0.78).138 
1.4.7.2 Components of the SGA 
The SGA involves five areas of nutritional assessment (Figure 1.7). The first four areas cover aspects 
of patient history such as recent weight changes, dietary intake, GI symptoms and functional 
capacity. The SGA is unique in the sense that it looks at these aspects in much more detail than the 
other NRSTs. For instance it includes questions on weight changes in the past six months and also 
about weight changes experienced in the last two weeks. The SGA thus includes historical 
information as well as current symptoms and tries to establish the pattern of abnormalities. Change 
in dietary intake is assessed by not only asking about whether it occurs, but for how long it has been 
occurring and also the severity of the changes i.e. suboptimal diet versus liquid diet versus 
starvation. The last area of nutritional assessment entails a physical examination to look for evidence 
of muscle wasting, fat loss or oedema.43 
It is worth noting that originally the SGA included a question pertaining to the degree of metabolic 
stress that was experienced by the patient due to the presence of underlying disease. The authors 
however recommended that this question be excluded from the SGA in the future since clinicians 
found it difficult to rate this question and importantly, it did not seem to influence overall SGA 
ratings.43 
Using the SGA, patients can be classified as well nourished, moderately malnourished (or at risk of 
malnutrition) or severely malnourished. The scoring of patients into these categories is however not 
based on definite numerical scorings, but rather on a subjective basis of using clinical judgment to 
arrive at a classification. It has been reported that SGA classifications are most influenced by weight 
loss patterns and physical evidence of muscle or fat wasting.43 
The SGA is not linked to a specific nutritional care plan bases on the outcome of the assessment.43 
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Figure 1.7 The Subjective Global Assessment (SGA) form139 
 
1.4.7.3 Clinical studies 
The SGA has been most widely studied of all the NRSTs. Due to its comprehensive nature it is often 
used as a gold standard of nutritional assessment against which other NRSTs are validated.140,141 Its 
use as an assessment tool is recommended by international bodies such as ASPEN, especially when 
initial screening has indicated risk of malnutrition.42 
Mostly the SGA’s validity has been studied using objective measurements of nutritional status as 
reference standards. The SGA has been shown to correlate well with anthropometrical 
measurements such as BMI, percentage of weight loss, MUAC, arm muscle circumference and 
triceps skin fold, and biochemical variables such as s-albumin, pre-albumin and total lymphocyte 
count (TLC).125,142-151 These correlations illustrate the SGA’s convergent validity for a wide variety of 
patient groups: surgical patients,144,152 general hospitalised patients,125,148 elderly patients,147 patients 
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with digestive diseases149 or renal failure,143,145,150 oncology patients142,146 and cardiac patients.151 
However, some studies have failed to show significant correlations before or after controlling for 
confounding factors. A study in Chinese patients only found a strong agreement with percentage of 
weight loss and not with BMI, s-albumin, pre-albumin or TLC.153 Another study in GI surgery patients 
did not find a significant correlation with s-albumin or pre-albumin.152 In elderly as well as surgical 
patients the SGA has been correlated with BMI, but not with biochemical measures154 or other 
anthropometrical indices.155,156 A lack of correlation does however not disprove the SGA’s validity, 
but may rather be an indication of the SGA’s superiority to these single or combined objective 
measurements in identifying malnutrition.155,156 
In one study the SGA was also compared to Dual-Energy X-Ray Absorptionmetry (DEXA) 
measurements of fat free mass. Here the SGA fared poorly scoring only 46% for sensitivity. The 
authors argued that it is difficult to pick up loss of fat free mass in overweight or obese patients and 
that this limits the SGA’s sensitivity.157 
Only a few studies have looked at the criterion validity of the SGA. Against a detailed nutritional 
assessment including measures of anthropometry, biochemistry, dietary intake and risk factors for 
malnutrition, the SGA scored fair-to-good: 77% for sensitivity and 84% for specificity. A kappa value 
of 0.4 indicated a moderate agreement between the two questionnaires.158 The SGA also showed 
good agreement (κ=0.79) with a similar full nutritional assessment.148 Compared to body fat 
percentage, biochemistry variables and a prognostic nutritional index, the SGA showed good 
sensitivity (82%) and fair specificity (72%).159 Pablo et al. found that when combining the SGA with 
measures of s-albumin and TLC for a nutritional assessment and comparing it with just the SGA, the 
SGA alone still has 100% sensitivity, but specificity is only 59%.160 SGA is thus an excellent tool for 
identifying malnourished patients but it also tends to overestimate and misclassify well nourished 
patients as malnourished. 
Moderate to good agreement with other NRSTs such as the NRS-2002, MUST and MNA have been 
found.16,140,154 
The SGA has mostly demonstrated good predictive validity with regard to patient outcomes, 
although there is also some opposing evidence. The SGA seems to be predictive of LOS in oncology 
patients,146,153,161 renal failure patients,162 general hospitalised patients,17,21,37,163,164 patients with 
digestive diseases149 and trauma patients.165 It is also linked to the development of complications in 
internal medicine and patients with GI diseases149,166 as well as acute renal failure,150 elderly,139 
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trauma,165 surgery,138,144,167,168 oncology142 and general hospitalised patients.37 It is also predictive of 
mortality in most of these patients groups.37,147,150,154,162,165,167 
In stroke patients, however, Davis et al. found that after adjusting for confounding factors such as 
age and stroke severity the SGA was unable to predict poor patients’ outcomes.159 Often, authors 
find that although univariate analysis may reveal associations between malnutrition and poor 
patient outcomes, adjusting for confounders through multivariate analysis or stratification dismiss 
these.169-171 Sungurtekin et al. also could not find any significant association with SGA category and 
LOS.167 In Chinese patients with GI cancer there was a trend for increased LOS in malnourished 
subjects, but this was not significant.153 In another similar sample the SGA could predict 
complications but not mortality or LOS. Alvares da Silva et al also found no significant associations 
between malnourished subjects with liver cirrhosis and morbidity and mortality.172,173 
In spite of its subjective nature the SGA seems to be a reliable tool. The initial papers on the 
development, validation and use of the SGA already reported good agreement between 
examiners.43,138 Today, many other research papers support these findings.174 The level of agreement 
between examiners ranges from 54-95% with kappa values from 0.48–0.9.32,141,143,147 
The prevalence of hospital malnutrition across various patient groups ranges from 10-59% for risk or 
moderate malnutrition and 0-42% for severe malnutrition.16,17,21,37,43,125,142,144,146,148-
150,152,153,157,160,161,163,165,167,169,175-179 
Three small studies have looked at the use of the SGA in ICU patient populations. The first employed 
only a small portion of ICU patients (n=55) in its sample of elderly hospitalised patients. The ICU 
patients (also elderly only) had a 22% prevalence of moderate malnutrition and a 7% prevalence of 
severe malnutrition. This was similar to what was found in the total sample i.e. 28% moderate 
malnutrition and 6% severe malnutrition. The SGA categories for the whole sample was not 
predictive of LOS or mortality, although in the ICU patients there was a trend towards higher 
APACHE II scores in the malnourished patients; however, this was not significant.31 Sungurtekin et al. 
studied the SGA in medical and surgical ICU patients (n=124) and found that 26% of patients were 
moderately malnourished and 11% were severely malnourished. In this study the moderate and 
severely malnourished patients had significantly higher APACHE II scores than the well nourished 
subjects. The SGA also correlated significantly with percentage weight loss, body weight, s-albumin 
and mortality, but not with LOS. The authors concluded that the SGA is a simple and feasible tool 
with predictive validity that can be used in ICU patients. However they did not describe how they 
collected data from unconscious or ventilated patients, or whether they excluded these patients.33 
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The third study was designed to measure the reproducibility of the SGA in a mechanically ventilated 
patient population (n=57). The authors collected data by using alternative methods such as 
reviewing doctor or nursing files, asking family members for information and using their nutrition 
management software programme that is used to store patient information. Fifty-four percent of 
patients were found to be moderately malnourished and 5% severely malnourished. There were no 
associations with malnutrition categories and APACHE II scores. Associations with mortality or 
patient outcomes were not reported. The authors found 95% concordance between the two 
dieticians conducting the SGAs. They concluded that the SGA is reliable and reproducible in an ICU or 
mechanically ventilated patient sample, but that the validity of the tool should still be ascertained.32 
One of the negative qualities of the SGA that has been highlighted in the literature is the fact that it 
is subjective in nature which may lead to bias.63,159,169,180 Some have even questioned its applicability 
for research purposes because of its high level of subjectivity.63 However, as mentioned before the 
SGA demonstrates moderate to excellent inter-rater reliability which indicates that bias may not be 
as prevalent as expected. The importance of examiner training and experience should be 
emphasized as this will help to decrease bias and improve reliability.16,169 Ozkalkani et al. have also 
pointed out that the SGA does not provide for a categorization of mild malnutrition and that it is not 
sensitive to pick up short-term changes in nutritional status.168 
There are a few other versions of the SGA that are worth mentioning. The Patient-Generated 
Subjective Global Assessment (PG-SGA) is similar to the SGA but includes additional questions 
regarding patient symptoms that could influence nutritional status.141,161 It is supposed to be more 
sensitive to short-term changes in nutritional status than the original SGA.174 The questionnaire part 
is completed by patient themselves whereafter the health care worker completes the physical 
examination.161 This tool was specifically developed and also validated for oncology patients.161,174 
The scored PG-SGA is exactly similar to the PG-SGA except that numerical scores are used and added 
up to classify a patient as well nourished or malnourished.161 Due to the fact that patient 
participation is crucial in the use of this tool it is unrealistic to study its use in an ICU setting. 
From the literature it is clear the SGA has been widely studied, even in ICU patients. Although there 
is contradicting evidence it seems that the SGA is valid in terms of concurrent measures of 
nutritional status and its ability to predict clinical outcomes in different patients groups. The SGA has 
also been shown to be reliable. There is also evidence of reliability and reproducibility in ICU 
patients, but this, as well as the validity of the SGA in this population, needs to be studied further. 
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1.4.7.4 Feasibility and applicability 
Most studies making use of the SGA have described it as simple and easy to use.152,176 Still, it is 
reported to take between 5-15 minutes, with the average assessment lasting 9 minutes.17,163,176 A 
few studies have indicated that the SGA is too time-consuming and comprehensive to use for all 
hospitalised patients.66,123,124 The tool is however inexpensive and non-invasive as no measurements 
are taken and no specialised equipment or biochemical tests are necessary.17,176  
No studies commenting on the rate of successful completion of assessments in hospitalised patients 
could be found. 
The SGA is meant to be implemented by health care workers.141 In the literature it has mostly been 
utilised by physicians, registered dieticians, nurses and students in the medical or nursing 
professions.32,43,138,141,143,147,153,174,181 It seems that the most important issues are training of the 
examiner16,43,168 and proper experience169 before using the tool in clinical practice. Training can be 
done with relative ease17 and produce good results in a maximum of three hours.181 The technique 
involved in using the SGA is described in sufficient detail so that it can be implemented by even an 
inexperienced examiner.141 
The SGA seems to be applicable for a wide variety of hospitalised patients. It was initially developed 
and validated for use in pre-operative surgical patients43, but since then it has been applied with 
acceptable validity in most hospitalised adult patients.141,174 
As with the other NRSTs there are possible hurdles that the SGA will face in the ICU setting. One of 
them is unconscious, intubated or demented patients who will be unable to answer the necessary 
questions and thus hamper the completion of the questionnaire.174 Yet, one study has successfully 
made use of alternative methods, as discussed previously, to collect the necessary information in 
mechanically ventilated patients. The study however does not report the rate of completion of 
assessments. It is realistic to expect that some information may not be obtained from sources other 
than the patient. Also, it is possible that the sources of information used in the study were more 
elaborate than those available in TAH i.e. the nutrition management software programme which is 
routinely used to capture patient care data.32 This study also points out that the physical 
examination of patients in the ICU may be inaccurate as loss of lean body mass may easily be 
masked by fluid disturbances and obesity, two common phenomena among the critically ill.32 One 
advantage of the SGA which will be of benefit in the ICU setting is that no anthropometrical 
measurements need to be taken. The tool is thus feasible in bedridden patients. It seems that 
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although the SGA has previously been used in the critically ill with relative success there are still 
doubts regarding its feasibility and applicability. 
 
1.5 CONCLUSION AND MOTIVATION OF STUDY 
The literature clearly indicates that hospital malnutrition is a serious and wide-spread problem. 
Likewise, the ICU setting poses a large risk for malnutrition and its debilitating consequences.11 The 
evidence suggests that ICU malnutrition is linked to increased ventilator dependence, deterioration 
of the gut-barrier function, longer LOS and higher morbidity and mortality.11,34 This in turn drives up 
health care costs dramatically and burdens hospital resources.4,20 
To counteract this problem, international nutrition bodies recommend nutritional risk screening of 
all hospitalised patients, followed by proper nutritional care.40,42 This recommendation aims to 
increase the recognition and treatment of hospital malnutrition, an area that merits attention as 
treatment of malnutrition has been shown to improve patient outcomes.12 Various NRSTs exist for 
screening purposes and have been a topic of extensive study, but there is still no consensus on the 
optimal screening tool for detecting hospital malnutrition. 
Screening all hospital patients would include screening ICU patients. However, very little information 
is available on the feasibility and accuracy of using existing screening tools in this patient population. 
Most studies on NRSTs exclude critically ill patients from their patient populations and as such, no 
single NRST has been recommended for use specifically in the critically ill. This can be seen as a 
major obstacle in the fight against hospital malnutrition as it prevents a group of patients at high risk 
for malnutrition from being screened and from being identified for nutritional intervention. 
This study therefore aimed to shed light on the possible use of existing NRSTs in an ICU setting. The 
purpose was to identify NRSTs that could effectively predict clinical outcomes in critically ill patients 
and that were feasible, in order to make some suggestions on their adequacy for this patient 
population. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2: METHODS 
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2.1 AIM AND OBJECTIVES 
The primary aim of this study was to determine which nutritional risk screening tool (MUST, MNA-
SF, SGA, NRI, NRS-2002, SNAQ or MST) most effectively predicts clinical outcomes in adult patients 
admitted to the Surgical Intensive Care Unit (SICU) of Tygerberg Academic Hospital (TAH), Cape 
Town, South Africa. The secondary aim was to comment on the feasibility and applicability of these 
NRSTs in a SICU setting. 
Research objectives: 
 To determine which NRST most effectively predicts clinical outcomes in adult SICU patients; 
 To determine the relationship between nutritional status classification at admission and the 
clinical outcomes of SICU stay; 
 To reflect on the applicability of NRSTs for this population; 
 To comment on the feasibility of using NRSTs in this population and 
 To identify elements of NRSTs that are applicable for screening adult SICU patients. 
 
2.2 HYPOTHESIS 
All NRSTs (MUST, MNA-SF, SGA, NRI, NRS 2002, SNAQ and MST) effectively predict clinical outcomes 
in adult patients admitted to the SICU of TAH, but some are likely to be more effective than others. 
 
2.3 STUDY PLAN 
2.3.1 Study type 
A descriptive, prospective study design with an analytical component was followed. The data 
collected was quantitative. 
2.3.2 Study population 
2.3.2.1 Overall study population 
Census sampling was used to select study participants. All eligible patients admitted to the SICU of 
TAH from November 2010 to June 2011 were included in the study after obtaining a waiver of 
consent – see Section 2.6 Ethical and legal considerations. 
The only inclusion criterion was that patients had to be admitted to ward A1 West (SICU) of TAH. 
Exclusion criteria were patients younger than 18 years, patients who were included in the pilot study 
and patients with an SICU stay of less than 48 hours. 
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2.3.2.2 Sample size and subgroups 
For statistical purposes, the sample size needed was calculated at 48 patients per subgroup if 
comparing the different NRST classifications of each screening tool to each other. Delta/Root Mean 
Square Standardized Effect equal to 0.25 and a statistical power of 90% were used by the statistician 
to arrive at this sample size. These parameters would allow the researcher to detect small 
differences with a good confidence level. The majority of the NRSTs have three nutritional risk 
classifications and therefore at least 142 patients (3 x 48 patients) would be needed if the patients 
were equally distributed among the three classifications. That was however highly unlikely and 
therefore a total sample size of 200-250 patients was estimated by the researcher to be sufficient to 
allow for adequate comparison. 
About 60 new patients are admitted to TAH’s SICU per month. Of these, roughly 30 have a SICU stay 
of at least 48 hours, which was necessary for data analysis. Over an eight month period it was thus 
estimated that 240 patients would be included in the study. 
2.3.3 Methods of data collection 
This study formed part of a bigger study entitled “Determination of the nutritional status of patients 
admitted to the surgical ICU of TAH and identification of correlations thereof with clinical 
outcomes”. Data for both the main and the sub-study was collected simultaneously from November 
2010 to June 2011 in the SICU of TAH. All the data was collected by the same researcher; thus there 
was no need for standardization of fieldworkers. The researcher is a registered dietician. 
This was a non-invasive study only using data that is routinely collected in the SICU. Data collection 
for the study therefore depended on the availability of information. 
2.3.3.1 General information 
Data was gathered for every patient on each of the following: 
 Age 
 Gender 
 ICU admission and discharge date 
 Relevant medical history prior to admission 
 Reason for ICU admission 
 Diagnosis at ICU admission 
 Surgical procedures/investigations (continuously). 
51 
 
Age and gender was obtained to describe the patient demographics while ICU admission and 
discharge dates were used to calculate LOS. The reason for admission, diagnosis at admission and 
ongoing surgical procedures were obtained to identify the primary diagnostic groups found in the 
study. The groups were not defined before the onset of the study, but were selected based on the 
most prevalent diagnostic categories among the patients once the data was collected. 
2.3.3.2 Nutritional risk screening information 
All patients were screened within 48 hours after admission. All information needed to complete all 
seven screening tools was summarised; the collection of the data is discussed below. 
Note: In some cases where biochemical data (s-albumin) only became available at a later stage, the 
screening was completed as soon as possible. If a patient’s s-albumin was not tested during the 
duration of their ICU stay then the NRI screening tool was not completed. This study was non-
invasive and thus tests could not be ordered for research purposes only. 
When patients were unable to converse effectively with the researcher (i.e. comatose, sedated, 
demented) alternative methods were used to collect the necessary data. First, the medical file was 
studied for information on weight loss, dietary intake, gastrointestinal symptoms, disease severity 
etc. Second, close friends or family members were asked to provide the relevant information. If 
these were not present within the first 48 hours after admission and a contact number was specified 
in the patients’ file, the contact person was phoned. Only one call was made even if the call was 
unsuccessful. It was decided that since screening tools are meant to be simple, quick-and-easy to 
complete, more than one phone call would require too much time and effort for screening purposes. 
If no or insufficient screening information could be gathered, the patient was noted as a failed 
screening patient. In these cases none of the different screening tools were completed; however the 
patients were still followed up until discharge. This was done to be able to compare information 
about the development of clinical outcomes in patients who could not be screened versus patients 
who could be screened. 
a) Anthropometrical data 
Height 
Height was determined using lower arm length. This method has shown good correlation (r=0.98) 
with standing height and has a five percent error rate. Its use is recommended in patients who are 
unable to stand or where arm-span measurements are not possible, which is often the case in the 
ICU patient due to intravenous lines etc.182 
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Method: The patient’s arm was held relaxed at his/her side with the elbow bent to form a 90 degree 
angle, wrist in a neutral position and fingers extended. The lower arm length was measured (in cm) 
from the olecranon to the tip of the third finger. The measurement was taken twice and the average 
used as lower arm length. The recommended conversion table was used to determine height from 
lower arm length (Figure 2.1).182 
 
Figure 2.1 Conversion table for determining height from lower arm length182 
In a few cases it was impossible to measure lower arm length, for example where both arms were in 
casts. In these cases the bed length method was used to determine height. 
Method: The patient was positioned so that the body (head, shoulder, trunk and extremities) was 
aligned and then a mark was made at the base of the patient’s heels as well as the top of their 
crown. A measuring tape was used to measure the distance between the two marks (in cm) which 
was then subtracted from the length of the bed.183 
Body weight 
Body weight is extremely difficult to measure in ICU patients as they are mostly bedridden and often 
also sedated. Furthermore, the use of bed scales is not a common practice in South African hospitals 
due to a lack of resources. The current practice among dieticians in the SICU of TAH is to estimate 
body weight in order to calculate nutritional requirements. It was thus decided that for the purpose 
of this study weight would be estimated. 
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Care was taken to increase the accuracy of estimations and an objective method was also 
implemented to verify the estimations (see Section 2.3.5 Reliability and validity). It was decided that 
two investigators would independently estimate the weight (in kg) of each patient: the researcher as 
well as the SICU dietician. The average of the two observer’s estimations was used as body weight. 
When estimating body weight of ICU patients it is important to take into consideration that they are 
often fluid overloaded. Therefore, if fluid retention was prevalent the fluid-weight was subtracted 
from estimated body weight to arrive at an oedema-free body weight. To assess fluid status a clinical 
examination was performed and the patient’s fluid balance records were studied. In the case of 
uncertainty the attending physician was asked to assist with the evaluation of fluid status. 
The following guideline was used to compensate for edema/ascites:184 
Table 2.1 Guideline for deducting weight for oedema and ascites184 
 Oedema Ascites 
Mild 1 kg 2.2 kg 
Moderate 5 kg 6 kg 
Severe  10 kg 14 kg 
 
In the case of a patient with an amputation, the weight of the amputated limb(s) was subtracted 
from total body weight.183 Therefore, when estimating body weight, the observer did not have to 
compensate for the amputation. Body weight was estimated as if the amputated limb was present. 
The following table indicates the percentage of total body weight that each limb represents.183 
 
Table 2.2 Guideline for deducting weight for amputated limbs183 
Body part % of total body weight 
Entire arm 6.5 
Upper arm 3.5 
Forearm 2.3 
Hand 0.8 
Entire leg 18.5 
Upper leg 11.6 
Lower leg 5.3 
Foot 1.8 
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Body mass index 
BMI was calculated by dividing weight (after subtracting for fluid overload or amputation if 
necessary) with height in meters squared.183 
b) Weight changes 
Each patient was asked about recent changes in weight. Patients were asked to be as specific as 
possible and provide weight loss in kilograms as well as the time frame of the weight loss. To 
accommodate the different screening tools, patients were asked about weight loss in the previous 
two weeks, three months and six months. Patients were also asked about their usual weight before 
weight loss occurred. From this the researcher was able to calculate percentage of weight loss using 
the formula below: 
Percentage of weight loss = (usual weight – amount of weight lost) / usual weight x 100183 
Of the seven NRSTs, only the MST and the MNA-SF provide options for when patients or health care 
providers are unsure about changes in weight. For the other screening tools a definite answer is 
necessary and the following methods were used: where patients could not quantify the amount of 
weight lost, they were asked to classify it as mild, moderate or severe. If patients were unsure about 
weight loss, they were asked about symptoms such as anorexia or decreased food intake that could 
have led to weight loss. They were also asked whether their clothes fit as normal or if they have 
dropped in dress size. From this the researcher then estimated the amount of weight lost. 
c) Dietary intake 
The patient was asked about recent changes in appetite or dietary intake. If there had been a 
decrease in appetite or intake, the patient had to specify the degree (mild, moderate or severe), the 
time frame and the specific type of restriction (suboptimal intake, liquids only, starvation). Patients 
were also asked about use of supplemental drinks or tube feed in the previous month as well as 
their functional ability to eat. 
d) Biochemistry 
The NRI tool required s-albumin values for screening and therefore the first s-albumin value 
available for each patient was noted. No additional bloods were drawn for this study. 
e) Clinical examination 
Only the SGA tool required a physical examination of each patient. Therefore the methods described 
by Detsky et al.43 for completion of the SGA physical examination were used. All patients were 
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examined for evidence of loss of subcutaneous fat, muscle wasting, and oedema which was then 
graded as normal, mild moderate or severe. 
 To assess loss of subcutaneous fat the shoulders, triceps, chest and hands was examined for 
loss of fullness. 
 To assess the presence of muscle wasting the deltoid muscles and quadriceps femoris 
muscles was examined. The deltoid muscles are the muscles at the sides of the shoulders 
and the quadriceps femoris muscles are the muscles of the anterior thigh. 
 To assess the presence of oedema, the ankles and sacrum were examined. The area was 
tested for pitting oedema by pressing down with a finger for two seconds and then 
observing for a persistent indentation.43 
 
f) Gastrointestinal symptoms 
Patients were asked about any symptoms of nausea, vomiting, diarrhoea or anorexia in the past two 
weeks. 
g) Medical data 
The patient was asked about the severity of their disease, their history of acute disease, any 
neuropsychological problems and their mobility. The medical file was also studied and the attending 
doctor consulted to verify the answers. 
2.3.3.3 Observation of clinical outcomes 
Patients were followed up daily for the duration of their SICU stay. The following clinical outcomes 
were documented for each patient: 
a) Length of stay:  The number of days from admission to discharge or death of the patient was 
noted. 
 
b) Length of ventilation: The number of days that a patient required ventilation (full or partial 
ventilation) was recorded. 
 
c) Mortality: If death occurred during SICU stay this was recorded. Only in-SICU mortality was 
studied. 
 
d) APACHE II: The Acute Physiology, Age and Chronic Health Evaluation II (APACHE II) score was 
used as the scoring system for severity of disease as this is the current practice in TAH. The 
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APACHE II scoring system is an ICU scoring system that measures disease severity and risk of 
death. A number of physiological variables (age, white cell count, hematocrit, mean arterial 
pressure, rectal temperature, heart rate, respiratory rate, Glasgow coma scoring, serum 
sodium, serum potassium, serum creatinine, arterial pH, history of severe organ insufficiency 
or immunosuppression and oxygenation) are measured, scored and added together to arrive 
at a total score. A higher total score is indicative of higher risk of death.185 The attending 
doctor calculated each patient’s APACHE II score before discharge. 
 
e) Complications: The occurrence of any complications during SICU stay was noted daily. The 
modified criteria of Buzby et al. were used to classify complications according to their 
severity.186 
Table 2.3 Classification of complications according to severity186 
Grade List of complications 
Mild 
Cutaneous, catheter and urinary infections, cellulites, oral and 
oesophageal candidiasis, lobar atelectasis and infectious 
diarrhea 
Moderate 
Pulmonary infection, extra- and intra-abdominal abscesses, 
spontaneous bacterial peritonitis, venous thrombosis, liver 
dysfunction, cardiac arrhythmia, pancreatic or biliary 
gastrointestinal fistula, renal and congestive heart failure, 
wound dehiscence, gastrointestinal bleeding, decubitis ulcers, 
post-operative bleeding and empyema 
Severe 
Sepsis or bacteremia, septic shock, coagulopathy or septic 
coagulopathy, cholangitis, cardiac arrest, rejection of 
transplanted organ, respiratory failure, myocardial infarction, 
pancreatitis, osteomyelitis and pulmonary embolism 
 
The medical file and bed chart were used to obtain information about the development of 
complications and the attending doctor was asked to assist if the classification of complications was 
unclear. 
f) Biochemistry: The following biochemical values were noted on a daily basis or as they 
became available: s-albumin, C-reactive protein (CRP) and white cell count (WCC). Total 
protein is not routinely tested in the SICU of TAH and therefore it could not be included in 
the outcomes studied. Only routinely collected laboratory data was noted – no additional 
bloods were drawn. For s-albumin the lowest value observed during SICU stay was noted as 
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minimum s-albumin. For CRP and WCC the highest value observed during SICU stay was 
noted as maximum CRP and maximum WCC. 
2.3.4 Measuring feasibility and applicability 
The applicability and feasibility of using NRSTs in the SICU was assessed by noting the availability of 
the necessary data within the first 48 hours of SICU stay. The method of obtaining data was recorded 
e.g. could data be obtained from the patient, medical folder, family member or friend or was no data 
available. It was also noted on which day the patient was first able to communicate effectively with 
the researcher. This enabled the researcher to identify which NRSTs and, more specifically, which 
elements of NRSTs, are applicable for use in this population. 
2.3.5 Reliability and validity 
2.3.5.1 General reliability and validity 
The validity and reliability of the various NRSTs have been discussed in the literature overview. The 
researcher familiarized herself with the screening methodology for each of the screening tools to 
ensure valid screening results. Inter-observer variation was eliminated by having only one researcher 
collect all the relevant data (except for body weight – see above). 
Standardised methods, in which the researcher was trained, were used for all anthropometrical 
measurements. A non-stretchable tape measure was used for MUAC, lower arm length and bed 
length. 
If any uncertainty existed the attending medical doctor was asked to assist with the determination of 
the degree of fluid overload and the physical assessment of muscle and fat wastage. 
Data was entered into Excel spreadsheets by the same researcher and was spot-checked before 
analysis to minimize the prevalence of data-capturing errors. A qualified statistician performed all 
data-analyses. 
2.3.5.2 Reliability and validity of body weight estimations 
To increase the accuracy of body weight estimations, a second observer (the SICU dietician) was 
asked to also provide a weight estimation for each patient. The average of the two estimations was 
used as estimated body weight. 
To test the reliability and validity of the body weight estimations two tests were conducted. First, 
the agreement between the two observer’s weight estimations was measured to provide 
information about inter-observer reliability. 
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Second, the estimated body weight was also compared to an objective measurement of body weight 
as determined by knee height (KH) and MUAC. This method is recommended for use in bedridden 
patients and uses KH and MUAC in a formula to calculate an estimated body weight.183 However the 
method is labour intensive and specialised equipment is necessary, which makes it impractical for 
screening purposes. It also has a wide accuracy range which may imply it is not necessarily more 
accurate that visual body weight estimations. Nonetheless it was decided to use this method as an 
objective measure of body weight with which to compare the dieticians’ estimations. 
Measuring MUAC 
The patient rested in the supine position and the left or right arm was used. The upper arm was held 
parallel to the body, with the elbow bent to form a 90 degree angle and the forearm resting on the 
upper body with the palm facing downwards. The midpoint of the arm was marked halfway between 
the tip of the acromion process and the olecranon process. The arm was then stretched out parallel 
to the body with the palm facing upwards. The arm was elevated by placing a pillow under the 
elbow. A tape measure was used to measure the arm circumference in a vertical plane in line with 
the midpoint of the arm. The soft tissue was not compressed and the measurement was taken to the 
nearest millimeter.183 
Measuring KH 
Knee height was measured using a length-measuring rod with one fixed and one moveable blade. 
The patient rested in the supine position with the left leg positioned so that the knee and ankle were 
at a right angle. The fixed blade of the measuring instrument was then placed under the heel of the 
foot while the adjustable blade was positioned on the anterior surface of the thigh. The shaft of the 
measuring instrument was positioned parallel to the fibula, posterior to the head of the fibula and 
over the lateral malleolus. Soft tissue was compressed as the purpose was to measure the bone 
only. The measurement was taken to the nearest millimeter.183 
Table 2.4 lists the formulae used to calculate body weight from MUAC and KH.183 
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Table 2.4 Formulae for calculating body weight from MUACa and KHb 183 
Age Race Equation Accuracy 
    Female 
6 - 18 
Black Wt = (KH x 0.71) + (MUAC x 2.59) – 50.43 ± 7.65 kg 
White Wt = (KH x 0.77 ) + (MUAC x 2.47) – 50.16 ± 7.20 kg 
19 - 59 
Black Wt = (KH x 1.24) + (MUAC x 2.97) – 82.48 ± 11.98 kg 
White Wt = (KH x 1.01) + (MUAC x 2.81) – 66.04 ± 10.60 kg 
60 - 80 
Black Wt = (KH x 1.50) + (MUAC x 2.58) – 84.22 ± 14.52 kg 
White Wt = (KH x 1.09) + (MUAC x 2.68) – 65.51 ± 11.42 kg 
Male 
6 - 18 
Black Wt = (KH x 0.59) + (MUAC x 2.73) – 48.32 ± 7.50 kg 
White Wt = (KH x 0.68) + (MUAC x 2.64) – 50.08 ± 7.82 kg 
19 - 59 
Black Wt = (KH x 1.09) + (MUAC x 3.14) – 83.72 ± 11.30 kg 
White Wt = (KH x 1.19) + (MUAC x 3.21) – 86.82 ± 11.42 kg 
60 - 80 
Black Wt = (KH x 0.44) + (MUAC x 2.86) – 39.21 ± 7.04 kg 
White Wt = (KH x 1.10) + (MUAC x 3.07) – 75.81 ± 11.46 kg 
 a  Mid-Upper Arm Circumference,   b  Knee Height 
Note: If a patient’s fluid status influenced MUAC measurements (e.g. in the case of upper body 
oedema) the same methods as described previously were used to correct for the extra fluid weight. 
This was done so that oedema-free estimated body weight could be compared with oedema-free 
calculated body weight. Limb amputations were also corrected for as described previously. 
2.3.6 Data extraction 
A summary was made of all the information necessary to complete all seven screening tools. The 
researcher designed a single extraction form to gather all the relevant information since there were 
many overlaps between the screening tools and to improve use of time. The information was then 
used to complete the different screening tools upon data capturing. 
The data extraction sheet was pilot tested during October 2010 on 4 SICU patients. The extraction 
sheet was found to be sufficient to collect all the necessary data. An example of the data extraction 
sheet can be seen in Addendum 1. 
2.4 DATA ANALYSIS 
2.4.1 NRSTs 
Table 2.5 (following pages) indicates how the various screening tools were used to classify each 
patient’s nutritional status. Each NRST was used according to the guidelines set out by the various 
developers and as described in the literature overview. The only exception was measuring disease 
severity for the MUST. In practice, when screening hospitalized patients, it is recommended that 
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critically ill patients should be scored two, which would automatically classify them as malnourished. 
However as this would have classified 100% of our study population as malnourished it seemed 
pointless and it was decided to follow the usual protocol for scoring disease severity. 
 
Table 2.5 Nutritional Risk Screening Tool scoring and classification43,46,53,65,66,109,130 
NRST SCORING CLASSIFICATION 
MUST a) BMI  
 >20     0 
 18.5-20     1 
 <18.5     2 
b) Unintentional weight loss in past 3-6months 
 <5%     0 
 5-10%     1 
 >10%     2 
c) If patients is acutely ill AND there has been or is 
likely  to be no or very little nutritional intake >5 days:
       2 
Add up a, b and c for total 
score 
 
0  =  Well-nourished 
1  =  Risk of malnutrition 
>2  =  Malnourished 
MNA-SF a) Declined food intake  
 Severe     0 
 Moderate     1 
 None     2 
b) Weight loss in last 3 months 
 >3kg     0 
 Unsure     1 
 1-3kg     2 
 none     3 
c) Mobility 
 Bed/chair bound     0 
 Mobile but sedentary      1 
 Active     2 
d) Psychological stress/acute disease in past 3 months 
 Yes     0 
 No     2 
e) Neuropsychological problems 
 Severe dementia/depression  0 
 Mild dementia     1 
 None     2 
f) BMI 
 <19     0 
 19-21     1 
 21-23     2 
 ≥ 23     3 
Add up a, b, c, d, e and f for 
total score 
 
12-14  Well-nourished 
8-11 Risk of malnutrition 
0-7 Malnourished 
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NRS-2002 a) Nutritional screening 
Normal      0 
Weight loss >5% in 3 months OR food intake 
<50-75% of normal in preceding week  1 
Weight loss >5% in 2 months OR BMI  
18.5-20.5 OR food intake 25-60% of normal  
in preceding week    2 
Weight loss >5% in 1 month OR BMI <18.5  
OR food intake 0-25% of normal in preceding  
week       3 
b) Severity of disease screening 
Normal nutritional requirements  0 
Hip fracture/Chronic patients with acute complications: 
cirrhosis, COPD, hemodialysis, diabetes, oncology 
(nutritional requirements  
met with oral supplementation)   1 
Major abdominal surgery, stroke, severe pneu- 
monia, hematologic malignancy (increased 
requirements, need artificial feeding)  2 
Head injury, bone marrow transplant, ICU  
(APACHE >10)(ventilation, inotropic support,  
protein requirements very high, difficult to 
provide)     3 
Add up a and b for total 
score: 
 
0  Well-nourished 
1-2   Risk of malnutrition 
≥ 3  Malnourished 
 
NRI NRI score = (1.519 x s-albumin) + 0.417 x (current 
weight/usual weight x 100) 
>100   
Well-nourished 
97.6-100  
Mild malnutrition 
83.6-97.5  
Moderate malnutrition 
≤ 83.5   
Severe malnutrition 
MST a) Recent unintentional weight loss 
 No     0 
 Unsure     2 
 1-5kg     1 
 6-10kg     2 
 11-15kg     3 
 >15kg     4 
b) Poor intake due to decreased appetite? 
 No     0 
 Yes     1 
Add up a and b for total 
score: 
 
0-1 Well-nourished 
≥ 2 Malnourished 
SNAQ a) Unintentional weight loss 
 None / little    0 
 ≥ 6kg in past 6 months   3 
 ≥ 3kg in past months   2 
Add up a, b and c for total 
score: 
 
0-1 Well-nourished 
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b) Decreased appetite over past month   
 No     0 
 Yes     1 
c) Supplemental drinks /tube feed in past month 
 No     0 
 Yes     1 
2 Risk of malnutrition 
≥3 Malnourished 
SGA a) Recent weight change (0-12 months) 
 <5% A 
 5-10% B 
 >10% C 
b) Weight change last two weeks 
 Kept losing C 
 No change B 
 Gained A 
c)Dietary intake – amount 
 No change A 
 Moderate decrease B 
 Severe decrease C 
d) Dietary intake – type 
 Normal A 
 Suboptimal solids/full liquid B 
 Little fluids / NPO C 
e) Gastrointestinal symptoms >2weeks 
     (Nausea, vomiting, diarrhoea, dysphagia/ 
      odinophagia, anorexia) 
 None A 
 One symptom B 
 Two or more symptoms C 
f) Functional impairment  
 None A 
 Mild B 
 Severe C 
g) Muscle wasting 
 None  A 
 Mild-moderate B 
 Severe C 
h) Fat wasting 
 None A 
 Mild-moderate B 
 Severe C 
i) Oedema  
 None A 
 Mild-moderate B 
 Severe C 
Count number of A, B and 
C’s for question numbers  
a-i: 
 
Mostly A’s  
Well-nourished 
 
Mostly B’s 
Moderately malnourished 
 
Mostly C’s 
Severely malnourished 
 
NB: A, B and C allocations is 
only a guideline - subjective 
clinical judgment should be 
used to classify the patient 
in the end. 
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2.4.2 Statistical analysis 
MS Excel was used to capture the data and STATISTICA version 9 (StatSoft Inc. (2009) STATISTICA 
(data analysis software system, www.statsoft.com ) was used to analyse the data. 
Summary statistics were used to describe variables such as patient demographics, NRST 
classifications and clinical outcomes. Distributions of variables are presented with frequency tables. 
Medians or means were used as the measures of central location for ordinal and continuous 
responses and standard deviations and quartiles as indicators of spread. 
The relationships between continuous response variables such as LOS, length of ventilation (LOV), 
APACHE II score, complications, and biochemistry values, and nominal input variables such as the 
different NRST classifications were analysed using appropriate analysis of variance (ANOVA). For 
completely randomized designs the Mann-Whitney test or the Kruskal-Wallis test was used. 
The relation between two nominal variables such as NRST classification and mortality was 
investigated with contingency tables and likelihood ratio chi-square tests. 
Relationships between two continuous variables such as comparing body weight estimations 
between investigators and comparing estimated body weight with calculated body weight was 
analysed with regression analysis and the strength of the relationship measured with the Pearson 
correlation, or Spearman correlation if the continuous variables were not normally distributed. 
A p-value of p <0.05 represented statistical significance in hypothesis testing and 95% confidence 
intervals were used to describe the estimation of unknown parameters.  
The adequacy of NRSTs to predict clinical outcomes was judged based on overall performance. In 
other words, all clinical outcomes carried equal weight. NRSTs that were significantly and positively 
associated with more clinical outcomes than other tools were considered to have better predictive 
ability. If a tool could not significantly predict any clinical outcomes then it was considered to have 
poor predictive ability. 
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2.5 BUDGET 
The following table depicts the research expenses. The umbrella study was granted R50,000 by Sub-
Committee C of the Research Committee of the Faculty of Health Sciences and this was applied to 
cover all research costs. 
Table 2.6 Research project budget 
Item Quantity Cost per item Total 
Data extraction sheets 2016 R0.25 / page R504 
Telephone calls 40 calls R5.00 / call average R200 
Total R704 
 
Expenses related to the researcher’s thesis (language editing and printing) were covered by the 
researcher. 
2.6 ETHICAL AND LEGAL CONSIDERATIONS 
Ethical approval was granted for the umbrella study in August 2010 (Project number: N10/07/243). 
There was no need for further ethical approval as this study formed part of the aims, objectives and 
methodology outlined in the umbrella study. 
The protocol for the umbrella study was also reviewed by the Medical Superintendent of Research in 
TAH and permission was obtained to proceed with the study. 
A waiver of informed consent was requested by the umbrella study, due to the fact that ICU patients 
are often sedated and family members are not always present. The study was also non-invasive and 
only made use of routinely collected data. The waiver was granted and permission from the Head of 
the SICU was considered as consent on behalf of the patients. 
Privacy and confidentiality was at all times respected. Identifying information was and will be kept 
confidential. The data gathered was and will be used only for the purpose of this study as well as the 
umbrella study. 
2.7 TIME SCHEDULE 
The pilot study for the data extraction sheet was conducted during October 2011. The research 
project then began in November 2011 and data collection continued until June 2012. Data was thus 
collected for a total of eight months. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3: RESULTS 
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3.1 STUDY POPULATION 
During the eight month study period a total of 252 SICU patients met the inclusion criteria and were 
included in the study. Of these patients, 46 patients (18.25%) failed nutritional risk screens due to 
the unavailability of data. These patients were not able to effectively communicate with the 
researcher and their data could not be gathered from other sources such as the medical file or 
friends or family. Therefore these patients were excluded from the data analysis on the relationship 
between NRST classification and clinical outcomes. The final study population thus consisted of 206 
SICU patients. 
3.1.1 Demographic data 
The demographics of the SICU patients included in the study are summarized in Table 3.1. Of the 206 
patients, 62.62% were males and 37.38% were females. The mean age of study participants was 
49.52 (SD 17.39) years, with 78.16% younger than 65 years and 21.84% older than or equal to 65 
years of age. More than half (57.78%) of the patients were emergency admissions; the rest (42.23%) 
being elective surgery patients. 
Table 3.1 Demographic characteristics of patient population (n=206) 
Patient demographics n (%) n (%) 
Gender 
Male 
129 (62.62%) 
Female 
77 (37.38%) 
Age 
Mean: 49.52 (SD 17.39) years 
<65 years 
161 (78.16%) 
≥ 65 years 
45 (21.84%) 
Admission status 
Emergency 
119 (57.77%) 
Elective 
87 (42.23%) 
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The majority (43.69%) of the study participants fell into the gastrointestinal surgery diagnostic 
group. Vascular surgery (15.53%) and polytrauma (12.62%) were the second and third largest 
diagnostic groups. Seven patients did not fit into any of the diagnostic groups and were grouped 
together in the category “other” (Table 3.2). Their diagnoses were as follows: GIST tumor, ankle 
fracture, spinal injury, Fournier’s gangrene, necrotic penis, Gilberts’ syndrome and typhosis. 
Table 3.2 Primary diagnosis of patient population (n=206) 
Diagnostic group n (%) 
Gastrointestinal surgery 90 (43.69%) 
Vascular surgery 32 (15.53%) 
Polytrauma 26 (12.62%) 
Gynaecological surgery 13 (6.31%) 
Urogenital surgery 13 (6.31%) 
Other 7 (3.40%) 
Assault 6 (2.91%) 
Respiratory 6 (2.91%) 
Infectious 5 (2.43%) 
Trauma 4 (1.94%) 
Metabolic 3 (1.46%) 
Renal 1 (0.49%) 
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The majority of study patients (n=166; 80.58%) had a BMI of more than 20.00, while 21 (10.19%) had 
a BMI between 18.50 and 19.99 and 19 (9.22%) had a BMI of less than 18.50. The average BMI of the 
group was 24.78 (SD 5.86). Figure 3.1 depicts the spread of patients according to BMI category. 
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Figure 3.1 Number of patients within the five BMI categories (n=206) 
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3.1.2 Clinical outcomes 
The mean LOS in SICU was 5.75 (SD 5.52) days and the mean LOV was 2.93 (SD 5.08) days. Only five 
patients (2.44%) died during SICU stay. The mean APACHE II score was 10.41 (SD 5.51). The mean of 
the minimum s-albumin values was 22.77 (SD 6.20) and the mean of the maximum CRP and WCC 
levels were respectively 182.01 (SD 117.11) and 15.89 (SD 9.51). Forty-one percent (41.26%, n=85) of 
SICU patients did not develop any complications whereas 23.30% (n=48) developed one 
complication, 15.05% (n=31) developed two complications and 20.39% (n=42) developed three or 
more complications. Regarding the different complication categories, 21.36% (n=44) of SICU patients 
developed at least one mild complication, 45.63% (n=94) developed at least one moderate 
complication and 33.01% (n=68) developed at least one severe complication. The average number of 
total, mild, moderate and severe complications were respectively 1.51 (SD 2.04), 0.28 (SD 0.63), 0.70 
(SD 0.98) and 0.53 (SD 0.92). Patient outcomes are summarised in Table 3.3. 
Table 3.3 Summary of clinical outcomes observed in patient population (n=206) 
Clinical outcome Mean (SD) 
LOS (days) 5.75 (5.52) 
LOV (days) 2.93 (5.08) 
APACHE II score (score) 10.41 (5.51) 
Complications (number) 
Total 
Mild 
Moderate 
Severe 
 
1.51 (2.04) 
0.28 (0.63) 
0.70 (0.98) 
0.53 (0.92) 
Biochemistry 
Minimum s-albumin (g/l) 
Maximum WCC (x 109/l) 
Maximum CRP (mg/l) 
 
22.77 (6.20) 
15.89 (9.51) 
182.01 (117.11) 
Clinical outcome n (%) 
Mortality 5 (2.44%) 
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3.2 PREVALENCE OF MALNUTRITION 
The NRST classifications for the various screening tools are summarised in Table 3.4. 
Table 3.4 Patient classification according to the various NRSTsa 
NRST Well-nourished Risk of malnutrition Malnourished 
MUST 105 (50.97%) 39 (18.93%) 62 (30.10%) 
MNA 63 (30.58%) 109 (52.91%) 34 (16.50%) 
SNAQ 132 (64.10%) 14 (6.80%) 60 (29.13%) 
NRS-2002 1 (0.49%) 55 (26.70%) 150 (72.82%) 
SGA 105 (50.97%) 63 (30.58%) 38 (18.45%) 
 Well-nourished Malnourished 
MST 45 (21.84%) 161 (78.16%) 
 Well-nourished 
Mildly 
malnourished 
Moderately 
malnourished 
Severely 
malnourished 
NRI 3 (1.70%) 4 (2.27%) 37 (21.02%) 132 (75.00%) 
 a  Nutritional Risk Screening Tools  
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3.3 NRST PREDICTIONS OF CLINICAL OUTCOMES 
3.3.1 MUST 
According to the MUST 105 patients (50.97%) were classified as well-nourished, 39 (18.93%) as at 
risk of malnutrition and 62 (30.10%) as malnourished (Figure 3.2). 
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Figure 3.2 Prevalence of malnutrition according to the Malnutrition Universal Screening Tool 
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No significant correlations were found between the MUST and any of the clinical outcomes. The 
malnourished patients seemed to have the lowest s-albumin levels and the highest APACHE II scores, 
but this was non-significant. There was also a trend for the malnourished or at risk of malnutrition 
patient groups to have a longer LOS and LOV as well as more mild complications and a higher WCC 
than the well nourished patients, but none of this reached statistical significance. Also, the group at 
risk of malnutrition seemed to have the worst outcomes for LOS, LOV, mild complications and WCC 
and not, as may have been expected, the malnourished group. Although not significant, the well 
nourished group had the highest mortality and the most total, moderate and severe complications. 
Tables 3.5 and 3.6 summarize the non-significant results for the MUST. 
When the group at risk of malnutrition and the group classified as malnourished were analysed 
together (n=101; 49.03%) and compared to the well-nourished group (n=105; 50.97%), there were 
still no significant correlations with any of the clinical outcomes measured. The group combining the 
at risk patients and the malnourished patients had a longer LOS and LOV, higher APACHE II scores, 
more mild complications, lower s-albumin levels and higher WCC and CRP levels than the well-
nourished group, but none of this reached statistical significance. The non-significant results can be 
seen in Tables 3.7 and 3.8. 
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Table 3.5 Non-significant clinical outcome results for the MUSTa nutritional risk categories 
 Total Normal Risk Malnutrition Malnourished p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99 – 6.51 
(n=105) 
5.37 
4.36 
4.53 – 6.21 
(n=38) 
7.09 
8.47 
4.31 – 9.88 
(n=62) 
5.56 
4.94 
4.31 – 6.82 
p=0.91 Kruskal-Wallis 
test 
 
Mean LOV (days) 
SD 
CI 
(n=205) 
2.93 
5.08 
2.23 – 3.63 
(n=105) 
2.54 
4.22 
1.73 – 3.36 
(n=38) 
3.81 
6.88 
1.55 – 6.08 
(n=62) 
3.03 
5.15 
1.72 – 4.34 
p=0.92 Kruskal-Wallis 
test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63 – 11.18 
(n=102) 
10.28 
5.48 
9.21 – 11.36 
(n=36) 
9.34 
6.15 
7.31 – 11.47 
(n=59) 
11.24 
5.11 
9.91 – 11.36 
p=0.11 Kruskal-Wallis 
test 
 
Mean number of total complications 
SD 
CI 
(n=206) 
1.51 
2.04 
1.23 – 1.79 
(n=105) 
1.60 
2.08 
1.20 – 2.00 
(n=39) 
1.46 
2.53 
0.64 – 2.28 
(n=62) 
1.40 
1.60 
1.00 – 1.81 
p=0.61 Kruskal-Wallis 
test 
 
Mean number of mild complications 
SD 
CI 
(n=206) 
0.28 
0.63 
0.19 – 0.36 
(n=105) 
0.25 
0.60 
0.13 – 0.36 
(n=39) 
0.31 
0.69 
0.08- 0.53 
(n=62) 
0.31 
0.64 
0.14 – 0.47 
p=0.81 Kruskal-Wallis 
test 
 
Mean number of moderate 
complications 
SD 
CI 
(n=206) 
0.70 
 
0.98 
0.57 – 0.84 
(n=105) 
0.78 
 
1.07 
0.57 – 0.99 
(n=39) 
0.64 
 
1.01 
0.31 – 0.97 
(n=62) 
0.61 
 
0.78 
0.42 – 0.81 
p=0.71 Kruskal-Wallis 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41 – 0.66 
(n=105) 
0.57 
0.91 
0.40 – 0.75 
(n=39) 
0.51 
1.21 
0.12 – 0.91 
(n=62) 
0.48 
0.72 
0.30 – 0.67 
p=0.43 Kruskal-Wallis 
test 
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Mean s-albumin (g/l) 
SD 
CI 
(n=176) 
22.77 
6.20 
21.85 – 23.70 
(n=90) 
23.47 
5.96 
22.22 – 24.72 
(n=33) 
23.28 
6.60 
21.14 – 25.83 
(n=53) 
21.15 
6.17 
19.45 – 22.85 
p=0.07 Kruskal-Wallis 
test 
 
Mean CRP (mg/l) 
SD 
CI 
(n=164) 
182.01 
117.11 
163.95 – 200.06 
(n=83) 
179.26 
102.94 
156.79 – 201.74 
(n=31) 
200.39 
161.49 
141.15 – 259.62 
(n=50) 
175.16 
102.94 
144.48 – 205.84 
p=0.93 Kruskal-Wallis 
test 
 
Mean WCC (x 109/l) 
SD 
CI 
(n=189) 
15.89 
9.51 
14.52 – 17.25 
(n=97) 
15.34 
9.57 
13.41 – 17.26 
(n=36) 
16.22 
6.50 
14.01 – 18.42 
(n=56) 
16.63 
11.02 
13.68 – 19.58 
p=0.45 Kruskal-Wallis 
test 
 a  Malnutrition Universal Screening Tool 
 
Table 3.6 M-L Chi-square test of the presence or absence of death by MUSTa category (p=0.29) 
MUST Death - present Death - absent Row - Totals 
Normal 4 (3.81%) 101 (96.19%) 105 
Risk malnutrition 1 (2.63%) 37 (97.37%) 38 
Malnourished 0 (0.00%) 61 (100.00%) 62 
Totals 5 200 205 
    a  Malnutrition Universal Screening Tool 
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Table 3.7 Non-significant clinical outcome results for the MUSTa nutritional risk outcomes 
 Total Well-nourished 
At risk of 
malnutrition + 
malnourished 
p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99-6.51 
(n=105) 
5.37 
5.36 
4.53-6.21 
(n=100) 
6.14 
6.51 
4.85-7.44 
p=0.70 Mann-Whitney U 
test 
 
Mean LOV (days) 
SD 
CI 
(n=205) 
2.93 
5.08 
0.23-3.63 
(n=105) 
2.54 
4.22 
1.73-3.36 
(n=100) 
3.33 
5.85 
2.17-4.49 
p=0.80 Mann-Whitney U 
test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63-11.18 
(n=102) 
10.28 
5.48 
9.21-11.36 
(n=95) 
10.54 
5.57 
9.40-11.67 
p=0.98 Mann-Whitney U 
test 
 
Mean number of total complications 
SD 
CI 
(n=206) 
1.51 
2.04 
1.23-1.79 
(n=105) 
1.60 
2.08 
1.20-2.00 
(n=101) 
1.43 
2.00 
1.03-1.82 
p=0.76 Mann-Whitney U 
test 
 
Mean number of mild complications 
SD 
CI 
(n=206) 
0.28 
0.63 
0.19-0.36 
(n=105) 
0.25 
0.60 
0.13-0.36 
(n=101) 
0.31 
0.66 
0.18-0.44 
p=0.69 Mann-Whitney U 
test 
 
Mean number of moderate complications 
SD 
CI 
(n=206) 
0.70 
0.98 
0.57-0.84 
(n=105) 
0.78 
1.07 
0.57-0.99 
(n=101) 
0.62 
0.87 
0.45-0.80 
p=0.49 Mann-Whitney U 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41-0.66 
(n=105) 
0.57 
0.91 
0.40-0.75 
(n=101) 
0.50 
0.93 
0.31-0.68 
p=0.51 Mann-Whitney U 
test 
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Mean s-albumin (g/l) 
SD 
CI 
(n=176) 
22.77 
6.20 
21.85-23.70 
(n=90) 
23.47 
5.96 
22.22-24.72 
(n=86) 
22.05 
6.40 
20.67-23.42 
p=0.10 Mann-Whitney U 
test 
 
Mean CRP (mg/l) 
SD 
CI 
(n=164) 
182.01 
117.11 
163.95-200.06 
(n=83) 
179.26 
102.94 
156.79-210.74 
(n=81) 
184.81 
130.64 
155.93-213.70 
p=0.84 Mann-Whitney U 
test 
 
Mean WCC (x 109/l) 
SD 
CI 
(n=189) 
15.89 
9.51 
14.52-17.25 
(n=97) 
15.34 
9.57 
13.41-17.26 
(n=92) 
16.47 
9.47 
14.51-18.43 
p=0.27 Mann-Whitney U 
test 
 a  Malnutrition Universal Screening Tool 
 
 
Table 3.8   M-L Chi-square test of the presence or absence of death by MUSTa outcome (p=0.12) 
MUST Death - present Death - absent Row - Totals 
Well-nourished  2 (2.86%) 68 (97.14%) 70 
At risk of malnutrition 
+ malnourished 
0 (0.00%) 59 (100.00%) 59 
Total 2 127 129 
    a  Malnutrition Universal Screening Tool 
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3.3.2 MNA-SF 
Overall the MNA-SF classified 63 patients (30.58%) as well-nourished. One-hundred and nine 
patients (52.19%) were classified as at risk of malnutrition and 34 (16.50%) as malnourished  
(Figure 3.3). 
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Figure 3.3 Prevalence of malnutrition according to the Mini-Nutritional Assessment  
- Short Form 
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A significant correlation was found between the MNA-SF and s-albumin levels (p<0.01; Kruskal-
Wallis test) when analysing for all three groups (Figure 3.4). The malnourished patients had a lower 
mean s-albumin level (19.83; SD 6.89; CI 17.21-22.45) than the well-nourished patients (24.13; SD 
5.70; CI 22.56-25.70) and the patients at risk of malnutrition (22.91; SD 6.02; CI 21.68-24.15) When 
analysing for two groups only, the difference was significant between the malnourished and the 
well-nourished patients (p<0.01; Bonferroni test) and borderline significant between the 
malnourished and at risk of malnutrition patients (p=0.05; Bonferroni test). The patients at risk of 
malnutrition also had lower s-albumin levels than the well-nourished group, but this was not 
statistically significant. 
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Figure 3.4 Mean minimum serum-albumin per Mini-Nutritional Assessment - Short Form  
category (p<0.01) 
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The MNA-SF was also correlated with WCC (p=0.01; Kruskal-Wallis test) when analysing for all three 
groups (Figure 3.5). The patients at risk of malnutrition had the highest WCC (17.58; SD 11.62; CI 
15.27-19.88). Compared to the well nourished patients (13.19; SD 5.35; CI 11.79-14.58) this was 
significantly higher (p=0.01; Bonferroni test) but not when compared to the malnourished group 
(15.57; SD 6.62; CI 13.09-18.04). There was also no significant difference between the WCC of the 
malnourished and well-nourished groups. 
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Figure 3.5 Mean maximum white cell count per Mini-Nutritional Assessment - Short Form 
category (p=0.01) 
 
Although not significant, there was a trend for malnourished patients to have the longest LOS and 
LOV followed by at risk of malnutrition patients. The APACHE II scores and number of mild, 
moderate and total complications were also higher in the malnourished and at risk of malnutrition 
groups than in the well-nourished group, but once again there were no statistical significance. 
Tables 3.9 and 3.10 (following pages) summarize the non-significant results of the MNA-SF. 
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Table 3.9 Non-significant clinical outcome results for the MNA-SFa nutritional risk categories 
 Total Normal Risk Malnutrition Malnourished p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99 – 6.51 
(n=63) 
5.39 
4.44 
4.27 – 6.51 
(n=109) 
5.62 
4.72 
4.73 – 6.52 
(n=33) 
6.85 
8.89 
3.70 – 10.00 
p=0.73 Kruskal-Wallis 
test 
 
Mean LOV (days) 
SD 
CI 
(n=205) 
2.93 
5.08 
2.23 – 3.63 
(n=63) 
2.54 
4.13 
1.50 – 3.58 
(n=109) 
2.80 
4.57 
1.93 – 3.67 
(n=33) 
4.09 
7.70 
1.36 – 6.82 
p=0.78 Kruskal-Wallis 
test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63 – 11.18 
(n=61) 
9.70 
5.51 
8.29 – 11.12 
(n=105) 
10.49 
5.66 
9.39 – 11.58 
(n=31) 
11.52 
4.93 
9.71 – 13.33 
p=0.22 Kruskal-Wallis 
test 
 
Mean number of total complications 
SD 
CI 
(n=206) 
1.51 
2.04 
1.23 – 1.79 
(n=63) 
1.33 
1.75 
0.89 – 1.77 
(n=109) 
1.55 
1.98 
1.17 – 1.93 
(n=34) 
1.74 
2.65 
0.81 – 2.66 
p=0.75 Kruskal-Wallis 
test 
 
Mean number of mild complications 
SD 
CI 
(n=206) 
0.28 
0.63 
0.19 – 0.36 
(n=63) 
0.19 
0.59 
0.04 – 0.34 
(n=109) 
0.29 
0.58 
0.18 – 0.40 
(n=34) 
0.38 
0.82 
0.10 – 0.67 
p=0.25 Kruskal-Wallis 
test 
 
Mean number of moderate 
complications 
SD 
CI 
(n=206) 
0.70 
 
0.98 
0.57 – 0.84 
(n=63) 
0.60 
 
0.83 
0.39 – 0.81 
(n=109) 
0.79 
 
1.04 
0.59 – 0.99 
(n=34) 
0.62 
 
1.04 
0.25 – 0.98 
p=0.35 Kruskal-Wallis 
test 
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Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41 – 0.66 
(n=63) 
0.54 
0.78 
0.34 – 0.74 
(n=109) 
0.47 
0.92 
0.29 – 0.64 
(n=34) 
0.74 
1.14 
0.34 – 1.13 
p=0.22 Kruskal-Wallis 
test 
 
Mean CRP (mg/l) 
SD 
CI 
(n=164) 
182.01 
117.11 
163.95 – 200.06 
(n=49) 
210.18 
114.26 
177.36 – 243.00 
(n=89) 
170.30 
122.89 
144.42 – 196.19 
(n=26) 
168.96 
84.74 
130.69 – 207.23 
p=0.12 Kruskal-Wallis 
test 
 a  Mini-Nutritional Assessment – Short Form 
 
 
Table 3.10 M-L Chi-square test of the presence or absence of death by MNA-SFa category (p=0.84) 
MNA-SF Death - present Death - absent Row - Totals 
Normal 2 (3.17%) 61 (96.83%) 63 
Risk malnutrition 2 (1.83%) 107 (98.17%) 109 
Malnourished 1 (3.03%) 32 (96.97%) 33 
Totals 5 200 205 
    a  Mini-Nutritional Assessment – Short Form 
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Analyses were also done comparing the well-nourished group (n=63; 30.58%) to a combined group 
of the malnourished and at risk of malnutrition patients (n=143; 69.42%). This time the MNA-SF 
categories were significantly correlated with WCC (Figure 3.6) and CRP (Figure 3.7) levels. The 
combined malnutrition group had a significantly higher (p<0.01; Mann-Whitney U test) mean WCC 
(17.11; SD 10.69; CI 15.26-18.97) than the well-nourished group (13.19; SD 5.35; CI 11.79-14.58). 
However, their mean CRP level of 170.00 (SD 116.74; CI 148.44-191.56) was significantly lower 
(p=0.04; Mann-Whitney U test) than the mean CRP level of the well nourished group (210.18; SD 
114.26; CI 177.36-243.00). 
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Figure 3.6 Mean maximum white cell count per Mini-Nutritional Assessment - Short Form 
outcome (p<0.01) 
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Figure 3.7 Mean maximum C-Reactive Protein level per Mini-Nutritional Assessment - Short 
Form outcome (p=0.04) 
 
The group combining the at risk of malnutrition and malnourished patients had a longer LOS and 
LOV, higher APACHE II scores, more total, mild and moderate complications and lower s-albumin 
scores than the well-nourished group, but this did not reach statistical significance.  
The non-significant results can be seen in Tables 3.11 and 3.12. 
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Table 3.11 Non-significant clinical outcome results for the MNA-SFa nutritional risk outcomes 
 Total Well-nourished 
At risk of 
malnutrition + 
malnourished 
p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99-6.51 
(n=63) 
5.39 
4.44 
4.27-6.51 
(n=142) 
5.91 
5.94 
4.92-6.89 
p=0.95 Mann-Whitney U 
test 
 
Mean LOV (days) 
SD 
CI 
(n=205) 
2.93 
5.08 
2.23-3.63 
(n=63) 
2.54 
4.13 
1.50-3.58 
(n=142) 
3.10 
5.46 
2.19-4.00 
p=0.54 Mann-Whitney U 
test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63-11.18 
(n=61) 
9.70 
5.51 
8.29-11.12 
(n=136) 
10.72 
5.50 
9.78-11.65 
p=0.22 Mann-Whitney U 
test 
 
Mean number of total complications 
SD 
CI 
(n=206) 
1.51 
2.04 
1.23-1.79 
(n=63) 
1.33 
1.75 
0.89-1.77 
(n=143) 
1.59 
2.15 
1.24-1.95 
p=0.50 Mann-Whitney U 
test 
 
Mean number of mild complications 
SD 
CI 
(n=206) 
0.28 
0.63 
0.19-0.36 
(n=63) 
0.19 
0.59 
0.04-0.34 
(n=143) 
0.31 
0.64 
0.21-0.42 
p=0.24 Mann-Whitney U 
test 
 
Mean number of moderate complications 
SD 
CI 
(n=206) 
0.70 
0.98 
0.57-0.84 
(n=63) 
0.60 
0.83 
0.39-0.81 
(n=143) 
0.75 
1.04 
0.58-0.92 
p=0.49 Mann-Whitney U 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41-0.66 
(n=63) 
0.54 
0.78 
0.34-0.74 
(n=143) 
0.53 
0.98 
0.37-0.69 
p=0.50 Mann-Whitney U 
test 
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Mean s-albumin (g/l) 
SD 
CI 
(n=176) 
22.77 
6.20 
21.85-23.70 
(n=53) 
24.13 
5.70 
22.56-25.70 
(n=123) 
22.19 
6.34 
21.05-23.32 
p=0.06 One-way ANOVA 
test 
 a  Mini-Nutritional Assessment – Short Form 
 
 
Table 3.12 M-L Chi-square test of the presence or absence of death by MNA-SFa outcome (p=0.66) 
MNA-SF Death - present Death - absent Row - Totals 
Well-nourished  2 (3.17%) 61 (96.83%) 63 
At risk of malnutrition 
+ malnourished 
3 (2.11%) 139 (97.89%) 142 
Total 5 200 205 
    a  Mini-Nutritional Assessment – Short Form 
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The MNA-SF is specifically indicated for elderly patients and therefore it was decided to do a 
separate analysis for the elderly group of patients in the study sample. When only the elderly 
patients were analysed (n=45), 9 (20%) patients were classified as well-nourished, 27 (60%) as at risk 
of malnutrition and 9 (20%) as malnourished. 
The only significant finding was that s-albumin levels declined with declining nutritional status 
(p=0.03; Kruskal-Wallis test; Figure 3.8). The malnourished patients had the lowest average s-
albumin (19.38; SD 4.81; CI 15.35-23.40) and this was significantly lower (p=0.03; Bonferroni test) 
than the average s-albumin in the well-nourished patients (27.86; SD 5.84; CI 22.45-33.26). The s-
albumin levels in the group at risk of malnutrition (24.64; SD 6.30; CI 22.04-27.24) was higher than 
the malnourished group and lower than the well-nourished group, but this was not statistically 
significant. 
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Figure 3.8 Mean minimum serum-albumin level for patients ≥ 65 years 
per Mini-Nutritional Assessment - Short Form category (p=0.03) 
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Combining the group at risk of malnutrition with the malnourished group (n=36; 80%) and 
comparing them to the well-nourished group (n=9; 20%) revealed an almost significant association 
(Figure 3.9). The combined malnutrition group had borderline (p=0.05) significantly higher WCCs 
(15.24; SD 4.81; CI 13.59-16.90) than the well-nourished group (11.34; SD 3.80; CI 8.16-14.51; Figure 
3.9). 
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Figure 3.9 Mean maximum white cell count for patients ≥65 years 
per Mini-Nutritional Assessment - Short Form outcome (p=0.05) 
 
Although none of the other associations seen were significant, a trend for longer LOS and LOV as 
well as more mild and severe complications was seen when all three groups were analysed. 
Furthermore, the combined malnutrition group showed a trend for worse results in all of the other 
outcomes (except mortality) studied.  
Tables 3.13, 3.14, 3.15 and 3.16 summarize the non-significant results for elderly patients. 
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Table 3.13 Non-significant clinical outcome results for the MNA-SFa nutritional risk categories for elderly patients 
 Total Normal Risk Malnutrition Malnourished p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=45) 
6.16 
7.75 
3.75 – 8.40 
(n=9) 
3.29 
0.79 
2.69 - 3.90 
(n=27) 
6.33 
6.51 
3.76 – 8.91 
(n=9) 
8.07 
13.35 
-2.19 – 18.34 
p=0.50 Kruskal-Wallis 
test 
 
Mean LOV (days) 
SD 
CI 
(n=45) 
2.82 
6.41 
0.90 – 4.75 
(n=9) 
0.56 
1.13 
-0.31 – 1.42 
(n=27) 
3.22 
6.09 
0.81 – 5.63 
(n=9) 
3.89 
9.84 
-3.68 – 11.45 
p=0.31 Kruskal-Wallis 
test 
 
Mean APACHE II score 
SD 
CI 
(n=42) 
11.98 
5.50 
10.26 – 13.69 
(n=8) 
10.50 
3.38 
7.67 – 13.33 
(n=25) 
12.64 
5.97 
10.18 – 15.10 
(n=9) 
11.44 
5.83 
6.96 – 15.93 
p=0.65 Kruskal-Wallis 
test 
 
Mean number of total complications 
SD 
CI 
(n=45) 
1.87 
2.70 
1.05 – 2.68 
(n=9) 
1.56 
1.74 
0.22 – 2.89 
(n=27) 
1.96 
2.59 
0.94 – 2.99 
(n=9) 
1.89 
3.89 
-1.10 - 4.88 
p=0.75 Kruskal-Wallis 
test 
 
Mean number of mild complications 
SD 
CI 
(n=45) 
0.20 
0.55 
0.04 – 0.36 
(n=9) 
0.11 
0.33 
-0.15 – 0.37 
(n=27) 
0.15 
0.36 
0.00 – 0.29 
(n=9) 
0.44 
1.01 
-0.33 – 1.22 
p=0.75 Kruskal-Wallis 
test 
 
Mean number of moderate 
complications 
SD 
CI 
(n=45) 
0.93 
 
1.30 
0.54 – 1.33 
(n=9) 
0.78 
 
0.83 
0.14 – 1.42 
(n=27) 
1.11 
 
1.42 
0.55 – 1.67 
(n=9) 
0.56 
 
1.33 
-0.47 – 1.58 
p=0.29 Kruskal-Wallis 
test 
 
Mean number of severe complications 
SD 
CI 
(n=45) 
0.73 
1.27 
0.35 – 1.11 
(n=9) 
0.67 
1.00 
-0.10 – 1.44 
(n=27) 
0.70 
1.27 
0.20 – 1.20 
(n=9) 
0.89 
1.62 
-0.35 – 2.13 
p=0.81 Kruskal-Wallis 
test 
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Mean CRP (mg/l) 
SD 
CI 
(n=38) 
148.73 
116.73 
110.37 – 187.10 
(n=7) 
143.13 
121.90 
30.39 – 255.87 
(n=24) 
156.03 
127.57 
102.21 – 209.95 
(n=7) 
129.14 
77.95 
57.05 – 201.24 
p=0.90 Kruskal-Wallis 
test 
 
Mean WCC (x 109/l) 
SD 
CI 
(n=43) 
14.52 
4.85 
13.02 – 16.01 
(n=8) 
11.34 
3.80 
8.16 – 14.51 
(n=27) 
15.33 
4.85 
13.41 – 17.25 
(n=8) 
14.95 
4.99 
10.78 – 19.12 
p=0.14 Kruskal-Wallis 
test 
 a  Mini-Nutritional Assessment – Short Form 
 
 
Table 3.14  M-L Chi-square test of the presence or absence of death in patients ≥ 65 years by MNA-SFa category (p=0.47) 
MNA-SF Death - present Death - absent Row - Totals 
Normal 1 (11.11%) 8 (88.89%) 9 
Risk malnutrition 2 (7.41%) 25 (92.59%) 29 
Malnourished 0 (0.00%) 9 (100.00%) 9 
Totals 3 42 45 
    a  Mini-Nutritional Assessment – Short Form 
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Table 3.15 Non-significant clinical outcome results for the MNA-SFa nutritional risk outcomes for elderly patients 
 Total Well-nourished 
At risk of 
malnutrition + 
malnourished 
p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=45) 
6.16 
7.75 
3.75 – 8.40 
(n=9) 
3.29 
0.79 
2.69 – 3.90 
(n=36) 
6.77 
8.53 
3.88 – 9.66 
p=0.44 Mann-Whitney U 
test 
 
Mean LOV (days) 
SD 
CI 
(n=45) 
2.82 
6.41 
0.90 – 4.75 
(n=9) 
0.56 
1.13 
-0.31 – 1.42 
(n=36) 
3.39 
7.06 
1.00 – 5.78 
p=0.19 Mann-Whitney U 
test 
 
Mean APACHE II score 
SD 
CI 
(n=42) 
11.98 
5.50 
10.26 – 13.69 
(n=8) 
10.50 
3.38 
7.67 – 13.33 
(n=34) 
12.32 
5.87 
10.28 – 14.37 
p=0.41 Mann-Whitney U 
test 
 
Mean number of total complications 
SD 
CI 
(n=45) 
1.87 
2.70 
1.05 – 2.68 
(n=9) 
1.56 
1.74 
0.22 – 2.89 
(n=36) 
1.94 
2.91 
0.96 – 2.93 
p=0.92 Mann-Whitney U 
test 
 
Mean number of mild complications 
SD 
CI 
(n=45) 
0.20 
0.55 
0.04 – 0.36 
(n=9) 
0.11 
0.33 
-0.15 – 0.37 
(n=36) 
0.22 
0.59 
0.02-0.42 
p=0.80 Mann-Whitney U 
test 
 
Mean number of moderate complications 
SD 
CI 
(n=45) 
0.93 
 
1.30 
0.54 – 1.33 
(n=9) 
0.78 
0.83 
0.14-1.42 
(n=36) 
0.97 
1.40 
0.50 – 1.45 
p=0.89 Mann-Whitney U 
test 
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Mean number of severe complications 
SD 
CI 
(n=45) 
0.73 
1.27 
0.35 – 1.11 
(n=9) 
0.67 
1.00 
-0.10 – 1.44 
(n=36) 
0.75 
1.34 
0.30 – 1.20 
p=0.79 Mann-Whitney U 
test 
 
Mean s-albumin (g/l 
SD 
CI 
(n=40) 
24.15 
6.41 
22.10 – 26.20 
(n=7) 
27.86 
5.84 
22.45-33.26 
(n=33) 
23.36 
6.33 
21.12 – 25.61 
p=0.19 Mann-Whitney U 
test 
 
Mean CRP (mg/l) 
SD 
CI 
(n=38) 
148.73 
116.73 
110.37 – 187.10 
(n=7) 
143.13 
121.90 
30.39 – 255.87 
(n=31) 
150.00 
117.57 
106.87 – 193.13 
p=0.90 Mann-Whitney U 
test 
 
Mean WCC (x 109/l) 
SD 
CI 
(n=43) 
14.52 
4.85 
13.02 – 16.01 
(n=8) 
11.34 
3.80 
8.16 – 14.51 
(n=35) 
15.24 
4.81 
13.59 – 16.90 
p=0.05 Mann-Whitney U 
test 
 a  Mini-Nutritional Assessment – Short Form 
 
 
Table 3.16 M-L Chi-square test of the presence or absence of death for patients ≥ 65 years by MNA-SFa outcome (p=0.57) 
MNA-SF Death - present Death - absent Row - Totals 
Well-nourished  1 (11.11%) 8 (88.89%) 9 
At risk of malnutrition 
+ malnourished 
2 (5.56%) 34 (94.44%) 36 
Total 3 42 45 
    a  Mini-Nutritional Assessment – Short Form 
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3.3.3 NRS-2002 
According to the NRS-2002, 150 patients (72.82%) were classified as malnourished and 55 (26.70%) 
were classified as at risk of malnutrition. Only one patient (0.49%) was classified as well-nourished 
and therefore results need to be interpreted with caution (Figure 3.10). 
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Figure 3.10 Prevalence of malnutrition according to the Nutritional Risk Score - 2002 
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When analysing all three groups, a significant correlation was found between the NRS-2002 and 
APACHE II scores (p=0.02; Kruskal-Wallis test). The malnourished patients had a mean APACHE II 
score of 10.94 (SD 5.31; CI 10.05-11.82) which was higher than the mean APACHE II score of the 
patients at risk of malnutrition (9.05; SD 5.87; CI 7.47-10.64), although when comparing the two 
groups only, this was not significant (Figure 3.11). The one well-nourished patient had an APACHE II 
score of 10 which was not significantly lower than the malnourished group and not significantly 
higher than the group at risk of malnutrition. 
 
Figure 3.11 Mean APACHE II score per Nutritional Risk Score - 2002 category (p=0.02) 
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A significant association between the three NRS-2002 classifications and mild (p=0.04; Kruskal-Wallis 
test), moderate (p<0.01; Kruskal-Wallis test) and total complications (p<0.01; Kruskal-Wallis) was 
also found (Figures 3.12 below, and 3.13 and 3.14, next page). 
The malnourished group had a mean rate of moderate complications of 0.79 (SD 1.03; CI 0.63-0.96) 
and a mean rate of total complications of 1.75 (SD 2.19; CI 1.39-2.10). Both of these were 
significantly higher (moderate: p=0.04; total: p=0.01; Bonferroni test) than the mean rate of 
moderate (0.42; SD 0.71; CI 0.23-0.61) and total (0.84; SD 1.33; CI 0.48-1.20) complications in the 
group at risk of malnutrition. The mean rate of mild complications was also higher in the 
malnourished group (0.33; SD 0.70; CI 0.21-0.44) than in the group at risk of malnutrition (0.13; SD 
0.34; CI 0.04-0.22, but this was not statistically significant. The one well-nourished patient had the 
highest rate of mild (1.00), moderate (3.00) and total (4.00) complications, but this was not 
statistically significant. 
 
Figure 3.12 Mean number of mild complications per Nutritional Risk Score – 2002 
 category (p=0.04) 
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Figure 3.13 Mean number of moderate complications per Nutritional Risk Score - 2002 
category (p<0.01) 
 
 
Figure 3.14 Mean number of total complications per Nutritional Risk Score - 2002  
category (p<0.01) 
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When analysing for all three groups no significant correlation was found for LOV. However, 
comparing only two groups at a time revealed that the malnourished group had a significantly longer 
(p=0.02; Bonferroni test) mean LOV (3.52; SD 5.73; CI 2.60-4.45) than the group at risk of 
malnutrition (1.33; SD 2.00; CI 0.79-1.87; Figure 3.15). The well-nourished patient had a LOV of 2.00 
days; this was not significantly higher than mean LOV of the group at risk of malnutrition or 
significantly lower than the mean LOV of the malnourished group. 
 
Figure 3.15  Mean length of ventilation in the at risk of malnutrition and 
malnourished Nutritional Risk Score - 2002 categories (p=0.02) 
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Analysing for all three groups as well as two groups only revealed a few trends, although these were 
not significant: the malnourished group seemed to have a longer LOS, a higher mortality, more 
severe complications, lower s-albumin levels and higher CRP and WCC levels than the group at risk of 
malnutrition. Tables 3.17 and 3.18 summarize the non-significant results of the NRS-2002. 
No analyses were done comparing the well-nourished group to a combination of the at risk of 
malnutrition and malnourished patients, as the well-nourished group consisted out of only one 
patient and this would have made comparison futile. 
 
Table 3.17  M-L Chi-square test of the presence or absence of death by NRS-2002a  
category (p=0.20) 
NRS-2002 Death - present Death - absent Row - Totals 
Normal 0 (0%) 1 (100%) 1 
Risk malnutrition 0 (0%) 55 (100%) 55 
Malnourished 5 (3.36%) 144 (96.64%) 149 
Totals 5 200 205 
 a   Nutritional Risk Score - 2002 
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Table 3.18 Non-significant clinical outcome results for the NRS-2002a nutritional risk categories 
 Total Normal Risk Malnutrition Malnourished p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99 – 6.51 
(n=1) 
6.96 
(n=55) 
4.40 
2.74 
3.66 – 5.14 
(n=149) 
6.24 
6.19 
5.23 – 7.24 
p=0.10 Kruskal-Wallis 
test 
 
Mean LOV (days) 
SD 
CI 
(n=205) 
2.93 
5.08 
2.23 – 3.63 
(n=1) 
2.00 
(n=55) 
1.33 
2.00 
0.79 – 1.87 
(n=149) 
3.52 
5.73 
2.60 – 4.45 
p=0.11 Kruskal-Wallis 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41 – 0.66 
(n=1) 
0.00 
(n=55) 
0.29 
0.60 
0.13 – 0.45 
(n=150) 
0.63 
1.00 
0.47 – 0.79 
p=0.07 Kruskal-Wallis 
test 
 
Mean s-albumin (g/l) 
SD 
CI 
(n=176) 
22.77 
6.20 
21.85 – 23.70 
(n=1) 
21 
(n=43) 
24.40 
5.84 
22.60 – 26.19 
(n=132) 
22.26 
6.27 
21.18 – 23.34 
p=0.14 One-way 
ANOVA test 
 
Mean CRP (mg/l) 
SD 
CI 
(n=164) 
182.01 
117.11 
163.95 – 200.06 
(n=1) 
345 
(n=40) 
158.60 
92.68 
128.96 – 188.24 
(n=123) 
188.29 
123.05 
166.33 – 210.26 
p=0.12 Kruskal-Wallis 
test 
 
Mean WCC (x 109/l) 
SD 
CI 
(n=189) 
15.89 
9.51 
14.52 – 17.25 
(n=1) 
17.26 
(n=47) 
15.33 
11.98 
11.81 – 18.84 
(n=141) 
16.06 
8.62 
14.63 – 17.50 
p=0.29 Kruskal-Wallis 
test 
 a   Nutritional Risk Score - 2002 
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3.3.4 SGA 
One hundred and five patients (50.97%) were classified as well-nourished according to the SGA. 
Sixty-three patients (30.58%) were classified as moderately malnourished and 38 (18.45%) as 
severely malnourished (Figure 3.16). 
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Figure 3.16 Prevalence of malnutrition according to the Subjective Global Assessment 
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The SGA classifications were significantly correlated with LOS (p=0.03; Kruskal-Wallis test; Figure 
3.17), LOV (p=0.01; Kruskal-Wallis test; Figure 3.18), mild complications (p=0.04; Kruskal-Wallis test; 
Figure 3.19) and s-albumin (p=0.01; Kruskal-Wallis test; Figure 3.20). 
In the case of LOS, LOV and mild complications the moderately malnourished patients showed the 
worst outcomes (LOS: 7.20; SD 7.18; CI 5.39-9.00; LOV: 4.60; SD 6.60; CI 2.94-6.27; mild 
complications: 0.46; SD 0.86; CI 0.24-0.68) followed by well-nourished patients (LOS:5.32; SD 4.56; CI 
4.44-6.21; LOV: 2.41; SD 3.85; CI 1.67-3.16; mild complications: 0.20; SD 0.45; CI 0.11-0.29) and with 
severely malnourished patients (LOS: 4.50; SD 4.22; CI 3.11-5.89; LOV: 1.55; SD 4.56; CI 0.05-3.05; 
mild complications: 0.18; SD 0.56; CI -0.00-0.37) showing the best outcomes. 
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Figure 3.17 Mean length of stay per Subjective Global Assessment category (p=0.03) 
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When comparing two SGA classifications at a time for LOV, the differences were significant for the 
moderately malnourished group compared to the well-nourished group (p=0.02; Bonferroni test) 
and the moderately malnourished group compared to the severely malnourished group (p=0.01; 
Bonferroni test). 
 
Figure 3.18 Mean length of ventilation per Subjective Global Assessment category (p=0.01) 
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For mild complications the only significant difference was between the moderately malnourished 
and well-nourished groups (p=0.03; Bonferroni test).  
 
Figure 3.19 Mean number of mild complications per Subjective Global Assessment  
category (p=0.04) 
 
No statistical significance remained when comparing only two groups for LOS. The moderately 
malnourished group had borderline longer LOS than the severely malnourished group (p=0.05; 
Bonferroni test). 
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S-albumin was lowest in the malnourished group (19.81; SD 5.61; CI 17.79-21.84). This was 
significantly lower (p=0.01; Bonferroni test) than the well-nourished group (23.70; SD 6.13; CI 22.41-
25.00). The moderately malnourished group had the second lowest s-albumin levels (23.00; SD 6.22; 
CI 21.33-24.67), but this was not significantly different from the malnourished or well-nourished 
groups (Figure 3.20). 
 
Figure 3.20 Mean minimum serum-albumin per Subjective Global Assessment  
category (p=0.01) 
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The moderately malnourished group also showed a (non-significant) trend for higher APACHE II 
scores, more moderate, severe and total complications, a higher mortality and a higher WCC than 
the well nourished group. However, for all of these variables the severely malnourished group 
showed the (non-significant) best outcomes: lowest APACHE II scores, WCC, mortality and least 
moderate, severe and total complications. The only significant finding was that the moderately 
malnourished group had more total complications (2.00; SD 2.58; CI 1.35-2.65) than the severely 
malnourished group (0.97; SD 1.42; CI 0.51-1.44; Figure 3.21). 
Tables 3.19 and 3.20 summarize the non-significant results for the SGA. 
 
Figure 3.21  Mean number of total complications per moderately and severely 
malnourished Subjective Global Assessment categories (p=0.04) 
 
Table 3.19   M-L Chi-square test of the presence or absence of death by SGAa category (p=0.05) 
SGA Death - present Death - absent Row - Totals 
Normal 1 (0.96%) 103 (99.04%) 104 
Risk malnutrition 4 (6.35%) 59 (93.65%) 63 
Malnourished 0 (0.00%) 38 (100%) 38 
Totals 5 200 205 
 a  Subjective Global Assessment 
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Table 3.20 Non-significant clinical outcome results for the SGAa nutritional risk categories 
 Total Normal Risk Malnutrition Malnourished p-value Test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63 – 11.18 
(n=101) 
10.29 
5.42 
9.22 – 11.36 
(n=60) 
11.02 
6.05 
9.45 – 12.58 
(n=36) 
9.72 
4.83 
8.09 – 11.36 
p=0.62 Kruskal-Wallis 
test 
 
Mean number of total complications 
SD 
CI 
(n=206) 
1.51 
2.04 
1.23 – 1.79 
(n=105) 
1.42 
1.80 
1.07 – 1.77 
(n=63) 
2.00 
2.58 
1.35 – 2.65 
(n=38) 
0.97 
1.42 
0.51 – 1.44 
p=0.09 Kruskal-Wallis 
test 
 
Mean number of moderate 
complications 
SD 
CI 
(n=206) 
0.70 
 
0.98 
0.57 – 0.84 
(n=105) 
0.72 
 
0.94 
0.54 – 0.90 
(n=63) 
0.84 
 
1.15 
0.55- 1.13 
(n=38) 
0.42 
 
0.72 
0.18 – 0.66 
p=0.12 Kruskal-Wallis 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41 – 0.66 
(n=105) 
0.50 
0.86 
0.33 – 0.66 
(n=63) 
0.70 
1.10 
0.42 – 0.98 
(n=38) 
0.37 
0.71 
0.13 – 0.60 
p=0.25 Kruskal-Wallis 
test 
 
Mean CRP (mg/l) 
SD 
CI 
(n=164) 
182.01 
117.11 
163.95 – 200.06 
(n=82) 
189.89 
110.15 
165.69 – 214.09 
(n=54) 
189.54 
127.24 
154.81 – 224.27 
(n=28) 
144.39 
113.38 
100.43 – 188.36 
p=0.11 Kruskal-Wallis 
test 
 
Mean WCC  (x 109/l) 
SD 
CI 
(n=189) 
15.89 
9.51 
14.52 – 17.25 
(n=97) 
15.19 
9.37 
13.30 – 17.08 
(n=59) 
17.52 
10.66 
14.74 – 20.30 
(n=33) 
15.02 
7.42 
12.39 – 17.66 
p=0.18 Kruskal-Wallis 
test 
 a  Subjective Global Assessment 
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Combining the moderately and severely malnourished patients (n=101; 49.03%) and comparing 
them to the well-nourished patients (n=105; 50.97%), there were no significant correlations with any 
of the clinical outcomes. S-albumin was lower in the malnourished group (21.84; SD 6.17; CI 20.53-
23.15) than in the well-nourished group (23.70; SD 6.13; CI 22.41-25.00) with a p-value of 0.05 
(Mann-Whitney U test) which indicates borderline significance (Figure3.22). 
 
Figure 3.22 Mean minimum serum-albumin per Subjective Global Assessment  
outcome (p=0.05) 
 
Furthermore, the malnourished group also had a longer mean LOS and LOV, higher mean APACHE II 
score, more total, mild and severe complications, a higher mean WCC and a higher mortality than 
the well-nourished group, although this did not reach significance.  
Tables 3.21 and 3.22 summarize the non-significant results for the malnourished vs. well-nourished 
groups. 
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Table 3.21 Non-significant clinical outcome results for the SGAa nutritional risk outcomes 
 Total Well-nourished 
Moderately + severely 
malnourished 
p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99-6.51 
(n=104) 
5.32 
4.56 
4.44-6.21 
(n=101) 
6.18 
6.34 
4.93-7.43 
p=0.27 Mann-Whitney U 
test 
 
Mean LOV (days) 
SD 
CI 
(n=205) 
2.93 
5.08 
2.23-3.63 
(n=104) 
2.41 
3.85 
1.67-3.16 
(n=101) 
3.46 
6.08 
2.26-4.66 
p=0.98 Mann-Whitney U 
test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63-11.18 
(n=101) 
10.29 
5.42 
9.22-11.36 
(n=96) 
10.53 
5.63 
9.39-11.67 
p=0.96 Mann-Whitney U 
test 
 
Mean number of total complications 
SD 
CI 
(n=206) 
1.51 
2.04 
1.23-1.79 
(n=105) 
1.42 
1.80 
1.07-1.77 
(n=101) 
1.61 
2.27 
1.17-2.06 
p=0.83 Mann-Whitney U 
test 
 
Mean number of mild complications 
SD 
CI 
(n=206) 
0.28 
0.63 
0.19-0.36 
(n=105) 
0.20 
0.45 
0.11-0.29 
(n=101) 
0.36 
0.77 
0.20-0.51 
p=0.37 Mann-Whitney U 
test 
 
Mean number of moderate complications 
SD 
CI 
(n=206) 
0.70 
0.98 
0.57-0.84 
(n=105) 
0.72 
0.94 
0.54-0.90 
(n=101) 
0.68 
1.03 
0.48-0.87 
p=0.55 Mann-Whitney U 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41-0.66 
(n=105) 
0.50 
0.86 
0.33-0.66 
(n=101) 
0.57 
0.98 
0.38-0.77 
p=0.77 Mann-Whitney U 
test 
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Mean s-albumin (g/l) 
SD 
CI 
(n=176) 
22.77 
6.20 
21.85-23.70 
(n=88) 
23.70 
6.13 
22.41-25.00 
(n=88) 
21.84 
6.17 
20.53-23.15 
p=0.05 Mann-Whitney U 
test 
 
Mean CRP (mg/l) 
SD 
CI 
(n=164) 
182.01 
117.11 
163.95-200.06 
(n=82) 
189.89 
110.15 
165.69-214.09 
(n=82) 
174.12 
123.86 
146.91-201.34 
p=0.28 Mann-Whitney U 
test 
 
Mean WCC (x 109/l) 
SD 
CI 
(n=189) 
15.89 
9.51 
14.52-17.25 
(n=97) 
15.19 
9.37 
13.30-17.08 
(n=92) 
16.63 
9.65 
14.63-18.62 
p=0.22 Mann-Whitney U 
test 
 a  Subjective Global Assessment 
 
 
Table 3.22 M-L Chi-square test of the presence or absence of death by SGAa outcome (p=0.15) 
NRI Death - present Death - absent Row - Totals 
Well-nourished  1 (0.96%) 103 (99.04%) 104 
Moderately + severely 
malnourished 
4 (3.96%) 97 (96.04%) 101 
Total 5 200 205 
    a  Subjective Global Assessment 
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3.3.5 SNAQ 
The SNAQ classified 132 (64.01%) patients as well-nourished, 14 (6.80%) patients as at risk of 
malnutrition and 60 (29.13%) as malnourished (Figure 3.23). 
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Figure 3.23 Prevalence of malnutrition according to the Short Nutritional Assessment 
Questionnaire 
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A significant correlation was found between SNAQ classification and LOV (p=0.02; Kruskal-Wallis 
test) as well as CRP level (p=0.03; Kruskal-Wallis). The well-nourished group had the longest mean 
LOV (3.19; SD 4.65; CI 2.39-4.00) followed by the malnourished group (2.67; SD 6.26; CI 1.05-4.28) 
The group at risk of malnutrition had the shortest LOV (1.57; SD 2.82; CI -0.06-3.2). When comparing 
only two groups none of the differences remained significant for LOV (Figure 3.24). 
 
Figure 3.24 Mean length of ventilation per Short Nutritional Assessment Questionnaire 
category (p=0.02) 
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The mean CRP level of the well-nourished group was 196.80mg/l (SD 118.14; CI 174.26-219.33) and 
this was significantly higher (p=0.03; Bonferroni test) than the mean CRP level of the malnourished 
group of 145.52mg/l (SD 11.58; CI 113.41-177.63). The group at risk of malnutrition had the highest 
mean CRP level of 201.25mg/l (SD 104.94; CI 113.52-288.98) but this was not statistically different 
from the malnourished or well-nourished groups (Figure 3.25). 
 
Figure 3.25 Mean maximum C-Reactive Protein level per Short Nutritional Assessment 
Questionnaire category (p=0.03) 
 
There was a trend for lower s-albumin levels and a higher WCC level in the malnourished and at risk 
of malnutrition groups, but this was not significant. 
The non-significant results of the SNAQ are summarized in Tables 3.23 and 3.24. 
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Table 3.23 Non-significant clinical outcome results for the SNAQa nutritional risk categories 
 
Total 
(n=206) 
Normal 
(n=132) 
Risk Malnutrition 
(n=14) 
Malnourished 
(n=60) 
p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99 – 6.51 
(n=131) 
5.89 
5.02 
5.02 – 6.76 
(n=14) 
4.18 
2.08 
2.98 – 5.39 
(n=60) 
5.80 
6.93 
4.00 – 7.59 
p=0.47 Kruskal-Wallis 
test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63 – 11.18 
(n=127) 
10.63 
5.71 
9.63 – 11.63 
(n=13) 
7.69 
3.07 
5.84 – 9.54 
(n=57) 
10.53 
5.38 
9.10 – 11.95 
p=0.14 Kruskal-Wallis 
test 
 
Mean number of total complications 
SD 
CI 
(n=206) 
1.51 
2.04 
1.23 – 1.79 
(n=132) 
1.62 
2.00 
1.28 – 1.97 
(n=14) 
1.14 
2.11 
-0.07 – 2.36 
(n=60) 
1.37 
2.12 
0.82 – 1.92 
p=0.34 Kruskal-Wallis 
test 
 
Mean number of mild complications 
SD 
CI 
(n=206) 
0.28 
0.63 
0.19 – 0.36 
(n=132) 
0.29 
0.64 
0.18 – 0.40 
(n=14) 
0.21 
0.43 
-0.03 – 0.46 
(n=60) 
0.27 
0.66 
0.10 – 0.44 
p=0.83 Kruskal-Wallis 
test 
 
Mean number of moderate 
complications 
SD 
CI 
(n=206) 
0.70 
 
0.98 
0.37 – 0.84 
(n=132) 
0.75 
 
0.95 
0.59 – 0.91 
(n=14) 
0.43 
 
1.09 
-0.20 – 1.06 
(n=60) 
0.67 
 
1.02 
0.40 – 0.93 
p=0.15 Kruskal-Wallis 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41 – 0.66 
(n=132) 
0.58 
0.92 
0.42 – 0.74 
(n=14) 
0.50 
0.85 
0.01 – 0.99 
(n=60) 
0.43 
0.93 
0.19 – 0.67 
p=0.34 Kruskal-Wallis 
test 
 
Mean s-albumin (g/l) 
SD 
CI 
(n=176) 
22.77 
6.20 
21.85 – 23.70 
(n=115) 
23.49 
5.98 
22.38 – 24.59 
(n=9) 
22.11 
6.47 
17.06 – 27.16 
(n=52) 
21.31 
6.48 
19.50 – 23.11 
p=0.09 Kruskal-Wallis 
test 
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Mean WCC  (x 109/l) 
SD 
CI 
(n=189) 
15.89 
9.51 
14.52 – 17.25 
(n=125) 
15.56 
9.24 
13.93 – 17.20 
(n=11) 
17.21 
6.99 
12.52 – 21.90 
(n=53) 
16.38 
10.66 
13.44 – 19.32 
p=0.5 Kruskal-Wallis 
test 
 a  Short Nutritional Assessment Questionnaire 
 
Table 3.24 M-L Chi-square test of the presence or absence of death by SNAQa category (p=0.59) 
SNAQ Death - present Death - absent Row - Totals 
Normal 3 (2.29%) 128 (97.71%) 131 
Risk malnutrition 1 (7.14%) 13 (92.86%) 14 
Malnourished 1 (1.67%) 59 (98.33%) 60 
Totals 5 200 205 
    a  Short Nutritional Assessment Questionnaire 
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When the group at risk of malnutrition and the malnourished group were combined (n=74; 35.92%) 
and compared to the well-nourished group (n=132; 64.08%), significant correlations were found with 
LOV, CRP and s-albumin. The combined malnutrition group had a significantly lower (p=0.03; Mann-
Whitney U test) mean s-albumin (21.43; SD 6.44; CI 19.78-23.08) than the well-nourished group 
(23.49; SD 5.98; CI 22.38-24.59; Figure 3.26). 
 
Figure 3.26 Mean minimum serum-albumin per Short Nutritional Assessment Questionnaire 
outcome (p=0.03) 
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However, the well-nourished group had a significantly higher (p=0.03; Mann-Whitney U test) mean 
CRP (196.80; SD 118.14; CI 174.26-219.33) and a significantly longer (p<0.01; Mann-Whitney U test) 
mean LOV (3.19; SD 4.65; CI 2.39-4.00) than the combined malnutrition group (CRP: 153.48; SD 
110.63; CI 123.86-183.11; LOV: 2.46; SD 5.77; CI 1.12-3.80; Figures 3.27 and 3.28, next page). 
 
Figure 3.27 Mean maximum C-Reactive Protein level per Short Nutritional Assessment 
Questionnaire outcome (p=0.03) 
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Figure 3.28 Mean length of ventilation per Short Nutritional Assessment Questionnaire 
outcome (p<0.01) 
 
There was a trend for the combined malnutrition group to have a higher mortality and mean WCC 
than the well-nourished group, but this did not reach statistical significance. 
The non-significant results are summarized in Tables 3.25 and 3.26. 
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Table 3.25 Non-significant clinical outcome results for the SNAQa nutritional risk outcomes 
 Total Well-nourished 
Moderately + 
severely 
malnourished 
p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99-6.51 
(n=131) 
5.89 
5.02 
5.02-6.76 
(n=74) 
5.49 
6.32 
4.03-6.96 
p=0.25 Mann-Whitney U 
test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63-11.18 
(n=127) 
10.63 
5.72 
9.63-11.63 
(n=70) 
10.00 
5.13 
8.78-11.22 
p=0.35 Mann-Whitney U 
test 
 
Mean number of total complications 
SD 
CI 
(n=206) 
1.51 
2.04 
1.23-1.79 
(n=132) 
1.62 
2.00 
1.28-1.97 
(n=74) 
1.32 
2.11 
0.84-1.81 
p=0.20 Mann-Whitney U 
test 
 
Mean number of mild complications 
SD 
CI 
(n=206) 
0.28 
0.63 
0.19-0.36 
(n=132) 
0.29 
0.64 
0.18-0.40 
(n=74) 
0.26 
0.62 
0.11-0.40 
p=0.68 Mann-Whitney U 
test 
 
Mean number of moderate complications 
SD 
CI 
(n=206) 
0.70 
0.98 
0.57-0.84 
(n=132) 
0.75 
0.95 
0.59-0.91 
(n=74) 
0.62 
1.03 
0.38-0.86 
p=0.20 Mann-Whitney U 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41-0.66 
(n=132) 
0.58 
0.92 
0.42-0.74 
(n=74) 
0.45 
0.91 
0.24-0.66 
p=0.26 Mann-Whitney U 
test 
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Mean WCC (x 109/l) SD 
CI 
(n=189) 
15.89 
9.51 
14.52-17.25 
(n=125) 
15.56 
9.24 
14.52-17.25 
(n=64) 
16.52 
10.08 
14.00-19.04 
p=0.41 Mann-Whitney U 
test 
 a  Short Nutritional Assessment Questionnaire 
 
 
Table 3.26 M-L Chi-square test of the presence or absence of death by SNAQa outcome (p=0.86) 
NRI Death - present Death - absent Row - Totals 
Well-nourished  3 (2.29%) 128 (97.71%) 131 
Moderately + severely 
malnourished 
2 (2.70%) 72 (97.30%) 74 
Total 5 200 205 
    a  Short Nutritional Assessment Questionnaire 
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3.3.6 NRI 
Only three patients (1.70%) were classified as well-nourished according to the NRI. Four (2.27%) 
were classified as mildly malnourished, 37 (21.02%) as moderately malnourished and 132 (75.00%) 
as severely malnourished (Figure 3.29). As the first two groups are very small (n=3, n=4), caution 
should be taken when interpreting the results. 
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Figure 3.29 Prevalence of malnutrition according to the Nutritional Risk Indicator 
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When analysing all four groups the NRI was significantly correlated with LOS (p=0.04; Kruskal-Wallis 
test; Figure 3.30) and LOV (p=0.02; Kruskal-Wallis test; Figure 3.31). The well-nourished group had a 
mean LOS of 2.69 days (SD 1.09; CI -0.03-5.4) and a mean LOV of 0.00 days (SD 0.00; CI 0.00 – 0.00) 
which were both shorter than those of all three malnourished groups. The mildly malnourished 
group had the longest LOS (9.51; SD 3.21; CI 4.39-14.63) and LOV (5.50; SD 3.70; CI -0.38-11.38) 
followed by the severely malnourished group (LOS: 6.52; SD 6.35; CI 5.42-7.61; LOV: 3.63; SD 5.80; CI 
2.62-4.63) and then the moderately malnourished group (LOS: 5.18; SD3.75; CI 3.93-6.43; LOV: 2.27; 
SD 3.91; CI 0.97-3.58). When comparing only two groups at a time, however, none of the results 
remained significant for either LOS or LOV. 
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Figure 3.30 Mean length of stay per Nutritional Risk Indicator category (p=0.04) 
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Figure 3.31 Mean length of ventilation per Nutritional Risk Indicator category (p=0.02) 
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A significant correlation was also found between NRI classification and s-albumin (p<0.01; Kruskal-
Wallis test; Figure 3.32). The well-nourished group had a mean s-albumin level of 33.33g/l (SD 9.81; 
CI 8.95-57.71) which was significantly higher (p<0.01; Bonferroni test) than the mildly malnourished 
group (30.00; SD 1.15; CI 28.16-31.84) and the severely malnourished group (20.69; SD 4.96; CI 
19.83-21.54) and higher, but not significantly, than the moderately malnourished group (28.57; SD 
5.14; CI 26.85-30.28). The severely malnourished group had the lowest s-albumin and this was 
significantly lower (p<0.01; Bonferroni) than moderately and mildly malnourished groups. 
 
Figure 3.32 Mean minimum serum-albumin per Nutritional Risk Indicator category (p<0.01) 
 
A trend was found for higher mortality in the severely malnourished group, but this was not 
significant compared to any of the other groups. All three of the malnourished groups also had more 
moderate, severe and total complications as well as higher CRP levels than the well-nourished 
group, but this also did not reach statistical significance. 
The non-significant results for the NRI can be seen in Tables 3.27 and 3.28. 
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Table 3.27 Non-significant clinical outcome results for the NRIa nutritional risk categories 
 Total Normal 
Mild 
malnutrition 
Moderate 
malnutrition 
Severe 
malnutrition 
p-value Test 
 
Mean APACHE II score 
SD 
CI 
(n=168) 
10.64 
5.66 
9.78 – 11.50 
(n=3) 
13.33 
5.13 
0.59 – 26.08 
(n=4) 
11.50 
5.07 
3.44 – 19.56 
(n=36) 
9.17 
5.33 
7.36 – 10.97 
(n=125) 
10.97 
5.75 
9.95 – 11.99 
p=0.28 Kruskal-
Wallis test 
 
Mean number of total 
complications 
SD 
CI 
(n=176) 
1.71 
 
2.12 
1.39 – 2.03 
(n=3) 
1.00 
 
1.73 
-3.30 – 5.30 
(n=4) 
2.75 
 
2.5 
-1.23 – 6.73 
(n=37) 
1.32 
 
1.78 
0.73 – 1.92 
(n=132) 
1.80 
 
2.21 
1.42 – 2.18 
p=0.39 Kruskal-
Wallis test 
 
Mean number of mild 
complications 
SD 
CI 
(n=176) 
0.32 
 
0.67 
0.22 – 0.42 
(n=3) 
0.33 
 
0.58 
-1.10 – 1.77 
(n=4) 
0.00 
 
0.00 
0.00 – 0.00 
(n=37) 
0.30 
 
0.66 
0.08 – 0.52 
(n=132) 
0.33 
 
0.68 
0.22 – 0.45 
p=0.66 Kruskal-
Wallis test 
 
Mean number of moderate 
complications 
SD 
CI 
(n=176) 
0.78 
 
1.02 
0.63 – 0.94 
(n=3) 
0.67 
 
1.15 
-2.20 – 3.54 
(n=4) 
1.50 
 
1.73 
-1.26 – 4.26 
(n=37) 
0.70 
 
1.00 
0.37 – 1.03 
(n=132) 
0.79 
 
1.00 
0.62 – 0.96 
p=0.68 Kruskal-
Wallis test 
 
Mean number of severe 
complications 
SD 
CI 
(n=176) 
0.61 
 
0.97 
0.46 – 0.75 
(n=3) 
0.00 
 
0.00 
0.00 – 0.00 
(n=4) 
1.25 
 
0.96 
-0.27 – 2.77 
(n=37) 
0.32 
 
0.58 
0.13 – 0.52 
(n=132) 
0.68 
 
1.04 
0.50 – 0.86 
p=0.06 Kruskal-
Wallis test 
 
Mean CRP (mg/l) 
SD 
CI 
(n=158) 
184.18 
117.66 
165.69 
(n=2) 
52.00 
67.88 
-557 – 661.90 
(n=4) 
224.25 
104.52 
57.94 – 390.56 
(n=34) 
170.44 
94.28 
137.55–203.34 
(n=118) 
189.02 
123.76 
166.45–211.58 
p=0.24 Kruskal-
Wallis test 
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Mean WCC (x 109/l) 
SD 
CI 
(n=174) 
16.09 
9.70 
14.64 – 17.54 
(n=3) 
15.14 
5.59 
1.26 – 29.02 
(n=4) 
12.85 
1.42 
10.59 – 15.11 
(n=37) 
14.92 
5.65 
13.04 – 16.80 
(n=130) 
16.55 
10.76 
13.04 – 18.41 
p=0.94 Kruskal-
Wallis test 
 a  Nutritional Risk Indicator  
 
    Table 3.28 M-L Chi-square test of the presence or absence of death by NRIa category (p=0.40) 
NRI Death - present Death - absent Row - Totals 
Normal 0 (0.00%) 3 (100.00%) 3 
Mild malnutrition 0 (0.00%) 4 (100.00%) 4 
Moderate 
malnutrition 
0 (0.00%) 37 (100.00%) 37 
Severe malnutrition 5 (3.82%) 126 (96.18%) 131 
Total 5 170 175 
    a  Nutritional Risk Indicator  
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Analyses were also done comparing the well-nourished and mildly malnourished patients (n=7; 
3.98%) to the moderately and severely malnourished patients (n=169; 96.02%). The only statistically 
significant correlation that was found was with s-albumin (Figure 3.33). The moderately and severely 
malnourished patients had a significantly lower (p<0.01; one-way ANOVA test) mean s-albumin 
(22.41; SD 5.96; CI 21.51-23.32) than the well-nourished and mildly malnourished patients (31.43; SD 
6.00; CI 25.88-36.97). 
 
Figure 3.33 Mean minimum serum-albumin per Nutritional Risk Indicator Outcome (p<0.01) 
 
There was also a trend for the moderately and severely malnourished patients to have a longer LOV, 
more mild complications, a higher mortality and higher WCC and CRP levels, but this did not reach 
statistical significance. 
The non-significant results can be seen in Tables 3.29 and 3.30. 
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Table 3.29 Non-significant clinical outcome results for the NRIa nutritional risk outcomes 
 Total 
Well-nourished + 
mildly malnourished 
Moderately + 
severely 
malnourished 
p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=175) 
6.24 
5.83 
5.37-7.11 
(n=7) 
6.59 
4.34 
2.57-10.60 
(n=168) 
6.22 
5.89 
5.33-7.12 
p=0.73 Mann-Whitney U 
test 
 
Mean LOV (days) 
SD 
CI 
(n=175) 
3.32 
5.40 
2.51-4.13 
(n=7) 
3.14 
3.93 
-0.50-6.78 
(n=168) 
3.33 
5.46 
2.50-4.19 
p=0.99 Mann-Whitney U 
test 
 
Mean APACHE II score 
SD 
CI 
(n=168) 
10.64 
5.66 
9.78-11.50 
(n=7) 
12.29 
4.75 
7.89-16.68 
(n=161) 
10.57 
5.70 
9.68-11.45 
p=0.31 Mann-Whitney U 
test 
 
Mean number of total complications 
SD 
CI 
(n=176) 
1.71 
2.12 
1.39-2.03 
(n=7) 
2.00 
2.24 
-0.07-4.07 
(n=169) 
1.70 
2.13 
1.38-2.02 
p=0.71 Mann-Whitney U 
test 
 
Mean number of mild complications 
SD 
CI 
(n=176) 
0.32 
0.67 
0.22-0.42 
(n=7) 
0.14 
0.38 
-0.21-0.49 
(n=169) 
0.33 
0.68 
0.22-0.43 
p=0.62 Mann-Whitney U 
test 
 
Mean number of moderate complications 
SD 
CI 
(n=176) 
0.78 
1.02 
0.63-0.94 
(n=7) 
1.14 
1.46 
-0.21-2.50 
(n=169) 
0.77 
1.00 
0.62-0.92 
p=0.57 Mann-Whitney U 
test 
 
Mean number of severe complications 
SD 
CI 
(n=176) 
0.61 
0.97 
0.46-0.75 
(n=7) 
0.71 
0.95 
-0.17-1.59 
(n=169) 
0.60 
0.97 
0.46-0.75 
p=0.71 Mann-Whitney U 
test 
127 
 
 
Mean CRP (mg/l) 
SD 
CI 
(n=158) 
184.18 
117.66 
165.69-202.66 
(n=6) 
166.83 
124.05 
36.65-297.01 
(n=152) 
184.86 
117.77 
165.99-203.74 
p=0.75 Mann-Whitney U 
test 
 
Mean WCC (x 109/l) 
SD 
CI 
(n=174) 
16.09 
9.70 
14.64-17.54 
(n=7) 
13.83 
3.59 
10.51-17.16 
(n=167) 
16.19 
9.86 
14.68-17.69 
p=0.72 Mann-Whitney U 
test 
 a  Nutritional Risk Indicator  
 
 
Table 3.30 M-L Chi-square test of the presence or absence of death by NRIa outcome (p=0.52) 
NRI Death - present Death - absent Row - Totals 
Well-nourished + 
mildly malnourished 
0 (0.00%) 7 (100.00%) 7 
Moderate + severe 
malnutrition 
5 (2.98%) 163 (97.02%) 168 
Total 5 170 175 
    a  Nutritional Risk Indicator  
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3.3.7 MST 
The MST classified 45 patients (21.84%) as well-nourished and 161 patients (78.16%) as 
malnourished (Figure 3.34). Note that the MST does not have categories for mild/moderate 
malnutrition or at risk of malnutrition. 
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Figure 3.34 Prevalence of malnutrition according to the Malnutrition Screening Tool 
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The only significant correlation that was found was between MST category and total complications 
(Figure 3.35). The malnourished group had a mean rate of total complications of 1.70 (SD 2.17; CI 
1.36-2.04) and this was significantly higher (p<0.01; Mann-Whitney U test) than the mean rate of 
total complications of the well-nourished group (0.84; SD 1.26; CI 0.47-1.22). 
 
Figure 3.35 Mean number of total complications per Malnutrition Screening Tool  
category (p<0.01) 
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Almost all the other variables (LOS, LOV, APACHE II score, mild, moderate and severe complications, 
s-albumin, WCC and mortality) showed worse outcomes for the malnourished group, but none of 
these reached statistical significance. 
Two variables did come close to statistical significance: WCC and APACHE II score were higher (WCC: 
p=0.06; APACHE II: p=0.07; Mann-Whitney U test) in the malnourished group than in the well-
nourished group (Figures 3.36 and 3.37, next page). 
 
Figure 3.36 Mean maximum white cell count per Malnutrition Screening Tool category 
(p=0.06) 
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Figure 3.37 Mean APACHE II score per Malnutrition Screening Tool category (p=0.07) 
 
Only the CRP variable showed worse outcomes for the well-nourished group than for the 
malnourished group, but this was not statistically significant. 
The non-significant results for the MST can be seen in Tables 3.31 and 3.32. 
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Table 3.31 Non-significant clinical outcome results for the MSTa nutritional risk categories 
 Total Well-nourished Malnourished p-value Test 
 
Mean LOS (days) 
SD 
CI 
(n=205) 
5.75 
5.52 
4.99-6.51 
(n=45) 
4.51 
2.93 
3.63-5.40 
(n=160) 
6.09 
6.01 
5.15-7.03 
p=0.12 Mann-Whitney U 
test 
 
Mean LOV (days) 
SD 
CI 
(n=205) 
2.93 
5.08 
2.23-3.63 
(n=45) 
1.69 
2.54 
0.93-2.45 
(n=160) 
3.28 
5.55 
2.41-4.14 
p=0.29 Mann-Whitney U 
test 
 
Mean APACHE II score 
SD 
CI 
(n=197) 
10.41 
5.51 
9.63-11.18 
(n=44) 
9.36 
5.67 
7.64-11.09 
(n=153) 
10.71 
5.44 
9.84-11.58 
p=0.07 Mann-Whitney U 
test 
 
Mean number of mild complications 
SD 
CI 
(n=206) 
0.28 
9.63 
0.19-0.36 
(n=45) 
0.09 
0.29 
0.00-0.18 
(n=161) 
0.33 
0.69 
0.22-0.44 
p=0.09 Mann-Whitney U 
test 
 
Mean number of moderate complications 
SD 
CI 
(n=206) 
0.70 
0.98 
0.57-0.84 
(n=45) 
0.47 
0.69 
0.26-0.68 
(n=161) 
0.77 
1.04 
0.61-0.93 
p=0.14 Mann-Whitney U 
test 
 
Mean number of severe complications 
SD 
CI 
(n=206) 
0.53 
0.92 
0.41-0.66 
(n=45) 
0.29 
0.63 
0.10-0.48 
(n=161) 
0.60 
0.98 
0.45-0.75 
p=0.08 Mann-Whitney U 
test 
 
Mean s-albumin (g/l) 
SD 
CI 
(n=176) 
22.77 
6.20 
21.85-23.70 
(n=35) 
24.31 
5.60 
22.39-26.24 
(n=141) 
22.39 
6.31 
21.34-23.44 
p=0.10 One-way ANOVA 
test 
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Mean CRP (mg/l) 
SD 
CI 
(n=164) 
182.01 
117.11 
163.95-200.06 
(n=33) 
213.79 
145.54 
162.18-265.39 
(n=131) 
174.00 
107.99 
155.33-192.67 
p=0.19 Mann-Whitney U 
test 
 
Mean WCC  (x 109/l) 
SD 
CI 
(n=189) 
15.89 
9.51 
14.52-17.25 
(n=41) 
13.93 
7.05 
11.70-16.15 
(n=148) 
16.43 
10.04 
14.80-18.06 
p=0.06 Mann-Whitney U 
test 
 a  Malnutrition Screening Tool 
 
Table 3.32 M-L Chi-square test of the presence or absence of death by MSTa category (p=0.91) 
MST Death - present Death - absent Row - Totals 
Well-nourished  1 (2.22%) 44 (97.50%) 45 
At risk of malnutrition 
+ malnourished 
4 (2.50%) 156 (97.89%) 160 
Total 5 200 205 
    a  Malnutrition Screening Tool 
  
134 
 
3.4 FEASIBILITY AND APPLICABILITY OF NRSTs 
Eighty-six patients (41.75%) were able to provide information on their actual weight and in 10 cases 
(4.85%) the actual weight could be found in the patient’s medical file. More than half (n=110; 
53.40%) of the patient population’s weight however had to be estimated, due to lack of information 
on actual weight. Weight loss/gain history could be precisely quantified in 50 of the cases (24.29%), 
either by the patient or by a friend/family member or from the medical file. In the rest of the patient 
population (n=156; 75.73%) the weight loss/gain history had to be estimated. 
Of the 252 patients that were originally included in the study, 83 (32.94%) patients could not 
effectively communicate within 48 hours, which was necessary to complete nutritional risk 
screening. However, 30 (11.90%) of these patients had a friend/family member who could provide 
the necessary information and for 7 patients (2.78%) the information could be gathered from their 
medical file. This left 46 patients (18.25%) for whom no screening information could be obtained. 
They were labeled as failed screens and excluded from data analysis. Figure 3.38 illustrates the 
availability of data and the number of successful and unsuccessful screens. 
 
 
 
 
 
 
 
 
 
 
Figure 3.38 The number of successful and unsuccessful screens based on the availability of 
nutritional risk screening tool information 
 
252 eligible patients 
Able to communicate 
within 48 hours: 
169 patients 
Unable to communicate 
within 48 hours: 
83 Patients 
Successfully screened: 
206 patients 
Data available from  
medical file: 
7 patients 
Data available from  
family/friend: 
30 patients 
No data available 
from other sources: 
46 patients 
Not screened:  
46 patients 
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Of the 206 included patients, 169 (82.04%) could effectively communicate with the researcher 
within 48 hours to provide information on weight loss, dietary intake, gastrointestinal symptoms and 
functionality. On average the patients were able to effectively communicate with the researcher on 
day 2.15 (SD 2.07). More than half of the patients (n=112; 54.37%) could effectively communicate 
with the researcher on day one and a further 23.30% (n=48) could communicate by day two. 
However, 37 patients (17.96%) were only able to communicate after day two. 
Information on disease severity was available from the medical file for all patients. Similarly, a 
physical examination could be performed for all patients. S-albumin was tested in only 176 patients 
(85.44% of the included patient population). On average the s-albumin test results were available by 
day 0.58 (SD 1.16). One-hundred and twenty-three patients (69.89%) had s-albumin test results 
available by day one and 31 patients (17.61%) had test results available by day two. In 22 cases 
(12.51%) the tests were only done or results only became available after day two. 
 
3.5 EXCLUDED PATIENTS 
Forty-six patients were excluded from data-analysis due to unavailability of data necessary to 
complete the various NRSTs. They were however still followed up until discharge or death and 
observed for clinical outcomes. Table 3.33 summarizes their demographical characteristics, Table 
3.34 summarizes their diagnostic categories and Figure 3.39 depicts the spread across BMI 
categories. 
Table 3.33 Demographic characteristics of excluded patient population (n=46) 
Patient demographics n (%) n (%) 
Gender 
Male 
32 (69.57%) 
Female 
14 (30.43%) 
Age 
Mean: 46.85 (SD 17.66) 
years 
<65 years 
37 (80.43%) 
≥ 65 years 
9 (19.57%) 
Admission status 
Emergency 
45 (97.83%) 
Elective 
1 (2.17%) 
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Table 3.34 Primary diagnosis of excluded patient population (n=46) 
Diagnostic group n (%) 
Gastrointestinal surgery 23 (50.00%) 
Polytrauma 11 (23.91%) 
Gynaecology 2 (4.35%) 
Other 2 (4.35%) 
Respiratory 2 (4.35%) 
Vascular surgery 2 (4.35%) 
Assault 1 (2.17%) 
Infectious 1 (2.17%) 
Trauma 1 (2.17%) 
 
The mean age of the excluded patients as well as their diagnoses was not statistically different from 
the mean age or diagnoses of the included patients.  
On the other hand the excluded patients had a significantly different admission status distribution 
from the included patients: 97.83% of the excluded patients were emergency admissions versus 
57.77% of the included patients (p<0.01; M-L Chi-square test). When all of the emergency 
admissions are considered (included and excluded patients; n=164), 27.44% of them could not be 
screened and were excluded from data-analysis. 
Also, when dividing the patients into age categories, the excluded patients had significantly more 
patients (80.43%) in the <65 years category than the included patients who had 78.16% (p<0.01; M-L 
Chi-square test). 
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The excluded patients had a mean BMI of 24.36 (SD 4.77); this was not statistically different from the 
included patients (p=0.66; T-test). The majority (80.00%) had a BMI of more than 20.00, while 6.67% 
had a BMI between 18.5 and 19.99 and 13.33% had a BMI of less than 18.5. 
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Figure 3.39 Number of patients within the five BMI categories 
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Table 3.35 summarizes the clinical outcomes observed in the excluded patient group and compares 
it to the included patient group. 
Table 3.35 Clinical outcomes observed in excluded (n=46) versus included patients (n=206) 
Clinical outcome 
Excluded patients 
Mean (SD) 
Included patients 
Mean (SD) 
p-value 
LOS 12.26 (10.19) 5.75 (5.52) p<0.01 (Mann-Whitney U test) 
LOV 9.82 (10.33) 2.93 (5.08) p<0.01 (Mann-Whitney U test) 
APACHE II score 14.95 (7.10) 10.41 (5.51) p<0.01 (Mann-Whitney U test) 
Complications 
Total 
Mild 
Moderate 
Severe 
 
3.67 (3.18) 
0.50 (0.75) 
1.52 (1.33) 
1.65 (1.66) 
 
1.51 (2.04) 
0.28 (0.63) 
0.70 (0.98) 
0.53 (0.92) 
 
p<0.01 (Mann-Whitney U test) 
p=0.08 (Mann-Whitney U test) 
p<0.01 (Mann-Whitney U test) 
p<0.01 (Mann-Whitney U test) 
Biochemistry 
S-albumin 
WCC 
CRP 
 
20.54 (6.16) 
18.53 (6.94) 
247.23 (104.10) 
 
22.77 (6.20) 
15.89 (9.51) 
182.01 (117.11) 
 
p=0.03 (One-way ANOVA test) 
p<0.01 (Mann-Whitney U test) 
p<0.01 (Mann-Whitney U test) 
 n (%) n (%) p-value 
Mortality 4 (8.89%) 5 (2.44%) p=0.06 (Mann-Whitney U test) 
 
From the table it can be seen that the excluded patient group showed worse outcomes for all of the 
variables measured and this was statistically significant for LOS, LOV, APACHE II score, total, 
moderate and severe complications, minimum s-albumin and maximum WCC and CRP levels. Only 
number of mild complications and mortality did not reach significance. 
 
3.6 RELIABILITY OF ESTIMATED BODY WEIGHT 
Body weight was estimated for study patients by the researcher (dietician 1) and the ICU dietician 
(dietician 2) and was also calculated using KH and MUAC measurements in a formula. The 
correlations between these estimations and calculations were tested to provide information about 
the reliability and validity thereof.  
Table 3.36 summarizes the mean values for the estimated body weights, the average estimated body 
weight and the calculated body weight. 
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Table 3.36 Summary of average estimated and average calculated body weights of study 
patients (n=206) 
 
The two dieticians’ average estimations differed by just over 2kg. However, a T-test for dependent 
samples revealed that this difference was statistically significant (p=0.02). When the estimated 
weights were used to calculate BMI the difference was much less pronounced (p=0.04; T-test for 
dependent sample). Moreover, a good correlation of r=0.85 was found between the two dieticians’ 
estimations and this was statistically significant at p=0.00 (Spearman rank correlation; Figure 3.40). 
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Figure 3.40 Correlation between dietician 1 and dieticians 2’s estimated body weights (p=0.00) 
  
 Dietician 1 Dietician 2 p-value 
Weight (kg) 71.69 (SD 17.46) 69.31 (SD 18.45) p=0.02 
BMI (kg/m2) 25.41 (SD 6.45) 24.65 (SD 7.47) p=0.04 
 Average estimated  Calculated p-value 
Weight (kg) 70.52 (SD 16.39) 69.88 (SD 14.77) p=0.28 
BMI (kg/m2) 24.70 (SD 5.67) 24.48 (5.10) p=0.30 
140 
 
The correlation between the average estimated body weight for each patient and the calculated 
body weight was also measured. A significant positive correlation was found with r=0.88 and 
p=0.00(Spearman rank correlation; Figure 3.41). A similar correlation (r=0.87; p=0.00; Spearman 
rank correlation) was found when comparing BMI calculated with estimated body weight and BMI 
using calculated body weight (Figure 3.42, next page). The differences between the estimated and 
calculated weights and the estimated and calculated BMI values were non-significant (p=0.28 and 
p=0.30 respectively; T-test for dependent sample). 
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Figure 3.41 Correlation between estimated body weight and calculated body weight (p=0.00) 
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Figure 3.42  Correlation between BMI using estimated body weight and BMI using  
calculated body weight (p=0.00) 
 
 
3.7 HYPOTHESIS 
Data-analyses have shown that not all NRSTs can effectively predict clinical outcomes in adult 
patients admitted to the SICU of TAH. Consequently, the hypothesis for this study can be rejected. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: DISCUSSION 
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Nutritional risk screening is currently recommended for all hospitalised patients as a way to improve 
the recognition and treatment of malnourished patients.40,42 Malnutrition seems to be a serious and 
widespread problem with deleterious consequences among hospitalised patients and therefore 
early recognition and intervention is crucial.11  
Since ICU patients are hospitalised patients with an exceptionally high risk for disease-related 
malnutrition,11 they too should then be screened. However, very little is known about the use of 
NRSTs in critically ill patients. Are they feasible in this patient population? How well do NRSTs 
perform in these patients? This study was one of the first to investigate such imperative knowledge. 
The aims were to determine the NRSTs that could effectively predict clinical outcomes in critically ill 
patients and to comment on the applicability and feasibility of these tools in this setting. 
 
4.1 PATIENT DEMOGRAPHICS 
The present study included a higher number of males than females. A few studies among ICU 
patients have also reported a higher percentage of males in their study samples.24,33,187,189 The mean 
age of the study population was in general younger than previously seen.24,58,100 However, a large 
study found an almost exactly similar mean age among their ICU patient population.187 It has also 
been reported that surgical ICU patients tend to be younger189 and this correlates well with the 
larger percentage of non-elderly patients found in the present study. 
The study sample represented a heterogeneous population and included patients from various 
diagnostic specialties. The majority of patients were however admitted for gastrointestinal surgery. 
Sungurtekin et al. also reported that among their population of critically ill patients, the most 
common admission diagnosis were abdominal surgery.33 In terms of admission status, the present 
study had a larger percentage of emergency admissions than elective admissions. Similarly, this 
finding has been reported before.187 
Based solely on BMI status and using the WHO classification system for BMI3, almost half of the 
patients had a normal nutritional status (BMI 18.5–24.99) and only a small percentage had 
malnourished BMI classifications (BMI <18.5). It is clear that BMI alone is not sufficient to determine 
undernutrition. Interestingly, a large number of patients were also classified as overweight (BMI 25-
29.99)) or obese (BMI >30). This technically also classifies them as malnourished and may indicate an 
increased risk of complications, but this was beyond the scope of the research project. It does 
however highlight the challenge of nutritional risk screening in the ICU setting as overweight and 
obesity can easily mask loss of lean body mass. The average BMI of the study population was on the 
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border between normal nutritional status and overweight. Both Sorensen et al. and Sheean et al. 
found that the average BMI of their ICU patients fell into the overweight category.24,32 It seems that 
the study population in the present study was slightly leaner, but still on average well-nourished and 
not malnourished according to BMI status. 
 
4.2 CLINICAL OUTCOMES 
The average LOS of the study population was 5.75 days. Previous studies among ICU patients have 
reported mean LOS ranging from 1.6 to 8 days.58,187-189 The present study however excluded patients 
with a LOS of less than 48 hours and therefore it is expected that the average LOS would be towards 
the higher end of the range. The mortality rate for ICU patients in the literature ranges from 8 to 
23.4%.187,188 In the present study a much lower mortality rate of 2.44% was found. This can once 
again be explained by the exclusion criteria employed as well as the fact that the study population 
was younger and also less severely ill. A large study by Strand et al. reported that the median LOS in 
ICU before death occurs is 1.5 days.188 As the present study excluded patients with a LOS of less than 
48 hours (2 days), a large number of mortality cases could have been excluded. The study population 
was also younger than many other ICU study samples reported on. It is a well-known fact that 
increased age is a risk factor for mortality, while younger patients are less likely to die.31 Similarly, 
illness severity scoring systems such as the APACHE II scores are good predictors of mortality.189 The 
present study population had a mean APACHE II score of 10.41 which is 7.1 to 12.7 points lower than 
the mean APACHE II scores seen in other ICU populations.189 A lower APACHE II score lowers the risk 
of mortality. It is unclear why APACHE II scores were lower in this study population. However, 
analysis of the excluded patients reveals that a large number of patients with higher APACHE II 
scores were eliminated from data-analysis. It is also possible that patients with higher APACHE II 
scores were excluded in the beginning based on the exclusion criteria used in this study (SICU stay of 
< 48 hours). 
More than half of the ICU patients developed at least one complication during the course of their 
ICU stay and those that developed complications were more likely to experience moderate or severe 
complications. Previous complication rates for non-ICU patients have ranged from 15 to 
28%.24,49,88,96,98,121 It is however expected that the rate of developing complications would be higher 
in ICU patients as these patients are more severely ill. Also, studies differ in terms of methodology 
and the specific complications that are evaluated, which could further explain the discrepancies 
seen. 
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As expected the mean-minimum s-albumin levels were well below normal in the present study. 
Critical illness is known to decrease s-albumin levels by causing capillary leakage and negatively 
affecting the rate of synthesis and degradation. Dilution of serum-levels may also occur due to 
administration of large fluid resuscitation volumes.190 The maximum WCC and CRP levels on the 
other hand were increased above normal. This is also expected as trauma, infection and 
inflammation may lead to a rapid increase of these immunological and acute phase markers.191 
 
4.3  PREVALENCE OF MALNUTRITION 
4.3.1 General prevalence of malnutrition 
In general the rates of malnutrition found with the various screening tools tend to correlate well 
with the rates reported in the literature for ICU patients, while it tends to be higher than what is 
reported for the general hospital environment. The rate of malnutrition or risk of malnutrition found 
in this study ranges from 35.93 to 82.04% depending on the screening tool used. This range falls in 
the malnutrition range of 29-100% reported in the literature for ICU patients.11,31-33 The MNA-SF, 
NRS-2002, NRI and MST screening tools showed the highest malnutrition rates (69.41-82.04%) which 
is higher than the range of 20-59% reported in the literature for general hospitalised patients.13-21,23-
25,38,39 It is however expected that the rate of malnutrition for ICU patients would be higher than in 
the general hospitalised population,11 as is also shown by the rate of 29-100% reported for ICU 
settings. The ICU setting poses a unique risk for malnutrition due to the prevalence of inflammation, 
hypermetabolism and hypercatabolism induced by critical illness.6,7 Furthermore, ICU patients are 
often dependent on alternative methods of feeding such as enteral or parenteral nutrition which are 
not always administered immediately and at full volume. Feeds are also often interrupted to allow 
for medical or surgical procedures.6,7,11 These factors inhibit the provision of adequate energy and 
nutrients that are vital to attenuate the effects of critical illness and therefore contribute to the 
development of malnutrition. The MUST, SNAQ and SGA showed slightly lower rates of malnutrition 
(35.93-49.03%) which correlates with both the ranges found for ICU and general hospitalised 
patients. 
4.3.2 Prevalence of malnutrition according to the MUST 
The MUST classified 18.93% of patients as at risk of malnutrition and 30.10% as malnourished. This is 
similar although towards the higher end to what has previously been reported in general 
hospitalised patients (10-25% and 18-41% respectively).16,39,46,48,50,54,56-59 The prevalence of 
malnourished patients is however much lower than the 77% that was found in another ICU sample.58 
This was however a small study that included only 13 critically ill patients of which 3 were classified 
146 
 
as well-nourished and 10 as malnourished. No other ICU comparisons are available. It is speculated 
that the MUST tends to overestimate malnutrition and underestimate risk of malnutrition in critically 
ill patients.39,49 This is due to the recommendation that an acute disease effect score of 2 should be 
given to all critically ill patients which would then routinely classify them as malnourished.46 This 
should be noted as one of the limitations to the MUST’s utility in hospitalised and especially critically 
ill patients.46 Not all critically ill patients are equally sick and therefore assigning an acute disease 
effect score of 2 to everyone could overestimate the prevalence of malnutrition. A system for 
grading disease severity is necessary. For the present study, the researcher decided not to routinely 
assign a score of 2 to all critically ill patients. The patients were evaluated as per protocol for general 
hospitalised patients where an acute disease effect score of 2 was given for the presence of acute 
disease with the addition of no nutritional intake for >5 days. This was done to avoid the 
overestimation of malnutrition and could explain the lower rate of malnutrition found. The 
prevalence of risk of malnutrition is however much higher than the zero rate reported in the other 
ICU study,58 indicating that the results of the present study may be a more accurate reflection of 
nutritional risk in an ICU setting. 
4.3.3 Prevalence of malnutrition according to the MNA-SF 
Overall the MNA-SF classified 52.91% of patients as at risk of malnutrition and 16.50% as 
malnourished. Only one study using the newer version of the MNA-SF in hospitalised patients is 
however available for comparison. The study by Vischer et al. included elderly hospitalised patients 
of which a slightly greater percentage (26%) were classified as malnourished and a similar 
percentage (51%) classified as at risk of malnutrition.75 The fact that the study only included elderly 
patients could however explain the higher rate of malnutrition. Hospitalised elderly patients are 
known to present with increased risk of malnutrition.62 When only the elderly patients in the present 
study were analysed, a somewhat higher percentage of patients were classified as at risk of 
malnutrition (60%) and as malnourished (20%), more in line with the findings by Vischer et al. 
To compare the malnutrition rate with the results from studies using the older version of the MNA-
SF, the group at risk of malnutrition and the malnourished group have to be added together. Doing 
this, 69.41% of patients from the present study can be considered as nutritionally at risk and this 
falls toward the higher end of the 28-73% reported in the literature.49,76-78,84,86,88 This can partially be 
explained by the fact that previous studies only included general hospitalised patients and a higher 
rate of malnutrition is to be expected in ICU patients.11 Then, when looking at the scoring of the 
question on recent weight loss it is possible that the patients in the present study may have scored 
lower than usual (a lower total score indicates malnutrition). The MNA-SF provides an option for 
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when the prevalence of weight loss is unknown. Choosing this option gives the patient a score of 1 
which is lower than the score for no weight loss or moderate weight loss of 1-3kg and just higher 
than the score for >3kg weight loss.65 Due to the fact that 75.73% of the study population could not 
provide information on recent weight loss it is reasonable to presume that a large number of the 
patients scored at least 1 point less than what they would have if they could have quantified their 
recent weight loss. This could have lead to a higher number of patients scoring less than 12 total 
marks and being classified as nutritionally at risk. 
4.3.4 Prevalence of malnutrition according to the NRS-2002 
The NRS-2002 classified 72.82% of patients as malnourished. This is much higher than the range of 6-
42% reported in the literature for non-ICU hospitalised patients.24,30,54,93-99,101-107 Looking at the NRS-
2002 screening protocol it can be expected that ICU patients will score higher than general 
hospitalised patients. According to the protocol, patients requiring intensive care with an APACHE II 
score over 10, ventilation, inotropic support and whose protein requirements are increased to a 
level that is difficult to provide should receive a score of 3, which would automatically classify them 
as malnourished.53 In the present study, patients were not routinely assigned a score of 3, but were 
critically evaluated and scored according to disease severity. Therefore only 72.82% of patients were 
classified a malnourished and not a 100%. Three studies have previously used the NRS-2002 in ICU 
patients, but only two reported the rate of malnutrition found.24,100,105 The first was a multicentre 
Turkish study that included 1655 ICU patients and found that 52% of patients were malnourished.105 
The second was an international study that included ICU patients from four centres. The prevalence 
of malnutrition according to the NRS-2002 was 87, 93, 97 and 100% at the four centres 
respectively.24 The result from the present study is thus more in line with the prevalence of 
malnutrition seen in other ICU patient populations. 
4.3.5 Prevalence of malnutrition according to the SNAQ 
The SNAQ classified 6.8% of patients as at risk for malnutrition and 29.13% as malnourished. This is 
in line with the 5-14% of hospitalised patients previously reported as at risk of malnutrition and the 
7-29% reported as malnourished.54,130,132,133,135 It seems however that in the present study more 
patients were classified as malnourished and a smaller percentage as at risk for malnutrition. This 
may be ascribed to the fact that the SNAQ has only previously been studied in non-ICU patients, 
making comparison challenging. The SNAQ does not include a question on disease severity, but it 
does include a question on the use of enteral nutrition where patients who have received a 
supplemental drink or tube feed in the past month will score an extra point.130 ICU patients, who are 
highly likely to receive enteral or parenteral nutrition,7 may thus easily score an extra point here 
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which would increase their likelihood of being classified as malnourished. Nonetheless, the SNAQ 
still classified the lowest number of ICU patients as at risk of malnutrition or malnourished, when 
compared to the other NRSTs. 
4.3.6 Prevalence of malnutrition according to the SGA 
The SGA classified 30.58% of patients as moderately malnourished and 18.45% of patients as 
severely malnourished. The percentage of patients classified as moderately malnourished correlates 
well with the 10-59% previously reported in general hospitalised patients and the 22-46% reported 
for ICU patients. The percentage of patients classified as severely malnourished also correlates with 
the 0-42% previously reported for general hospitalised patients, but is higher than the 5-11% 
previously reported for ICU patients.16,21,117,138,144,146,148,149,152,157,161,163,175-178,192 The range for ICU 
patients is based on the results from three studies conducted in ICU settings.31-33 However, all three 
were small (n=55, n=57, n=124) and included medical ICU patients only or a mix of medical and 
surgical ICU patients, whereas the present study included only surgical ICU patients. Patients 
undergoing surgical procedures are known to have high rates of malnutrition17 and this could explain 
why the results from the present study indicate a higher prevalence of severe malnutrition. Almost 
half (43.69%) of the study participants were admitted post-gastrointestinal surgery, a clinical 
condition associated with malnutrition rates of up to 82%.11,23 
4.3.7 Prevalence of malnutrition according to the NRI 
The NRI classified 82% of patients with moderate and severe malnutrition which is the highest 
malnutrition rate found in this study and is also somewhat higher than the range of 24-68% reported 
in the literature.39,115,116,118-120 The NRI was developed for its use in surgical patients and most 
previous study samples have included surgical patients.109 The effect of surgery on s-albumin has 
thus been reflected in previous results and cannot explain why a higher rate of malnutrition is seen 
in the present study. The studies in the literature however did not specifically include ICU patients. 
The acute phase response, sepsis and other complications can cause a further decrease in s-albumin 
levels.9 It is thus possible for surgical ICU patients to have higher rates of malnutrition than surgical 
patients not requiring intensive therapy. However no data on NRI outcomes in critically ill patients 
specifically is available for comparison. 
4.3.8 Prevalence of malnutrition according to the MST 
The MST classified a high percentage of 78.16% patients as malnourished. This is roughly 20% more 
than the range of 18-55% found in the literature.51,54,125,127 Once again however, previous studies did 
not include ICU patients in their study populations. Another rationale for the high percentage of 
patients classified as malnourished may be found when looking at the question on weight loss 
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included as one of the components of the MST. The MST, similar to the MNA-SF, provides an 
“unsure” option for patients who are unsure whether they have lost weight or how much weight 
they have lost. In this case however, the unsure option gives a score of 2 to the patient, which is all 
that is necessary to classify them as malnourished.66 The high percentage of patients (75.73%) in the 
present study not sure of their weight loss history can thus easily explain the high rate of 
malnutrition seen. The 78.16% may therefore not be an accurate reflection of malnutrition, but 
rather a reflection of the number of patients unsure about previous weight loss. 
 
4.4 THE ABILITY OF NRSTs TO PREDICT CLINICAL OUTCOMES 
The present study looked at the relationship between NRST classification at admission and clinical 
outcomes observed during ICU stay. This concept of associating nutritional status with clinical 
outcomes such as morbidity, mortality and LOS is not new and has been used frequently to assess 
the performance of NRSTs.22,24,49,50,56,59,70,88,92,93,96,102,146,167,170 Studying these relationships may be 
particularly valuable if other measures of performance are challenging e.g. a gold standard measure 
of nutritional status for comparison is lacking. Currently, very little data is available on the use of 
NRSTs in an ICU setting and a gold standard measure of nutritional status in this setting is certainly 
absent. It was therefore decided to study the relationship between nutritional status and clinical 
outcomes as way of assessing the performance each NRST. 
In general the NRSTs studied here could not effectively predict clinical outcomes in ICU patients. In 
most cases a malnourished or at risk of malnutrition classification was significantly associated with 
only one or two clinical outcomes. Furthermore, the non-significant trends seen did not always 
consistently indicate poorer outcomes for the malnourished patients. Only the NRS-2002 and MST 
showed adequate potential for predicting clinical outcomes in this setting as they reliably 
determined the group of patients with more adverse outcomes. Still, these trends did not always 
reach significance and therefore it is difficult to make final conclusions. 
4.4.1 MUST 
The MUST fared poorly and its malnutrition and malnutrition risk classifications either alone or 
combined were not significantly associated with any of the clinical outcomes. There appeared to be 
a few trends for malnourished or at risk of malnutrition patients to have more unfavourable 
outcomes, but these could not reach significance and were not consistently shown. In some cases 
the at risk of malnutrition patients or the well-nourished patients actually showed worse outcomes 
than the malnourished patients, although this was not significantly proven either. The findings are 
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similar to those seen in a large study (n=705) in a mixed hospital patient population. In this study the 
researchers could not find any predictive validity of the MUST with regard to LOS, mortality or rate 
of complications.49 
In contrast to this, a few smaller studies in general hospitalised patients have found an association 
between MUST classification and particularly LOS.16,22,50,51 In the present study a trend for longer LOS 
was seen when the group at risk of malnutrition was combined with the malnourished group and 
compared to the well-nourished group. A similar trend was seen when the two malnutrition groups 
were split, but in this case the group at risk of malnutrition had the longest LOS. The MUST may 
therefore be able to effectively predict LOS between individuals who are well-nourished and those 
who show some degree of malnutrition but not between different levels of malnutrition, although 
this would still have to be proven significant. This would correlate with the results reported by 
Amaral et al. and Velasco et al. who found that the at risk and malnourished MUST classifications 
together had a significantly increased LOS compared to the well-nourished classification.16,51 
However Kyle et al. were able to show that all three MUST classifications are predictive of LOS in 
medical and surgical hospitalised patients. In this study a cut-off of 11 days was used to define a long 
LOS, which might explain why different results were seen.22 In the present study LOS was analysed as 
a continuous variable and not as a categorical variable. Stratton et al. also demonstrated an 
association between LOS and all three MUST classifications and in this case LOS was analysed as a 
continuous variable.50 Although these results are therefore more comparable, the study only 
included elderly patients admitted for acute care, which is a very unique patient population. In the 
same study, Stratton et al. also found an association between MUST classification and in-hospital 
mortality.50 This was not seen in the present study; in fact, the well-nourished patients showed a 
trend for the highest mortality. A similar disparity is seen when comparing the results for total 
complications to the study done by Velasco et al. Velasco et al. found that the group at risk of 
malnutrition and the malnourished group together had significantly more complications than the 
well-nourished group16, while in the present study the well-nourished group showed a trend (not 
significant) for the most complications. 
No data on the MUST’s ability to predict clinical outcomes in ICU patients is available for 
comparison. It is clear however that the MUST seems unable to effectively predict clinical outcomes 
in ICU patients. It can be argued that the MUST was initially developed for the community setting 
and that it may therefore be inappropriate for ICU patients. Still, since its initial development it has 
successfully been used in many hospital settings as well.46 Rather, it may be that the MUST is not 
sensitive enough to the unique risk of malnutrition found in critically ill patients. The first two 
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components of the MUST look at BMI and percentage of weight loss in the preceding 3-6 months 
and uses accepted cut-off values in its scoring system.46 These components have been shown as 
good indicators of nutritional risk.3,40 The third component looks at risk of decreased dietary intake 
and presence of acute disease together.46 Though both of these components are important 
determinants of nutritional risk, using them together i.e. both must be present before a score of 2 is 
added, might impair its ability to identify nutritional risk. Also, the presence of acute disease is not 
graded, the impact of existing chronic diseases is not measured at all and decreased dietary intake is 
only indicated when it exists for longer than five days. The critical care setting is clearly associated 
with acute disease, but not all patients are equally sick. Simply measuring the presence of acute 
disease might therefore overestimate risk. Ignoring the presence of ongoing chronic disease that 
might debilitate nutritional status might on the other hand underestimate nutritional risk. Lastly, it is 
well known that a large energy and protein deficit can rapidly develop in ICU patients due to 
increased requirements and the effect of metabolic stress.3 The international guidelines on feeding 
the critically ill currently recommend that nutrition support should be initiated early and 
requirements met within 3-4 days after ICU admission to prevent the development of malnutrition 
and its associated adverse outcomes.193-195 Using a cut-off of at least five days of poor intake as a 
determinant of nutritional risk is thus too lenient for an ICU setting and may underestimate the 
presence of nutritional risk. 
The developers of the MUST currently recommend the tool as appropriate for use in all health care 
settings,46 though the ESPEN screening guidelines still limit its clinical value to that of the community 
setting.40 While it may be used in other hospital settings with adequate reliability and validity, this 
study indicates that the MUST lacks predictive validity in critically ill patients. This, as well as the 
absence of any other knowledge on its validity in this setting, discourages the use of the MUST as a 
screening tool for ICU patients. 
4.4.2 MNA-SF 
In general the full MNA has been reported to lack predictive validity. The MNA-SF however, 
especially the most recent form that includes a classification for at risk of malnutrition, has not been 
studied widely in this regard and therefore it is difficult to make conclusions. However, considering 
the results of the present the study, it appears the MNA-SF is not able to adequately predict clinical 
outcomes in critically ill patients. 
Overall, the MNA-SF could only effectively predict WCC and s-albumin levels. A significant 
association was also seen between MNA-SF categories and CRP levels, but in this case the 
association was inversely related i.e. the well-nourished group showed the highest CRP levels. It is 
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rather interesting that the MNA-SF classification should be associated with biochemical values since 
the tool itself does not take any biochemical measures into account. To the author’s best knowledge 
this has not previously been demonstrated with the MNA-SF. A study by Vischer et al. has 
demonstrated a weak association with s-albumin levels but this was seen using the full MNA and not 
the short form. In this same study malnutrition according to the MNA was not associated with CRP.75 
Previous studies among general hospitalised patients were able to find some significant associations 
between MNA-SF categories and outcomes such as LOS, mortality and complications e.g. Putwatana 
et al. found that the MNA-SF could predict risk of post-operative complications in all adult 
abdominal surgical patients88 and Raslan et al. studied elderly hospitalised patients and showed that 
the MNA-SF was able to predict LOS, mortality and complications.49 These studies however did not 
include ICU patients. In the present study, a trend for longer LOS and more complications was seen, 
but this was not significant. The present study also did not find a significant or non-significant trend 
for higher mortality in the malnourished patients. This is similar to the study by Vischer et al. on 
elderly patients who also did not find an association between the MNA-SF and mortality.75  
It has been reported that the MNA and MNA-SF may not be sensitive enough to disease-related 
malnutrition. By design the screening tool measures common conditions found in elderly patients 
e.g. psychological stress, neuropsychological impairment and functional abilities. Although valid 
indicators of nutritional risk in elderly, these components are not the best measures for malnutrition 
brought on by the presence of acute disease.75 The MNA-SF may thus struggle to predict outcomes 
in a hospital setting where acute disease and comorbidities are abundant. 
Since the MNA-SF was designed for elderly patients, a subgroup-analysis of the MNA-SF was done 
for all patients ≥ 65 years. However, the MNA-SF did not fare any better when only these patients 
were studied. Once again only biochemical parameters such as s-albumin and WCC showed 
significantly worse trends for the malnourished or at risk of malnutrition patients. The other 
outcomes studied (except mortality) were also systematically worse for the at risk of malnutrition 
and malnourished patients, but this could not reach significance. 
The MNA-SF is supposed to be specifically sensitive to malnutrition in elderly patients.62 Conversely, 
the present study did not find that the MNA-SF could predict clinical outcomes any better in elderly 
patients than in the whole patient population. It seems that even in the elderly, the presence of 
disease-related factors play a bigger role in the etiology of ICU malnutrition, than the other risk 
factors measured by the MNA-SF. It is however possible that the group of elderly patients (n=45) 
was simply too small to detect statistical significance in the trends seen. A more adequately powered 
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elderly subgroup might detect more significant trends and could reveal greater predictive ability of 
the MNA-SF in these patients. 
4.4.3  NRS-2002 
When interpreting the NRS-2002 results one has to bear in mind that the well-nourished group 
consisted of only one patient. This patient did not show any signs of decreased BMI, reduced dietary 
intake or recent loss of body mass nor was acute disease with increased nutritional requirements 
present and therefore the patient scored zero. Normally, this patient would have been eliminated 
during the initial screening phase of the NRS-2002.53 However, the initial screening phase was not 
conducted during this study, because it was assumed that all patients would progress to the second 
phase of screening based on their admission to the ICU (as indicated by the NRS-2002; see figure 
1.3). Even though the patient was therefore classified as well-nourished, he/she still showed poor 
clinical outcomes. In the results this reflects as a well-nourished “group” with worse outcomes than 
the malnourished or at risk of malnutrition groups, which may be misleading. 
The predictive ability of the NRS-2002 has been well studied. Not only was the NRS-2002 developed 
based on its ability to predict clinical outcomes, but a number of other studies have also shown 
positive results.24,53,92-97 However, this is the first study documenting the predictive ability of the 
NRS-2002 with regard to a number of clinical outcomes in ICU patients specifically. Leaving the one 
well-nourished patient out of consideration, the NRS-2002 showed the most potential for its ability 
to predict clinical outcomes in critically ill patients. In terms of significant results, associations were 
seen between NRS-2002 classification and APACHE II scores, LOV and mild, moderate and total 
complications and a trend for worse results for malnourished patients for all the other outcomes 
measured were also seen. 
The present study indicated that the NRS-2002 could predict the group of patients who would have 
significantly more mild, moderate and severe complications. This is similar to what was seen by 
Raslan et al. and Raslan et al. in two separate studies among general hospitalised patients (n=705 
and n=561).49,93 Schiesser et al. and Guo et al. also found increased rates of complications among 
their malnourished gastrointestinal surgery patients as classified by the NRS-2002.96,98 Moreover a 
large scale international study on 5051 hospital patients, including a small percentage of ICU 
patients (6.1%), also reported a higher rate of complications among the malnourished patients.24 
The present study also found that according to the NRS-2002 the malnourished patients had a 
significantly longer LOV and higher APACHE II scores than the patients at risk of malnutrition. With 
regard to LOV, the finding is not only statistically significant, but also clinically significant since the 
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difference between the two groups is more than two days of ventilation. A longer LOV may increase 
the risk of ventilator-acquired pneumonia and may lead to a longer LOS which may account for 
increased hospital costs.187 The association with APACHE II scores was also significant, but only when 
all three groups were compared and not when only the group at risk of malnutrition and the 
malnourished group were compared. Since LOV and APACHE II scores are mostly measured in 
critically ill patients and the NRS-2002 has not been widely studied in this patient population, no 
other data is available for comparison. 
The non-significant trends seen with the NRS-2002 all indicate worse outcomes in the malnourished 
group i.e. longer LOS, higher mortality, more severe complications, higher WCC and CRP levels and 
lower s-albumin levels. Except for biochemical outcomes, which have not been studied elsewhere in 
relation to the NRS-2002, these trends are generally seen among hospitalised patients. Three large 
scale studies reported a significantly longer LOS and higher mortality in their malnourished patient 
groups.24,49,93 Amaral et al., Guo et al. and Schiesser et al. likewise found a significantly longer LOS in 
their malnourished patient groups.95,96,98 Although the association with LOS was non-significant in 
the present study, the trend may still prove clinically significant. The malnourished patients had a 
mean LOS that was almost 2 days longer than the group at risk of malnutrition. A difference like that 
may have substantial cost-implications and to a certain extent proves the clinical utility of this 
screening tool. With regard to mortality the incidence of death may simply have been too low to pick 
up a significant difference between risk categories. All of the mortality cases were classified as 
malnourished by the NRS-2002, but since only five patients died in total the number is too small to 
prove statistical significance. 
The NRS-2002 is currently favoured by ESPEN as the best screening tool to use in hospitalised 
patients. This recommendation is based on the excellent results seen in terms of predictive ability, 
reliability and feasibility.40 It seems that the positive results may to some degree also be true for ICU 
patients. In the present study the NRS-2002 outperformed the other NRSTs in terms of predicting 
adverse clinical outcomes. Although not all of the associations seen were statistically significant, the 
malnourished patients consistently showed worse clinical outcomes than the patients at risk of 
malnutrition. The clinical importance of some of the trends seen further advocates the NRS-2002’s 
utility in this patient population. Although the results of the present study do not sufficiently prove 
the NRS-2002’s ability to effectively predict clinical outcomes in critically ill patients, it certainly 
shows potential and merits further investigation. 
The NRS-2002 has been praised for its recognition of disease-related malnutrition.93 The screening 
tool includes measures of general malnutrition i.e. BMI, weight loss and decreased dietary intake, 
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but also and with equal emphasis, measures the presence of acute disease. Furthermore, acute 
disease is graded according to the severity of the disease present.53 It seems that the focus on acute 
disease enables the NRS-2002 to more accurately identify malnutrition in ICU patients. It should be 
noted however that acute disease should still be graded in ICU patients. The present study did not 
routinely classify patients as malnourished based solely on their admission to ICU. Each patient was 
evaluated for disease severity using the prototypes outlined by the NRS-2002.53 
4.4.4 SGA 
The SGA classifications were significantly associated with a few of the outcomes studied, but 
considering the trends seen, could not effectively predict the group of patients who would 
experience worse outcomes. When all three classifications were studied, the general trend was for 
the moderately malnourished patients to experience the worst outcomes while the severely 
malnourished patients experienced the best outcomes. This was significant for LOS, LOV and mild 
complications and non-significant for APACHE scores, mortality, moderate, severe and total 
complications as well as CRP levels. 
The only outcome that was significantly and successfully associated with the SGA was s-albumin 
levels. These levels progressively declined as the SGA classification went from well-nourished to 
moderately and then severely malnourished. This trend has been seen previously in a large, 
multicentre Brazilian study by Waitzberg et al. as well as a smaller study by Wakahara et al.17,149 Both 
of these studies found that s-albumin levels decreased with a declining nutritional status. 
When the moderately and severely malnourished groups were analysed together and compared to 
the well-nourished group, the SGA seemed to fare slightly better with regard to predicting clinical 
outcomes. Although none of the trends were significant, the malnourished group consistently 
showed worse clinical outcomes than the well-nourished group. It seems therefore that the SGA is 
able to detect nutritional risk in critically ill patients, but that is struggles to grade the risk according 
to severity. However, the trend will still have to be proven significant before conclusions can be 
made. 
The results of the present study differ from previous studies that looked at the SGA’s predictive 
ability among other hospital patient populations. These studies generally found that the SGA is able 
to effectively predict the groups of patients who would present with significantly more 
complications, a significantly higher mortality and a significantly longer LOS.17,21,147,149,153,161,163,167 In 
comparison to this, the results are more in line with the findings from ICU patient populations where 
the SGA has been used. For example, Atalay et al. also found no association with LOS or mortality in 
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a subset of ICU patients (n=55) and the trend for higher APACHE scores among the malnourished 
patients was also not significant.31 Sungurtekin et al. also did not find a significant association with 
LOS and, in line with the present study, found that s-albumin levels were significantly lower in the 
severely malnourished group than in the well-nourished group. Sungurtekin et al. however found 
significantly higher APACHE II scores and mortality rates in the malnourished groups. Although a 
similar trend was seen in the present study, the association was not significant.33 Lastly, Sheean et al. 
also studied the SGA in a group of mechanically ventilated ICU patients. Although the primary goal 
was not to test the predictive ability of the SGA they did report that nutritional risk classifications 
were not associated with APACHE II scores.32 
Collectively, the available results on the predictive ability of the SGA in critically ill patients indicate 
poor performance. Although, Sheean et al. proved that the SGA is a reliable tool to use in this 
patient setting, they recommended that the validity of the tool should still be tested.32 In the 
absence of a gold standard measure of nutritional status with which to compare the SGA, a measure 
of the tool’s predictive ability can be used for validation. The results of the present study, which 
correlates with previous findings, indicate that the SGA is not a valid tool for critically ill patients. The 
association between malnourished patients and worse clinical outcomes is weak and only s-albumin 
levels are significantly and effectively associated with all three SGA classifications. 
The SGA was initially developed to determine the risk of patients developing nutrition-associated 
complications. The original study population did however not include ICU patients and could explain 
why it does not seem to perform well among the critically ill.138 It has also been reported that the 
SGA includes components which may not be accurately measured in critically ill patients e.g. loss of 
lean body mass may not be evident during the physical examination when fluid disturbances are 
present.32 Furthermore the SGA seems to accurately detect chronic malnutrition, but may struggle 
to detect acute changes in nutritional status.117 It does not include a measurement of disease 
severity as one of its components.43 Although chronic- or starvation-related malnutrition may exist 
and progress during ICU stay, it is of special importance to detect the risk of acute deterioration of 
nutritional status due to the presence of disease. It seems that the SGA may not be sensitive enough 
to disease-related malnutrition. 
Interestingly, the original SGA included a component that assessed and rated metabolic stress as 
either no stress present, mildly/moderately stressed or highly stressed. The authors however 
recommended excluding this question in the future since it did not seem to influence overall SGA 
rating and investigators found it difficult to rate.43 The present study therefore used the SGA form as 
recommended i.e. without the question on metabolic stress. It can be argued that metabolic stress 
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will play a greater role in ICU patients and that the question should therefore be included in the 
screening, but whether this will influence the overall SGA rating in this population is unknown. 
One of the SGA studies32 conducted in an ICU patient population used the older version of the SGA 
that included the question on metabolic stress. Even though metabolic stress was assessed in this 
study the prevalence of moderate and severe malnutrition seen (51%) was similar to the present 
study (49%) and the authors also did not find an association between SGA ratings and APACHE II 
scores. Furthermore, the well-nourished and malnourished groups had similar ratings of metabolic 
stress: mild/moderate stress was 82% and 83% respectively and high stress 18% and 17%. This may 
indicate that metabolic stress rating did not influence the overall SGA rating. It seem therefore that 
the SGA, with and without the question on metabolic stress, is of equal limited value in critically ill 
patients. 
4.4.5 SNAQ 
Only one study has previously looked at the ability of the SNAQ to predict clinical outcomes. This 
was a controlled trial that studied whether nutritional intervention according to the SNAQ protocol 
could reduce LOS in malnourished hospitalised patients. The authors were however unable to find a 
significant reduction when the dietary intervention group was compared to the control group 
receiving standard nutritional care. Only in a subset of the patients i.e. frail patients with reduced 
handgrip strength, a significant reduction in LOS was seen with the intervention group.130 There is 
thus a lack of information on the predictive validity of the SNAQ, both in ICU and general 
hospitalised patients. 
The present study did not find the SNAQ to have sufficient predictive validity in critically ill patients. 
Only two significant associations (LOV and CRP) were found when all three SNAQ classifications were 
compared to clinical outcomes and in both cases the malnourished patients had better results than 
the well-nourished patients. When the at risk of malnutrition and malnourished groups were 
analysed together and compared to the well-nourished groups the same significant trends were 
seen. The only effective prediction that surfaced was that the malnourished patients had 
significantly lower s-albumin levels compared to the well-nourished patients. This trend has not 
been studied or reported elsewhere. 
A 2006 literature review nominated the SNAQ as one of the two best NRSTs for use in hospitalised 
patients. This recommendation was based on its ease of use and high sensitivity and specificity seen 
in the literature.134 It seems though that the SNAQ may not be applicable for use in ICU patients as in 
the present study the SNAQ was unable to effectively predict clinical outcomes in the critically ill. 
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Possible explanations for the SNAQ’s poor performance include that it may lack sensitivity towards 
disease-related malnutrition since the screening process does not include a measure of disease 
severity. Also, the validity of the question on the use of enteral nutrition (tube feed or supplemental 
drink) in the past month can be queried.130 At face value the question appears applicable to ICU 
patients since a high number of ICU patients are dependent on such sources for dietary intake. 
However, contrary to general hospitalised patients where initiation of enteral nutrition is a definite 
sign of insufficient oral intake, ICU patients receiving enteral nutrition may actually have an 
increased dietary intake compared to those not receiving or tolerating feeds yet. The scoring of the 
question may thus predispose better nourished individuals to be classified as more malnourished. 
4.4.6 NRI 
Comparison between the NRI groups is troublesome since a large number of patients were classified 
as moderately and severely malnourished, while only 7 patients (3.4%) were classified as mildly 
malnourished or well-nourished. Nonetheless, LOV and LOS were highest in all three malnourished 
categories compared to the well-nourished group and overall the trends were significant. The NRI 
could however not effectively predict the malnourished groups with longer LOS and LOV. In both 
instances the mildly malnourished patients had the longest LOS and LOV followed by the severely 
and then moderately malnourished patients. None of the differences seen were however significant. 
It seems therefore that the NRI can identify nutritional risk, but that it struggles to grade severity of 
nutritional risk. It is also possible that the mildly malnourished and well-nourished groups were 
simply too small to allow adequate comparison. 
A few previous studies have compared NRI categories to LOS, but none have reported on 
associations with LOV. Similar to the present study, Filipovic et al., Sungurtekin et al. and Kuzu et al. 
found that mildly, moderately and severely malnourished hospitalised patients all had a longer LOS 
compared to the well-nourished patients. However they combined all three malnutrition categories 
and found a significantly longer LOS compared to the well-nourished patients.121,167,196 In the present 
study the well-nourished and mildly malnourished groups were combined in an effort to slightly 
enlarge the number of “well-nourished” patients. Compared to the combined moderately and 
severely malnourished group the “well-nourished” patients conversely had a slightly longer LOS. The 
difference of 0.37 days is however non-significant and even though the “well-nourished group” was 
slightly enlarged, it may still have been too small allow adequate comparison and to detect a 
genuine and significant trend. 
In the present study all five deaths were in the severely malnourished group. However, this was not 
significantly different from the other NRI classifications, most likely because the overall mortality 
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rate was too low to detect the difference. Only two small studies in gastric cancer surgery and 
obstructive jaundice patients respectively have previously reported an association between NRI and 
mortality: both found a significantly increased mortality in the severely malnourished patients 
compared to the well-nourished patients.111,116 The study on gastric cancer surgery patients however 
interpreted a p-value of 0.06 as significant.111 
With regard to rate of complications some previous studies have reported a significantly increased 
rate of complications among malnourished subjects compared to well-nourished subjects,118,120,121 
while others were unable to prove this.116,122 The present study found a tendency for all three 
categories of malnutrition to have more moderate, severe and total complications, but the trend 
was not significant. However, a worse nutritional status was significantly associated with lower s-
albumin levels. As s-albumin is one of the two components measured by the NRI to determine 
nutritional status, it is expected that a strong linear relationship will be seen between the two. Other 
studies using the NRI have found the same significant trend.117,119  
In summary, some similarities are seen when the results of the NRI are compared to studies done 
elsewhere. None of the studies were however conducted on ICU patients and therefore drawing 
conclusions is difficult. The group sizes of the different NRI categories also did not allow satisfactory 
comparison. The NRI appears to be able to predict the patients who could suffer from longer LOS, 
LOV and higher mortality, but a more adequately powered comparison is necessary before final 
assumptions can be made. 
With regard to the screening tool itself, the NRI seems to systematically classify surgical ICU patients 
as moderately or severely malnourished. This phenomenon most likely occurs due to the low levels 
of s-albumin seen in this patient population. It raises the question of whether the tool is clinically 
relevant, even if its predictive validity can be proven in a more adequately powered study. If the vast 
majority of patients are routinely classified as malnourished then the screening tool does not 
provide any useful information to help stratify nutritional risk in practice. The phenomenon 
alternatively points out that essentially the majority of ICU patients are at risk of malnutrition and 
that stratification may not be necessary. 
4.4.7 MST 
The MST showed good overall prediction trends: except for CRP levels, the malnourished patients 
had worse results for all of the outcomes studied. Only the trend for higher total complications was 
however significant, although the trend for increased APACHE II scores and WCCs almost reached 
statistical significance (p=0.07 and p=0.06 respectively). 
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The developers of the MST, Ferguson et al., found similar trends in their validation study among 408 
general hospitalised patients. They only studied LOS as an outcome, but also looked at the MST’s 
convergence with other measures of nutritional status such as s-albumin, WCC and CRP levels. In 
their study the MST could predict the patients with a significantly longer LOS and also the patients 
with the highest CRP levels and lowest s-albumin levels; the malnourished patients also had higher 
WCCs and this almost reached statistical significance (p=0.08).66 In the present study the association 
between malnutrition and a longer LOS was also seen. Although the association was not statistically 
significant, the 1.58 day increase in LOS may still be clinically relevant as this has substantial cost 
implications. If dietary intervention of patients classified as malnourished according to the MST can 
decrease LOS in ICU, it will go a long way in terms of reducing health care expenses. Two other 
studies have also looked at the MST’s ability to predict LOS. These studies did not analyse LOS as a 
continuous variable but used a cut-off of 7 and 8 days respectively as an indication of a long length 
of stay. Nevertheless, comparable to our study a non-significant trend for a longer LOS was 
seen.51,127 
Convergent with the study by Ferguson et al., the present study also found higher WCCs and lower s-
albumin levels in the malnourished patients. In both studies the association with WCC almost 
reached significance (p=0.06 and p=0.08) indicating that malnourished patients may be more 
severely ill with a higher immunological response to illness.66 In the present study s-albumin was not 
significantly lower in the malnourished patients, but there was still a nearly two point drop on 
average in the malnourished group. Ferguson et al. also found that malnourished patients had 
higher CRP levels that the well-nourished patients, but this was not seen in the present study.66 CRP 
was the only outcome studied where the well-nourished patients had worse results than the well-
nourished patients; however the difference was not statistically significant. The MST’s ability to 
predict biochemical measures has not been studied elsewhere, including not in ICU patients. 
The association with LOV and APACHE II scores has not previously been studied, mainly because the 
MST has not been studied in an ICU before. In the present study, similar to LOS, the malnourished 
patients had 1.59 days longer LOV than the well-nourished patients. Again this was not statistically 
significant, but it may still reveal a clinically significant relationship. The malnourished patients also 
had higher APACHE II scores indicating that they are more severely ill than their well-nourished 
counterparts. This association almost reached statistical significance (p=0.07). 
With regard to the development of complications, Putwatana et al. found a similar significant trend 
among abdominal surgery patients to the present study: The rate of post-operative complications 
was higher in the malnourished patient group. The significance however disappeared after adjusting 
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for other risk factors associated with increased post-operative complications such as presence of 
cancer, operative time, previous surgery, wound contamination, blood loss, s-albumin levels etc. The 
authors concluded that the MST (as well as NRS-2002 and MNA-SF) did not provide any additional 
information other than what is provided by the known risk factors for post-operative 
complications.88 Still, it can be argued that the MST provided a quick and easy way to establish the 
patients who would suffer more from post-operative complications without considering the wide 
range of other risk factors. Also, the purpose of nutritional screening is not only to identify risk but 
more to identify patients who could benefit from nutritional intervention. In theory, dietary 
intervention for patients classified as malnourished according to the MST should lead to improved 
outcomes such as decreased post-operative complications. 
The results seen in the present study indicate that the MST is able to predict the risk of developing 
complications in ICU patients. There is also a strong, though not significant, indication that the MST 
can recognize ICU patients who are more severely ill and have increased immunological responses. 
The MST can also predict the patients at risk of a clinically significant long LOS and LOV. Patients 
classified as malnourished according to the MST may thus benefit from nutritional intervention to 
help improve these clinical outcomes, although this would need to be studied in a randomized 
controlled trial first. 
The MST only measures two components of nutrition risk i.e. decreased appetite and unintentional 
weight loss. It does not measure disease severity or any biochemical parameters and therefore the 
association seen with APACHE II scores, s-albumin and WCC is strange. It seems that the 
combination of the two MST components and the specific cut-offs and scoring system used is able to 
identify more than just starvation-related malnutrition. 
The MST is different in the sense that it does not measure weight loss as a percentage of usual body 
weight but rather in kilograms ranging from 0-5kg, 6-10kg, 11-15kg and >15kg. Also, similar to the 
MNA-SF, it provides an option for when patients are unsure about weight loss. These patients are 
allocated a score of two which routinely classifies them as malnourished.66 The high prevalence of 
patients who were “unsure” about their recent weight loss in the present study therefore lead to 
almost 80% of the study population being classified as malnourished. Even though the MST 
systematically classified 4 out of 5patients as malnourished, it still seems to be one of the best NRSTs 
for predicting clinical outcomes in critically ill patients. A bigger sample size of well-nourished 
patients might allow for better comparisons in the future and may reveal more significant 
differences of the trends seen in the present study. 
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4.5 APPLICABILITY AND FEASIBILITY OF NUTRITIONAL RISK SCREENING TOOLS 
The clinical value of NRSTs is determined by how easily and accurately a screening tool can be 
administered in a given patient population. Furthermore, the information generated by screening 
should be clinically useful i.e. help to stratify patients in terms of nutritional risk in order to direct 
resource allocation and dietary intervention. It was therefore decided to comment on the feasibility 
and applicability of each NRST studied here in addition to a measuring their predictive abilities. As 
this was a secondary study objective the applicability and feasibility was not systematically 
measured for each screening tool; rather the general availability of information needed to complete 
the screening tools was measured. 
4.5.1 General feasibility of screening 
NRSTs could not be completed in 46 (18.25%) of the originally eligible 252 ICU patients. This was due 
to patients being unable to communicate with the researcher (due to ventilation, sedation, coma or 
confusion) and the necessary information not being available from other sources. This is a 
substantial number of failed screens and it means that roughly one in every five ICU patients cannot 
be screened using the NRSTs studied here. This factor alone raises questions on the applicability of 
the screening tools in this patient population. 
Previous studies have also reported failed screens among their patient populations, even in the 
general hospital population. Depending on the screening tool used and the patient population 
studied the rate of failed screens ranged from 1 to 19% and in some studies was even found to be as 
high as 32%, 41% and 62%.19,23,24,39,48,54,59,98,104,116,118,121,122 It appears that the rate of failed screens 
found in the present study is therefore not particularly high as it correlates well with what has 
previously been seen. Nonetheless, a number of strategies had to be put in place to attain the rate 
of successful screenings in this study. Most previous studies did not employ such strategies. 
The main reasons given for failed screens in previous studies was lack of anthropometrical data i.e. 
patients unable to be weighed or not knowledgeable about their current weight or weight loss 
history or patients unable to communicate with the researcher.19,23,24,39,59,98,104,116,118,121,122 In the 
present study the only reason for failed screens was patients being unable to communicate with the 
researcher and for whom no information could be gathered from other sources. With regard to 
anthropometry, surrogate measurements and estimations were used to obtain the necessary 
information so that this would not be a limiting factor. In line with other studies, patients who were 
able to communicate could provide general information on appetite, recent dietary intake and 
gastrointestinal symptoms. The only limiting factors were therefore ability to effectively 
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communicate or availability of the information from other sources such as the medical file or friends 
and family members. If patients had been excluded based on lack of exactly-measured 
anthropometrical data, then a very high rate of failed screens would have been seen and the study 
objectives would not have been met. 
Of the remaining 206 patients, almost another fifth could not effectively communicate with the 
researcher by the second day of ICU stay. This was necessary for the completion of the screening 
tools within 48 hours. Screening needs to be conducted as soon as possible after admission so that 
he screening outcomes can result in maximum benefits to the patient and hospital.40 The screening 
tools could however be completed in these patients as the information was gained from other 
sources. 
4.5.2 Availability of information from additional sources 
Other than providing information on illness severity, the medical file did not seem to be a good 
source of information needed for nutritional risk screening. Only in seven cases (3.40%) could the 
medical file provide all of the necessary information. Family members or friends fared slightly better 
at providing information such as dietary intake, recent weight loss and gastrointestinal symptoms 
and helped to screen 30 of the patients who could not communicate by day two. In total 46 patients 
had to be excluded as failed screens due to unavailability of NRST information, either from the 
patient themselves or from additional sources such as the medical file or family members and 
friends. It has to be noted that family members and friends were only questioned if they visited 
during day the first 48 hours after admission of the patient or if a telephone number was 
documented on the patient’s chart or medical file. When necessary, only one phone call was made 
for each patient as per study protocol, even if the call was unsuccessful in obtaining the information. 
It can be assumed that if repeat calls were made more information would have been gathered, but 
this would have been too much effort for screening purposes. The whole idea was to measure how 
readily available the screening information was. It seems that family members and friends could be 
an important source of NRST information and could increase the number of successful screens by 
almost 12% without it being too much effort. The medical file however does not provide sufficient 
information and only increased the number of successful screens by three percent. 
A previous study by Sheean et al. also reported on using alternative sources of information for 
screening mechanically ventilated medical ICU patients. They did not report the exact rate of 
successful screenings, but according to their article the majority of patients could be screened using 
the SGA. To gain the necessary information Sheean et al. used the medical file as well as a food and 
nutrition management software programme used by their institution. Once again they did not report 
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the exact amount of information available, but they mentioned that information such as height, 
previous weights, weight loss information and previous dietary treatment information could easily 
be gained from these sources.32 This was not the case in the present study. As mentioned above the 
medical file was a poor source of information and TAH does not use a comprehensive food and 
nutrition program, the likes of which they had access to. It seems therefore that the relevant patient 
information was more readily available to them, compared to the present study. Sheean et al. also 
mentioned that family members or friends were questioned if they visited during the screening 
window period, but this was secondary to the medical and nutrition information systems.32 Their 
study relied heavily on the available medical and nutrition information, whereas the present study 
found friends and family members to be most helpful in attaining NRST information. 
4.5.3 Feasibility and applicability of specific components of nutritional risk screening tools 
4.5.3.1 Anthropometry 
ICU patients are mostly bedridden and often also sedated or comatose, especially during the first 
day or two when screening needs to be completed. This challenges the applicability of some of the 
traditional screening tools as they require an accurate BMI measurement for which current weight 
and height is needed. For example, the MUST, MNA-SF and NRS-2002 use BMI as a measure of 
current nutritional status and therefore it was necessary to measure height and weight in the 
present study. 
It was decided to use self-reported height and weight as this has previously been shown to be good 
surrogate measures for the actual measurements and have been used in this regard before.24,49,55,58 
More than half of the included patients however did not know their current body weight (or were 
unable to communicate) and therefore it appears that self-reported measures are inadequate to 
complete nutritional risk screening in ICU patients. Too many patients are unable to communicate 
effectively or are not knowledgeable about their body weight. Previous studies among other hospital 
populations have reported similar problems i.e. failed screens due to patients not knowing their 
current weight or recent weight loss or gain history,19,24,39,59,98,104,116,118,122 or patients being unable to 
communicate.121  
Also, the medical file did not provide much assistance: current weight was documented in only 10 
patients. Thus, due to the lack of data on anthropometrical measurements it was necessary to use a 
surrogate measurement for height (forearm length or bed length) and estimate each patient’s body 
weight. These measurements were feasible in all patients and the validity and reliability thereof is 
discussed in Section 4.5.4. 
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4.5.3.2 Recent weight loss 
All seven screening tools studied included a measure of recent weight loss as an indicator of 
changing nutritional status. However, recent weight loss was not a feasible component to measure 
in this patient population. Less than a quarter of the patients were knowledgeable about their 
current as well as previous weights and therefore percentage of recent weight loss was mostly 
unattainable. Consequently, to enable more successful screenings, patients had to be asked to 
estimate their recent weight loss. Although this can be considered a limitation of the present study, 
this methodology has been used before in NRST studies.49,58 
Only the MNA-SF and MST accommodates patients who are uncertain about their weight loss history 
by providing an “unsure” option for the question on recent weight loss.65,66 Although this increases 
the feasibility of completing these NRSTs it may lead to an overestimation of nutritional risk. For 
example, in the case of the MST, choosing the “unsure” option automatically classifies a patient as 
malnourished.66 The MNA-SF measures more components than the MST and therefore the answer of 
one question does not carry as much weight. Still, the “unsure” score will already place the patient 
on the borderline of the at risk category where only one more unfavourable outcome can then lead 
to a worse classification.65  
Due to the large percentage of patients (>75%) for whom the “unsure” option had to be chosen, it 
can also be speculated that the question itself does not add value to the screening. Unintentional 
recent weight loss has been shown to be a good indicator of nutritional risk40, but if three quarters of 
the population are not able to accurately answer the question then the applicability of such a 
question is low. 
4.5.3.3 Physical examination 
The SGA was the only screening tool that assessed physical appearance as part of its screening 
procedure. Factors such as muscle wasting, fat wasting and oedema were assessed to provide 
information about current nutritional status.43 Although it was possible to conduct the physical 
examination in all critically ill patients, the validity of such findings has been questioned before. Fluid 
disturbances and obesity, both of which are common in ICU patients, are known to mask muscle 
wasting which may lead to an underestimation of malnutrition.32 A physical assessment may thus be 
a more feasible way to assess nutritional status, other than BMI measurements, but it may not 
always be a good indicator of nutritional risk. 
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4.5.3.4 Disease severity 
Disease severity was the most feasible and applicable component of nutritional status assessment 
included in this study. Information was easily obtained from the medical file in all cases and was 
consequently not limited by patients’ inability to communicate.  
Not all of the NRSTs included measured disease severity and those that did, did not measure it 
equally. The MUST and MNA-SF considers the presence of any acute disease as an indicator of 
severe illness and does not attempt to grade this.46,65 This is slightly problematic since almost all 
critically ill patients have a level of acute disease present, but not all are equally ill. The NRS-2002 on 
the other hand grades disease severity according to specifically defined prototypes. This might be 
more appropriate in critically ill patients as it differentiates between different levels of acute 
disease. 
The concept of malnutrition related to the presence of disease has been discussed previously. In the 
ICU setting the prevalence of disease-related malnutrition is high, probably more so than purely 
starvation-related malnutrition.3 It has been deduced that measurement of disease severity is a 
highly applicable component of nutritional risk screening in ICU patients. Since it is also highly 
feasible it could be recommended for assessing nutritional risk in the critically ill. An assessment that 
grades disease severity such as used in the NRS-2002 seems to be most applicable. 
4.5.3.5  Serum-albumin 
It seems that s-albumin levels are routinely measured in most surgical ICU patients. In the present 
study 85% of the included patients had s-albumin tests done during their ICU stay. It also seems that 
in the vast majority of cases the results were available within 48 hours for screening to be completed 
in time. Only 12.51% of the s-albumin results became available after 48 hours. 
The NRI is the only NRST that include s-albumin as one of its components to measure. The tool could 
not be completed in 30 patients due to no s-albumin tests done in these patients and therefore had 
the lowest feasibility of all the screening tools studied. As this was a non-invasive study, no 
additional bloods were drawn for laboratory tests. Kyle et al. and Schneider et al. also reported 
unsuccessful screens due to the unavailability of s-albumin values in their studies.39,118  However, a 
high number of NRI screens were still completed in the present study and most of them could be 
completed within the first 48 hours after admission. Also, the feasibility may be increased by 
insisting that s-albumin levels be tested within 48 hours for all ICU patients. This is not an 
unreasonable request since it is already routine practice in the large majority of patients. Whether 
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the request is justified however depends on the validity of the NRI in this patient population and if 
intervention based on screening outcomes could lead to improved patient care. 
The validity of s-albumin as a marker of nutritional status also has to be considered. As discussed 
previously, many factors other than nutritional status impacts on s-albumin levels. Especially in the 
critically ill the acute phase and inflammatory responses may lead to much lower than normal s-
albumin levels.9 In fact, in the present study, s-albumin levels were so low that only 1.70% of the 
study sample was classified as well-nourished according to the NRI. Using s-albumin for nutritional 
screening in ICU patients may therefore lead to overestimation of nutritional risk. Still, although it 
may not accurately reflect nutritional risk per se, s-albumin levels may be indicative of the level of 
inflammation present and the risk for developing adverse clinical outcomes.9,113 Low s-albumin levels 
for example, have been linked to adverse outcomes such as longer LOS, readmissions, more 
complications and higher mortality.9,111,114 It may thus be useful as a general indication of “risk”. 
Currently, screening guidelines by ASPEN recommends against the use of inflammatory markers for 
nutritional risk screening, mainly due to the lack of an accurate, nutritionally-related inflammatory 
marker.2 Even though s-albumin may be a feasible measure in critically ill patients its use as an 
indicator of nutritional status is thus not recommended. 
4.5.3.6 Dietary intake and GI symptoms 
Both dietary intake and GI symptom information was easily obtainable in patients who were able to 
communicate. It seems therefore that the only limitation with regard to feasibility is the ability of 
the patients to communicate effectively. 
4.5.4 Validity and reliability of weight estimations 
The difficulty in obtaining anthropometrical measurements was anticipated by the researcher and 
she therefore decided to also include surrogate measures for height (forearm length or bed length) 
and estimations of body weight in the study methodology. The surrogate measures used for height 
have been shown previously to be valid estimates of standing height.182 The concept of estimating 
body weight is also not a new practice; in the SICU of TAH estimating body weight is standard 
procedure for dieticians who need to calculate energy and nutrient requirements. Even physicians 
estimate body weight to calculate fluid requirements. A previous international research project has 
also successfully incorporated body weight estimations as part of the study methodology.24 
Nonetheless, due to the subjective nature of body weight estimations it was necessary to measure 
the validity and reliability of these “measurements”. 
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To verify reliability, the researcher and ICU dietician independently estimated body weight. A good 
and significant correlation was seen between the two estimates indicating good reliability. However, 
when the means of the two estimates were compared a significant difference was revealed which 
may be indicative of decreased reliability. Nonetheless, when BMI values were calculated from the 
weight estimates and compared between the two dieticians, the difference was less pronounced. 
This is of greater importance than the difference between the weights, since BMI is used to 
complete the screening tools and not body weight. It seems therefore that the reliability of the body 
weight estimates is adequate. 
The average of the dieticians’ estimates was used as the average estimated body weight for each 
patient. BMI was calculated from the average estimated body weight and used for screening 
purposes. To verify the validity of the average estimated body weight an objective measurement of 
body weight was used as comparison. This measurement uses KH and MUAC in a formula to 
determine body weight and is recommended for use as a surrogate measurement in bedridden 
patients.183 Comparison between the estimated and calculated variables (weight and BMI) revealed 
no significant differences. This indicates that the average estimated body weight, derived from the 
two dieticians’ estimations, is a valid estimate of body weight. The same applies to the BMI 
measurements. Additionally, strong correlations were found between the estimated and calculated 
body weights and BMIs which further indicates sufficient accuracy. 
 
4.6 EXCLUDED PATIENTS 
It is important to consider the group of patients who were eligible for screening, but in whom 
screening could not be completed due to insufficient information available. They represent a group 
of patients in whom nutritional risk screening appears to be unfeasible. 
The excluded patients differed significantly from the included patients in a number of aspects. First 
almost the entire excluded patient population were emergency admissions; only one patient was an 
elective admission. It seems therefore that nutritional risk screening is much more challenging in 
emergency ICU admissions. It is possible that these patients are more likely to be ventilated, sedated 
or comatose and that they are therefore less likely to be able to communicate within 48 hours. It is 
interesting that the diagnostic categories between the included and excluded patients did not differ 
significantly. This means that the emergency admissions represented the whole spectrum of 
diagnostic categories and not just one group e.g. trauma patients. The excluded patients had a 
similar mean age to the included patients, but significantly more of the excluded patients were 
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classified into the below 65 years age bracket. This implies that non-elderly patients may be more 
difficult to screen in an ICU. 
With regard to patient outcomes, the excluded patients seemed to be more critically ill and 
presented with much worse clinical outcomes than the included patients. The excluded patients had 
significantly more total complications and were also more likely to present with moderate or severe 
complications. They also had a much higher APACHE II scores. On average the excluded patients also 
required almost 7 days longer ventilation and stay in ICU. Furthermore, the excluded patients 
presented with a greater increase in inflammatory markers such as WCC and CRP levels and lower s-
albumin values. 
The important question to ask is what do these findings imply for nutritional risk screening in the 
ICU? First, it is clear that screening may be less feasible in a specific group of patients i.e. non-
elderly, emergency admissions. It may be unfeasible to screen up to a third of the emergency 
admissions. Second, it appears that the group of patients not screened ise actually that with the 
greatest risk of poor clinical outcomes. It is likely that they were more prone to malnutrition and that 
they may have benefited from nutritional intervention. In totality the results indicate that nutritional 
risk screening has low feasibility in the group of patients that appear to need it most. 
Even though some of the NRSTs studied here may show some predictive validity in an ICU setting, it 
seems that the clinical applicability of these NRSTs is low. The screening tools may identify patients 
with increased risks for adverse clinical outcomes, but they are unable to identify the patients with 
the highest risks due to the fact that cannot be completed in these patients. 
 
4.7  STUDY LIMITATIONS 
Studying NRSTs in ICU patients presented a huge challenge in terms of methodology. First, many of 
the patients could not communicate by day two and therefore could not be screened.  This meant 
that they had to be excluded from data-analyses which lead to a somewhat smaller study sample 
than anticipated. The exclusion of certain patients could also have lead to a biased included patient 
population which might have affected the study results. The excluded patients were in general more 
severely ill and showed worse outcomes than the included patients. However, the forced exclusion 
of certain patients illustrated an important point: nutritional risk screening is not possible in all ICU 
patients, especially patients who are prone to experience more unfavourable outcomes and are 
therefore more likely to be malnourished. 
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Second, due to the fact that the patients studied were mostly bedridden, surrogate measurements 
had to be performed for anthropometry. A previously validated method was used to measure 
height, but weight had to be visually estimated. Although visually estimating weight is not a new 
practice, it is a subjective method for determining body weight which poses an increased risk for 
inaccuracy. Strategies were however put in place to minimize inaccuracy and to measure the validity 
of estimations. The average estimated weight showed good correlation and no significant difference 
to an objective measurement of weight used to control for accuracy. This indicates that although a 
subjective method was used, it had acceptable accuracy. The objective method is considered too 
elaborate for screening purposes and therefore it was decided to only use it as a control measure. 
Very few patients were able to specify their current as well as previous weights which were needed 
to calculate weight loss trends. In order to complete screening the patients were thus asked to 
estimate their own weight loss in terms of mild, moderate or severe. This might not have been an 
accurate reflection of weight loss trends and can be considered a limitation of the present study. 
The methodology for completing the MUST tool was altered slightly. It was decided not to routinely 
assign a score of two for disease severity to all ICU patients as this would have resulted in a 100% 
malnutrition rate and would not have allowed for comparison among groups. This methodology has 
also previsouly been reported to overestimate malnutrition among critically ill.39,49 Rather, the usual 
protocol for scoring disease severity in hospitalised patients was followed i.e. a score of two was 
assigned to acutely ill patients who had or were likely to have no nutritional intake for five or more 
days.46 It was anticipated that this would provide a better estimate of nutritional risk in the patient 
population. This reasoning has also previously been used in another ICU population.58 Still, changing 
the way a NRST is applied could impact on its validity and the validity of the results found here and it 
could therefore be considered a limitation. Either way, the MUST does not seem like an appropriate 
NRST for ICU patients. Had the recommended scoring for ICU patients been applied it would have 
provided no useful screening information and using the standard method has shown no positive 
results for the MUST. 
Other than methodological issues, the study results were not favourable in terms of determining the 
relationship between nutritional status and mortality. Only five cases of death occurred in the 
included patients representing a 2.44% mortality rate. Although trends were still analysed, no 
significant associations were seen, most likely because the mortality rate was too low. Furthermore, 
the groups of patients within the different risk categories of each screening tool were not always 
evenly numbered. Some groups were small and made comparison between the different risk groups 
difficult. This especially affected the NRI screening tool where a very small percentage of patients 
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were classified as well-nourished or mildly malnourished. This hampered comparing the well-
nourished patients to the malnourished patients and as such the NRI did not perform very well. It 
could be worth exploring the predictive ability of the NRI in more adequately powered risk groups. 
Lastly, the fact the study population represented a heterogeneous group of patients could have 
impacted on the results. The NRSTs studied may have performed differently among certain groups of 
patients with similar diagnoses. However, the objective of the study was to assess the predictive 
ability of NRSTs in the broad ICU patient population and therefore this aim was met. It is however 
recommended that the NRSTs are studied among ICU subgroups in future projects. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 5: CONCLUSION AND RECOMMENDATIONS 
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5.1 CONCLUSIONS 
This study aimed to shed light on the use of NRSTs in ICU patients, specifically their ability to predict 
unfavourable clinical outcomes and their feasibility in this setting. Although the results presented 
here do not provide conclusive evidence on the topic, a number of important findings were made 
that can direct future investigation and implementation. 
 
First it can be concluded that only two of the NRSTs studied here showed potential ability to predict 
clinical outcomes in ICU patients. Both the NRS-2002 and MST could effectively determine the 
patients who experienced more unfavourable outcomes. LOV, APACHE II scores and the 
development of complications were significantly worse in the malnourished group according to the 
NRS-2002, while the malnourished group according to the MST had significantly more complications 
and borderline significantly higher APACHE II scores and WCCs. Although the rest of the predictions 
seen were not significant, these two screening tools consistently predicted worse results in the 
malnourished groups for all of the outcomes studied (except CRP in the MST). Furthermore, in terms 
of LOS the clinical significance of a 1.5-2 day longer LOS in the malnourished groups cannot be 
ignored. Still, more conclusive evidence is needed before the use of these screening tools for ICU 
patients can be validated. 
 
The remaining screening tools (MUST, SNAQ, SGA, NRI and MNA-SF) could not effectively predict 
clinical outcomes in ICU patients. They showed inconsistent trends for worse outcomes in the 
malnourished patients and in some cases significantly more favourable outcomes in the 
malnourished patients. Furthermore, a stepwise worsening of outcomes was not always seen for the 
different risk categories e.g. in some cases the at risk or moderately malnourished patients showed 
worse outcomes than the severely malnourished patients. 
The second conclusion that can be made is that existing NRSTs do not appear extremely feasible in 
ICU patients. Although the NRSTs included in this study are generally regarded as applicable for use 
in hospitalised patients, they all include components of nutritional risk screening that are challenging 
to measure in the critically ill. This may prevent up to a fifth of ICU patients from being screened. 
Although it can be argued that screening is still feasible in at least 80% of the population, it appears 
that the patients systematically excluded from screening are the ones specifically at risk of 
malnutrition. These patients presented with far worse clinical outcomes which may indicate an 
increased likelihood of malnutrition and a need for nutritional intervention. It seems therefore that 
nutritional risk screening is not adequately feasible in ICU patients who need it the most. The main 
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factor preventing screening was patients not being able to communicate effectively due to sedation, 
coma, confusion or mechanical ventilation. 
Third, with regard to the different components of screening, only one stood out in terms of excellent 
feasibility and applicability i.e. measurement of disease severity. Information on this component is 
easily obtainable from medical resources and no patient-interviewer communication is needed. In 
addition, it forms a vital part of screening for disease-related malnutrition. Two other screening 
components, s-albumin and physical examination for loss of lean body mass or fat wasting, have 
acceptable feasibility, but may lack clinical applicability. Both of these components can easily be 
measured in critically ill bedridden patients, but the accuracy of the findings in terms of indicating 
nutritional risk is questionable and their use is not currently recommended. 
Anthropometrical measurements were the least feasible since all patients were bedridden and few 
could self-report their own measurements. However, it seems that the surrogate measurements or 
estimations employed in this study can be used with acceptable accuracy. All other screening 
components (appetite and dietary intake, GI symptoms, functionality) required a patient that could 
effectively communicate. If communication was possible, then most of the information could easily 
be obtained. The only problem was obtaining recent weight loss information since very few of the 
patients could report on that and it did not seem to be documented in the medical file. In general 
the medical file was a very poor source of nutritional information and friends and family members 
were only available and able to provide information to a certain degree. 
Lastly, one of the most important findings in the present study is the high rate of malnutrition 
prevalent among critically ill patients. Depending on the screening tool used, 35.93 to 82.04% of the 
study population was either at risk of malnutrition or malnourished. Both the NRS-2002 and MST, 
the NRSTs that showed the best predictive validity in this study, identified more than 70% of the 
study population as malnourished. This raises an important question: is screening for nutritional risk 
necessary in a population where most of the patients are likely to be at high risk of malnutrition? 
According to Elia et al. screening might be of limited value in this situation.12 Screening takes up time 
and effort, especially if it requires anthropometry and complex calculations, which may not be 
justified if the majority of patients are known to be at risk. Furthermore, as most patients will be 
classified as malnourished and subsequently require dietary intervention; the information provided 
by nutritional screening may not be clinically helpful in terms of allocating resources. It is however 
possible that the screening tools studied here were simply not able to stratify nutritional risk 
adequately. These tools were developed for general hospitalised patients and may therefore not be 
sensitive enough to ICU malnutrition. 
175 
 
In summary, it seems that most of the NRSTs studied here are not able to effectively predict clinical 
outcomes in critically ill patients. Only the MST and NRS-2002 have shown adequate potential for 
predicting clinical outcomes and may be worth exploring further. In addition, nutritional risk 
screening is unfeasible in a number of patients, especially those who seem to be most at risk for 
malnutrition. Together with the fact that the screening outcomes may provide little information 
other than confirming that most patients are malnourished, the findings illustrate the limited value 
of the NRSTs studied here. There is a need for a screening tool that is feasible in all ICU patients and 
that is able to stratify nutritional risk to such a degree that it may direct dietary intervention and 
resource allocation more effectively. So far, the only screening component that has shown potential 
for inclusion in such a tool, is a measure of disease severity. 
 
5.2 RECOMMENDATIONS 
 Since the NRS-2002 and MST fared best in predicting clinical outcomes, it is recommended 
that these tools should be investigated further. Their predictive validity should be explored 
in other ICU populations, including medical ICU patients. Furthermore, the convergent 
validity of the two tools as well as their reliability in ICU patients should be explored. 
 The ICU population studied represented a heterogeneous group of patients. It is possible 
that some of the screening tools studied could perform better in specific patient groups e.g. 
specific diagnostic or age groups. It is therefore recommended that the data from the 
present study be analysed for different subgroups of patients or that future studies focus on 
more homogeneous groups of ICU patients. 
 One of the best ways to validate screening tools is to test their performance in a randomized 
controlled trial. Studies should be designed to test whether specialised dietary intervention 
is able to attenuate the prevalence of adverse clinical outcomes in malnourished 
intervention patients versus malnourished control patients. Positive results will go a long 
way to proving the clinical benefit of screening ICU patients. Both the NRS-2002 and MST 
can be studied in this regard. 
 Lastly, since none of the NRSTs studied here showed excellent feasibility and applicability, it 
is worth exploring the use of other screening tools in ICU patients or the development of a 
completely new screening tool. In terms of screening components it is recommended that 
disease severity be included in such a tool as it has shown high feasibility and applicability in 
this patient setting. 
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ADDENDUM 1: DATA EXTRACTION FORM 
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Hospital admission date                         To ward            
ICU admission date                                 Time                 
ICU discharge date                                 To                  
LOS      LOV   
Death   Y N  APACHE: 
 
Medical diagnosis Medical history History since admission Previous medication 
 
 
 
 
 
   
               
 Day 0 Day 1 Day 2 Day 3 Day 4 
Complications      
Treatment      
 
 
patient sticker 
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 Day  Day  Day  Day  Day  
Complications      
Treatment      
 
 Day  Day  Day  Day  Day  
Complications      
Treatment      
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Estimated weight 1:              Estimated weight 2 :                 Race : W / n-W 
KH :                                                          MUAC:    Oedema  Yes / No 
Real weight:                  Method: Scale  /  patient reported  /  f/f reported /   file /    unknown 
Height:                                           Method: Lower arm   /   Bed length  
Oedema:   kg          Grading: None /  Mild  /  Moderate (Mod)  /  Severe (Sev) 
 
Usual weight                     kg   /   Unknown 
Weight loss 1mnths 0   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   >15   ? 
Weight loss 2mnths 0   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   >15   ?     
Weight loss 3mnths 0   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   >15   ?     
Weight loss 6mnths 0   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   >15   ?     
Weight loss 2wks  No change    Increase    Decrease 
METHOD OBTAINED: patient (pt)  /   file  /    family/friend (f/f)  /   unknown (?)    Indicate: precise  /  estimated 
 
Appetite ↓ No   Yes 
Intake ↓  No   Mod   Sev How long:                     
Severity:  Suboptimal Full liquid Hypocaloric liquid     Starvation 
Intake last week: <25% <50% <75% Normal     Next 5 days:  none >none 
Last month Tube feed       Supplemental drink       None    METHOD OBTAINED: pt    file    dr    f/f    ? 
 
GI symptoms >2weeks    None / Nausea / Vomiting / Diarrhoea / Anorexia    METHOD OBTAINED: pt   file   dr   f/f   ? 
 
Nutritional functional impairment  No    Mod     Sev        Last 2 weeks:    Same    Improved    Regressed 
Mobility  Good Mod Bed/chair bound      METHOD OBTAINED: pt    file    dr    f/f    ? 
 
Neuropsychological problems No        Moderate dementia     Sev dementia/depression 
Psychological stress/acute disease in last 3months No        Yes    METHOD OBTAINED: pt    file    dr    f/f    ? 
 
Albumin                   g/dL  Available day          
 
Subcutaneous fat  N Mild Mod Sev 
Muscle wasting  N Mild Mod Sev   
Oedema   N Mild Mod Sev   
 
When could patient communicate?  Day                 
Could patient quantify wt changes?  Yes No Not applicable (no weight changes) 
 
